REKOMENDACJE DOTYCZĄCE POSTĘPOWANIA W ZAKAŻENIACH MĘSKIEGO UKŁADU MOCZOWEGO I PŁCIOWEGO
GUIDELINES ON UROLOGICAL INFECTIONS

G. Bonkat (przewodniczący), R.R. Bartoletti, F. Bruyère, T. Cai, S.E. Geerlings, B. Köves, S. Schubert, F. Wagenlehner, Mezei, A. Pilatz, B. Pradere, R. Veeratterapillay Tłumaczenie i przygotowanie wersji polskiej / Translation and elaboration of Polish version: Marta Sochaj1, Jolanta Słowikowska-Hilczer2
Katedra Humanizacji Medycyny i Seksuologii, Uniwersytet Zielonogórski; 2 Zakład Endokrynologii Płodności, Katedra Andrologii
i Endokrynologii Płodności, Uniwersytet Medyczny w Łodzi
Autor do korespondencji / corresponding author:
Jolanta Słowikowska-Hilczer, Zakład Endokrynologii Płodności, Katedra Andrologii i Endokrynologii Płodności, Uniwersytet Medyczny
w Łodzi, ul. Pomorska 251. 92-213 Łódź, tel.: 42 201-41-42, jolanta.slowikowska-hilczer@umed.lodz.pl
Otrzymano/received: 25.11.2019 r. Zaakceptowano/accepted: 27.12.2019 r.
DOI: 10.26404/PAO_2353-8791.2019.08


Skróty / Abbreviations
i.m. – domięśniowo (łac. iniectio intramuscularis); LE – poziom wiarygodności dowodu naukowego (ang. level of evidence); PCR – łańcuchowa reakcja polimerazy (ang. polymeras chain reaction); p.o. – doustnie (łac. per os); PSA – swoisty antygen prostaty (ang. prostate specific antigen)

Piśmiennictwo

strong>Piśmiennictwo
Abbara A., Davidson R.N.: Etiology and management of genitourinary tuberculosis. Nat Rev Urol. 2011, 8 (12), 678–688. doi: 10.1038/nrurol.2011.172. https://www.ncbi.nlm.nih.gov/pubmed/22157940
Abrutyn E., Berlin J., Mossey J., Pitsakis P., Levison M., Kaye D.: Does treatment of asymptomatic bacteriuria in older ambulatory women reduce subsequent symptoms of urinary tract infection? J Am Geriatr Soc. 1996, 44 (3), 293–295. doi: 10.1111/j.1532-5415.1996.tb00917.x https://www.ncbi. nlm.nih.gov/pubmed/8600199
Abrutyn E., Mossey J., Berlin J.A., Boscia J., Levison M., Pitsakis P. i wsp.: Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med. 1994, 120 (10), 827–833. doi: 10.7326/0003-4819-120-10-199405150- 00003. https://www.ncbi.nlm.nih.gov/pubmed/7818631
Abughosh Z., Margolick J., Goldenberg S.L., Taylor S.A., Afshar K., Bell R i wsp.: A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol. 2013, 189 (4), 1326–1331. doi: 10.1016/j.juro.2012.09.121. https://www. ncbi.nlm.nih.gov/pubmed/23041343
Albert X., Huertas I., Pereiró I.I., Sanfélix J., Gosalbes V., Perrota C.: Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004, CD001209. doi: 10.1002/14651858. CD001209.pub2. https://www.ncbi.nlm.nih.gov/pubmed/15266443
Alexander R.B., Ponniah S., Hasday J., Hebel J.R.: Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/ chronic pelvic pain syndrome. Urology. 1998, 52 (2), 744–749. doi: 10.1016/ s0090-4295(98)00390-2. https://www.ncbi.nlm.nih.gov/pubmed/9801092
Alexander R.B., Trissel D.: Chronic prostatitis: results of an Internet survey. Urology. 1996, 48 (4), 568–574. doi: 10.1016/s0090-4295(96)00234-8. https://www.ncbi.nlm.nih.gov/pubmed/8886062
Aliaev Iu G., Vinarov A.Z., Akhvlediani N.D.: [Wardenafil in combined treatment of patients with chronic bacterial prostatitis]. Urologiia. 2008, 52–55. https://www.ncbi.nlm.nih.gov/pubmed/19256057
Andersen B., van Valkengoed I., Sokolowski I., Møller J.K., Østergaard L., Olesen F.: Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Sex Transm Infect. 2011, 87 (2), 156–161. doi: 10.1136/sti.2010.042192. https://www.ncbi.nlm.nih. gov/pubmed/21097811
Angeletti S., Dicuonzo G., Fioravanti M., De Cesaris M., Fogolari M., Lo Presti A. i wsp.: Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination. Dis Markers. 2015, 2015: 951532. doi: 10.1155/2015/951532. https://www.ncbi.nlm.nih.gov/ pubmed/26635427
Antibacterial prophylaxis in surgery: 2 - Urogenital, obstetric and gynaecological surgery. Drug Ther Bull. 2004, 42, 9. https://www.ncbi.nlm.nih. gov/pubmed/15067952
Arnold A., Aitchison L.P., Abbott J.: Preoperative Mechanical Bowel Preparation for Abdominal, Laparoscopic, and Vaginal Surgery: A Systematic Review. J Minim Invasive Gynecol. 2015, 22 (5), 737–752. doi: 10.1016/j. jmig.2015.04.003. https://www.ncbi.nlm.nih.gov/pubmed/25881881
Aron M., Rajeev T.P., Gupta N.P.: Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study. BJU Int. 2000, 85 (6), 682–985. doi: 10.1046/j.1464-410x.2000.00576.x. https://www. ncbi.nlm.nih.gov/pubmed/10759665
Asscher A.W., Sussman M., Waters W.E., Evans J.A., Campbell H., Evans K.T. i wsp.: The clinical significance of asymptomatic bacteriuria in the nonpregnant woman. J Infect Dis. 1969, 120 (1), 17–26. doi: 10.1093/infdis/120.1.17. https://www.ncbi.nlm.nih.gov/pubmed/5803281
Badalyan R.R., Fanarjyan S.V., Aghajanyan I.G.: Chlamydial and ureaplasmal infections in patients with nonbacterial chronic prostatitis. Andrologia. 2003, 35 (5), 263–265. https://www.ncbi.nlm.nih.gov/pubmed/14535852
Bader M.S., Hawboldt J., Brooks A.: Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2010, 122 (6), 7–15. doi: 10.3810/pgm.2010.11.2217. https://www.ncbi.nlm.nih. gov/pubmed/21084776
Bailey R.R., Bishop V., Peddie B.A.: Comparison of single dose with a 5-day course of co-trimoxazole for asymptomatic (covert) bacteriuria of pregnancy. Aust N Z J Obstet Gynaecol. 1983, 23 (3), 139–141. doi: 10.1111/j.1479- -828x.1983.tb00562.x. https://www.ncbi.nlm.nih.gov/pubmed/6606421
Banyra O., Shulyk A.: Acute epididymo-orchitis: staging and treatment. Cent Eur J Urol. 2012, 65 (3), 139–143. doi: 10.5173/ceju.2012.03.art8. https:// www.ncbi.nlm.nih.gov/pubmed/24578950
Bauer H.W., Alloussi S., Egger G., Blümlein H.M., Cozma G., Schulman C.C.: A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005, 47 (4), 542–548. doi: 10.1016/j.eururo.2004.12.009. https:// www.ncbi.nlm.nih.gov/pubmed/15774256.
Bauer H.W., Rahlfs V.W., Lauener P.A., Blessmann G.S.: Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents. 2002, 19 (6), 451–456. https://www.ncbi.nlm.nih.gov/pubmed/12135831
Bayrak O., Cimentepe E., Inegöl I., Atmaca A.F., Duvan C.I., Koç A. i wsp.: Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy? Int Urogynecol J Pelvic Floor Dysfunct. 2007, 18 (5), 525–529. doi: 10.1007/s00192-006-0190-y. https://www.ncbi.nlm.nih.gov/pubmed/16941068
Beerepoot M.A., Geerlings S.E., van Haarst E.P., van Charante N.M., ter Riet G.: Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013, 190 (6), 1981–1989. doi: 10.1016/j.juro.2013.04.142. https://www. ncbi.nlm.nih.gov/pubmed/23867306
Bell B.G., Schellevis F., Stobberingh E., Goossens H., Pringle M.: A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014, 14, 13. doi: 10.1186/1471-2334- 14-13. https://www.ncbi.nlm.nih.gov/pubmed/24405683
Bent S., Nallamothu B.K., Simel D.L., Fihn S.D., Saint S.: Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002, 287 (20), 2701–2710. doi: 10.1001/jama.287.20.2701. https://www.ncbi.nlm. nih.gov/pubmed/12020306
Berger R.E.: Epididymitis. W: Red. K.K. Holmes, P.A. Mardh, P.F. Sparling, P.J. Wiesner. Sexually transmitted diseases. McGraw-Hill, New York 1984. Bint A., Bullock D., Reeves D., Wilkinson P.: A comparative trial of pivmecillinam and ampicillin in bacteriuria of pregnancy. Infection. 1979, 7 (6), 290–293. doi: 10.1007/bf01642151. https://www.ncbi.nlm.nih.gov/pubmed/232697
Bjerklund Johansen T.E., Grüneberg R.N., Guibert J., Hofstetter A., Lobel B., Naber K.G. i wsp.: The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol. 1998, 34 (6), 457–466. doi: 10.1159/000019784. https://www.ncbi.nlm.nih.gov/pubmed/9831786
Blok B., Castro-Diaz D., Del Popolo G., Groen J., Hamid R., Karsenty G. i wsp.: EAU Guidelines on Neuro-urology. In: EAU Guidelines, edition presented at the annual EAU Congress Barcelona 2019. ISBN 978-94-92671-04-2. https://uroweb.org/guideline/neuro-urology/
Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A. i wsp.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101 (6), 1644–1655. doi: 10.1378/chest.101.6.1644. https:// www.ncbi.nlm.nih.gov/pubmed/1303622
Bonkat G., Braissant O., Cai T., Köves B., Bjerklund Johansen T.E., Pickard R. i wsp.: Non-molecular Methods to Detect Bacteriuria Prior to Urological Interventions: A Diagnostic Accuracy Systematic Review. Eur Urol Focus. 2017, 3 (6), 535–537. doi: 10.1016/j.euf.2018.03.004. https://www.ncbi. nlm.nih.gov/pubmed/29627196
Bonkat G., Pickard R., Bartoletti R., Cai T., Bruyère F., Geerlings S.E. i wsp.: EAU Guidelines on Urological Infection. In: EAU Guidelines, edition presented at the annual EAU Congress Copenhagen 2018. ISBN 978-94-92671-01-1. Bonkat G., Widmer A.F., Rieken M., van der Merwe A., Braissant O., Müller G. i wsp.: Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation. World J Urol. 2013, 31 (3), 565–571. doi: 10.1007/s00345-012-0930-1. https://www.ncbi.nlm.nih. gov/pubmed/22926265
Bootsma A.M.J., Laguna Pes M.P., Geerlings S.E., Goossens A.: Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review. Eur Urol. 2008, 54 (6), 1270–1286. doi: 10.1016/j.eururo.2008.03.033. https://www.ncbi. nlm.nih.gov/pubmed/50098356
Borchardt K.A., al-Haraci S., Maida N.: Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med. 1995, 71 (6), 405–406. doi: 10.1136/sti.71.6.405. https://www.ncbi.nlm.nih.gov/ pubmed/8566985
Boscia J.A., Kobasa W.D., Knight R.A., Abrutyn E., Levison M.E., Kaye D.: Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women. JAMA. 1987, 257 (8), 1067–1071. https://www.ncbi.nlm.nih. gov/pubmed/3806896
Bradbury S.M.: Collection of urine specimens in general practice: to clean or not to clean? J R Coll Gen Pract. 1988, 38, 363–365. https://www.ncbi. nlm.nih.gov/pubmed/3256648
Bremer V., Buder N., Eigentler A>, Esser S., Hagedorn H.J., Hartmann M. i wsp.: Gonorrhoea in adults and adolescents AWMF S2k guidelines. 2013. Nr. 059/004. http://www.egms.de/static/en/journals/id/2014-2/id000010.shtml
Brown R.W., Warner J.J., Turner B.I., Harris L.F., Alford R.H.: Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology. 1981, 18 (2), 145–148. doi: 10.1016/0090-4295(81)90425-8. https://www.ncbi.nlm. nih.gov/pubmed/7269016
Brun-Buisson C., Meshaka P., Pinton P., Vallet B.: EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004, 30 (4), 580–588. doi: 10.1007/s00134- 003-2121-4. https://www.ncbi.nlm.nih.gov/pubmed/14997295
Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R.: Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 2000, 26 Suppl 2, S148–S152. doi: 10.1007/ BF02900728. https://www.ncbi.nlm.nih.gov/pubmed/18470710
Budia A., Luis Palmero J., Broseta E., Tejadillos S., Benedicto A., Queipo J.A. i wsp.: Value of semen culture in the diagnosis of chronic bacterial prostatitis: a simplified method. Scand J Urol Nephrol. 2006, 40 (4), 326– 331. doi: 10.1080/00365590600748247. https://www.ncbi.nlm.nih.gov/ pubmed/16916775
Busolo F., Camposampiero D., Bordignon G., Bertollo G.: Detection of Mycoplasma genitalium and Chlamydia trachomatis DNAs in male patients with urethritis using the polymerase chain reaction. New Microbiol. 1997, 20 (4), 325–332. https://www.ncbi.nlm.nih.gov/pubmed/9385602
Cafferkey M.T., Falkiner F.R., Gillespie W.A., Murphy D.M.: Antibiotics for the prevention of septicaemia in urology. J Antimicrob Chemother. 1982, 9 (6), 471–477. doi: 10.1093/jac/9.6.471. https://www.ncbi.nlm.nih.gov/ pubmed/7107549
Cai T., Mazzoli S., Addonisio P., Boddi V., Geppetti P., Bartoletti R.: Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study. Methods Find Exp Clin Pharmacol. 2010, 32 (1), 39–45. doi: 10.1358/mf.2010.32.1.1423885. https://www. ncbi.nlm.nih.gov/pubmed/20383345
Cai T., Mazzoli S., Bechi A., Addonisio P., Mondaini N., Pagliai R.C. i wsp.: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. Int J Antimicrob Agents. 2009, 33 (6), 549–593. doi: 10.1016/j.ijantimicag.2008.11.012. https://www.ncbi.nlm.nih.gov/pubmed/19181486
Cai T., Mazzoli S., Mondaini N., Meacci F., Nesi G., D’Elia C. i wsp.: The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: To treat or not to treat? Clin Infect Dis. 2012, 55 (6), 771–777. doi: 10.1093/cid/cis534. https://www.ncbi.nlm.nih.gov/pubmed/22677710
Cam K., Kayikci A., Akman Y., Erol A.: Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy. Int J Urol. 1001, 15 (11), 997–1001. doi: 10.1111/j.1442-2042.2008.02147.x. https://www.ncbi.nlm.nih.gov/ pubmed/18721198
Campbell-Brown M., McFadyen I.R., Seal D.V., Stephenson M.L.: Is screening for bacteriuria in pregnancy worth while? Br Med J (Clin Res Ed). 1987, 294, 1579–1582. doi: 10.1136/bmj.294.6587.1579. https://www.ncbi.nlm. nih.gov/pubmed/3113538
Carey M.M., Zreik A., Fenn N.J., Chlosta P.L., Aboumarzouk O.M.: Should We Use Antibiotic Prophylaxis for Flexible Cystoscopy? A Systematic Review and Meta-Analysis. Urol Int. 2015, 95 (3), 249–259. doi: 10.1159/000381882. https://www.ncbi.nlm.nih.gov/pubmed/26138144
Carlet J., Dumay M.F., Gottot S.: Guidelines for prevention of nosocomial infections in intensive care unit. Arnette Ed Paris 1994, 41. Caskurlu T., Arikan O., Yildrim A., Tanidir B., Canakci C., Danacioglu Y.A. i wsp.: MP48-01 Prevalence of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and clinical impact of targeted antibiotic prophylaxis. J Urol. 2015, 193, e594. https://www.jurology.com/doi/ pdf/10.1016/j.juro.2015.02.1675
Cefai C., Charani E., Craven L.: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. NICE Guidelines, 2015. https://www.nice.org.uk/guidance/ng15
Cek M., Tandoğdu Z., Wagenlehner F., Tenke P., Naber K., Bjerklund-Johansen T.E.: Healthcare-associated urinary tract infections in hospitalized urological patients – a global perspective: results from the GPIU studies 2003-2010. World J Urol. 2014, 32 (6), 1587–1594. doi: 10.1007/s00345-013-1218-9. https://www.ncbi.nlm.nih.gov/pubmed/24452449
Centers for Disease Control and Prevention. 2015 Sexually Transmitted Diseases Treatment Guidelines – Epididymitis. 2015. https://www.cdc. gov/std/tg2015/epididymitis.htm Centers for Disease Control and Prevention. Procedure-associated Module 9: Surgical Site Infection (SSI) Event. 2017. https://www.cdc.gov/nhsn/pdfs/ pscmanual/9pscssicurrent.pdf
Chae Y., Kim Y.J., Kim T., Yun S.J., Lee S.C., Kim W.J.: The Comparison between Transperineal and Transrectal Ultrasound-Guided Prostate Needle Biopsy. Korean J Urol. 2009, 50 (2), 119–124. doi: 10.4111/kju.2009.50.2.119. https:// synapse.koreamed.org/Synapse/Data/PDFData/0020KJU/kju-50-119.pdf Chazan B., Zelichenko G., Shental Y., Edelstein H., Raz R.: Antimicrobial prophylaxis for transrectal ultrasound guided biopsy of prostate: A comparative study between single dose of Gentamicin vs. Ofloxacin. Int J Inf Dis. 2010, 14, Suppl 1, 199–200. doi: 10.1016/j.ijid.2010.02.1930. https://www.ijidonline.com/article/S1201-9712(10)01970-3/fulltext
Chennamsetty A., Khourdaji I., Burks F., Killinger K.A.: Contemporary diagnosis and management of Fournier’s gangrene. Ther Adv Urol. 2015, 7 (4), 203–215. doi: 10.1177/1756287215584740. https://www.ncbi.nlm.nih. gov/pubmed/26445600
Chong J.T., Klausner A.P., Petrossian A., Byrne M.D., Moore J.R., Goetz L.L. i wsp.: Pre-procedural antibiotics for endoscopic urological procedures: Initial experience in individuals with spinal cord injury and asymptomatic bacteriuria. J Spinal Cord Med. 2015, 38 (2), 187–192. doi: 10.1179/2045772313Y.0000000185. https://www.ncbi.nlm.nih.gov/ pubmed/24621035
Chou Y.H., Tiu C.M., Liu J.Y., Chen J.D., Chiou H.J., Chiou S.Y. i wsp.: Prostatic abscess: transrectal color Doppler ultrasonic diagnosis and minimally invasive therapeutic management. Ultrasound Med Biol. 2004, 30 (6), 719–724. doi: 10.1016/j.ultrasmedbio.2004.03.014. https://www.ncbi.nlm.nih.gov/ pubmed/15219951
Christopher L.J., Thompson G.R.: A trial of hippramine in the treatment of bacteriuria of pregnancy. Ir J Med Sci. 1969, 8 (7), 331–337. doi: 10.1007/ bf02955410. https://www.ncbi.nlm.nih.gov/pubmed/5806178
Classen D.C., Larsen R.A., Burke J.P., Stevens L.E.: Prevention of catheter-associated bacteriuria: clinical trial of methods to block three known pathways of infection. Am J Infect Control. 1991, 19 (3), 136–142. doi: 10.1016/0196- 6553(91)90019-9. https://www.ncbi.nlm.nih.gov/pubmed/1863002
Cooper F.P., Alexander C.E., Sinha S., Omar M.I.: Policies for replacing longterm indwelling urinary catheters in adults. Cochrane Database Syst Rev. 2016, 7, CD011115. doi: 10.1002/14651858.CD011115.pub2. https://www. ncbi.nlm.nih.gov/pubmed/27457774
Cordero-Ampuero J., González-Fernández E., Martínez-Vélez D., Esteban J.: Are antibiotics necessary in hip arthroplasty with asymptomatic bacteriuria? Seeding risk with/without treatment. Clin Orthop Relat Res. 2013, 471 (12), 3822–3829. doi: 10.1007/s11999-013-2868-z. https://www.ncbi.nlm. nih.gov/pubmed/23430723
Cormio L., Berardi B., Callea A., Fiorentino N., Sblendorio D., Zizzi V. i wsp.: T Antimicrobial prophylaxis for transrectal prostatic biopsy: A prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int. 2002, 90 (7), 700–702. doi: 10.1046/j.1464-410x.2002.02991.x. https://www.ncbi. nlm.nih.gov/pubmed/12410751
Çek M., Sturdza L., Pilatz A.: Acute and Chronic Epididymitis in EAU-EBU Update Series. Eur Urol Suppl 2017. 16: 124. https://www.sciencedirectcom/ journal/european-urology-supplements/vol/16/issue/4
Dadashpour M., Bagheri S.M.: Acute Prostatitis After Transrectal Ultrasoundguided Prostate Biopsy: Comparing Two Different Antibiotic Prophylaxis Regimen. Biomed Pharmacol J. 2016, 9 (2), 593–597. doi: 10.13005/bpj/977. http://biomedpharmajournal.org/vol9no2/acute-prostatitis/
Dahm P., Dmochowski R.: Evidence-based Urology. BMJ Books, London 2010, 50. Damiano R., Quarto G., Bava I., Ucciero G., De Domenico R., Palumbo M.I. i wsp.: Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol. 2011, 59 (4), 645–651. doi: 10.1016/j. eururo.2010.12.039. https://www.ncbi.nlm.nih.gov/pubmed/21272992
Darouiche R.O., Thornby J.I., Cerra-Stewart C., Donovan W.H., Hull R.A.: Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis. 2005, 41 (10), 1531–1534. doi: 10.1086/497272. https://www.ncbi. nlm.nih.gov/pubmed/16231269
Dasgupta R., Grabe M.: Preoperative antibiotics before endourologic surgery: current recommendations. J Endourol. 2009, 23 (10), 1567–1570. doi: 10.1089/end.2009.1520. https://www.ncbi.nlm.nih.gov/pubmed/19785548
Davey P., Brown E., Charani E., Fenelon L., Gould I.M., Holmes A. i wsp.: Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013, 4: CD003543. doi: 10.1002/14651858. CD003543.pub3. https://www.ncbi.nlm.nih.gov/pubmed/23633313
DeGroot-Kosolcharoen J., Guse R., Jones J.M.: Evaluation of a urinary catheter with a preconnected closed drainage bag. Infect Control Hosp Epidemiol. 1988, 9 (2), 72–76. doi: 10.1086/645788. https://www.ncbi.nlm.nih.gov/ pubmed/3343502
Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J. i wsp.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004, 32 (3), 858–873. doi: 10.1097/01. ccm.0000117317.18092.e4. https://www.ncbi.nlm.nih.gov/pubmed/15090974
Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M. i wsp.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013, 39 (2), 165–228. doi: 10.1007/s00134-012-2769-8. https://www.ncbi.nlm.nih. gov/pubmed/23361625
Dellit T.H., Owens R.C., McGowan J.E. Jr, Gerding D.N., Weinstein R.A., Burke J.P. i wsp.: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007, 44 (2), 159–177. doi: 10.1086/510393. https://www.ncbi.nlm.nih.gov/pubmed/17173212
Del Rio C., Hall G., Holmes K., Soge O., Hook E., Kirkcaldy R. i wsp.: Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012, 61, 590–594. https://www. ncbi.nlm.nih.gov/pubmed/22874837
Doble A., Carter S.S.: Ultrasonographic findings in prostatitis. Urol Clin North Am. 1989, 16 (4), 763–772. https://www.ncbi.nlm.nih.gov/pubmed/2683305
Dumville J.C., McFarlane E., Edwards P., Lipp A., Holmes A., Liu Z.: Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev, 2015: CD003949. doi: 10.1002/14651858. CD003949.pub4. https://www.ncbi.nlm.nih.gov/pubmed/25897764
Eickhoff J.H., Frimodt-Møller N., Walter S., Frimodt-Møller C.A.: doubleblind, randomized, controlled multicentre study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of age. BJU Int. 1999, 84 (7), 827–834. doi: 10.1046/j.1464- 410x.1999.00252.x. https://www.ncbi.nlm.nih.gov/pubmed/10532980
Eke N.: Fournier’s gangrene: a review of 1726 cases. Br J Surg. 2000, 87 (6), 718–728. doi: 10.1046/j.1365-2168.2000.01497.x. https://www.ncbi.nlm. nih.gov/pubmed/10848848
El Amari E.B., Hadaya K., Bühler L., Berney T., Rohner P., Martin P.Y. i wsp.: Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. Nephrol Dial Transplant. 2011, 26 (12), 4109–4114. doi: 10.1093/ndt/gfr198. https://www.ncbi.nlm.nih.gov/pubmed/21592976
Elder H.A., Santamarina B.A., Smith S., Kass E.H.: The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol. 1971, 111 (3), 441–462. doi: 10.1016/0002-9378(71)90793-9. https://www. ncbi.nlm.nih.gov/pubmed/4937729
Elder H.A., Santamarina B.A., Smith S.A., Kass E.H.: Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrob Agents Chemother (Bethesda). 1966, 6, 142–148. https://www.ncbi.nlm.nih.gov/ pubmed/4862162 Estebanez A., Pascual R., Gil V., Ortiz F., Santibáñez M., Pérez Barba C.: Fosfomycin in a single dose versus a 7-day course of amoxicillin- clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. Eur J Clin Microbiol Infect Dis. 2009, 28 (12), 1457–1464. doi: 10.1007/ s10096-009-0805-6. https://www.ncbi.nlm.nih.gov/pubmed/19768649
Etienne M., Pestel-Caron M., Chavanet P., Caron F.: Performance of the urine leukocyte esterase and nitrite dipstick test for the diagnosis of acute prostatitis. Clin Infect Dis. 2008, 46 (6), 951–953. doi: 10.1086/528873. https:// www.ncbi.nlm.nih.gov/pubmed/18288905
European Centre for Disease Prevention and Control (ECDC). Systematic review and evidence-based guidance on perioperative antibiotic prophylaxis. 2013. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Perioperative%20antibiotic%20prophylaxis%20-%20 June%202013.pdf
European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 – Healthcare-associated infections acquired in intensive care units. 2016. https://ecdc.europa.eu/en/publications-data/healthcare-associated-infections-intensive-care-units-annual-epidemiological-0
Evans B.A., Bond R.A., MacRae K.D.: Racial origin, sexual behaviour, and genital infection among heterosexual men attending a genitourinary medicine clinic in London (1993-4). Sex Transm Infect. 1998, 74 (1), 40–44. doi: 10.1136/sti.74.1.40. https://www.ncbi.nlm.nih.gov/pubmed/9634302
Falagas M.E., Kotsantis I.K., Vouloumanou E.K., Rafailidis P.I.: Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect. 2009, 58 (2), 91–102. doi: 10.1016/j.jinf.2008.12.009. https://www.ncbi.nlm.nih.gov/ pubmed/19195714
Fang Y.Q., Li T.C., Si T.J., Pang J., Gao X.: Antibiotic prophylaxis at time of catheter removal following laparoscopic radical prostatectomy: A prospective randomized study. Acta Medica Mediterranea. 2014, 30, 161. http:// www.actamedicamediterranea.com/archive/2014/medica-1/antibioticprophylaxis-at-time-of-catheter-removal-following-laparoscopic-radicalprostatectomy-a-prospective-randomized-study
Fihn S.D.: Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med. 2003, 349 (3), 259–266. doi: 10.1056/NEJMcp030027. https://www.ncbi.nlm.nih.gov/pubmed/12867610 Foon R., Toozs-Hobson P., Latthe P.: Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies [Systematic Review]. Cochrane Database of Systematic Reviews. 2012. 10: 10. doi: 10.1002/14651858.CD008224.pub2. https://www.ncbi.nlm.nih.gov/ pubmed/23076941
Foxman B.: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003, 49 (2), 53–70. doi: 10.1067/mda.2003.7. https://www.ncbi.nlm.nih.gov/pubmed/12601337
Foxman B.: Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003, 17 (2), 227– 241. doi: 10.1016/S0891-5520(03)00005-9. https://www.ncbi.nlm.nih. gov/pubmed/12601337
Foxman B., Somsel P., Tallman P., Gillespie B., Raz R., Colodner R. i wsp.: Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol. 2001, 54 (7), 710–718. doi: 10.1016/s0895- 4356(00)00352-8. https://www.ncbi.nlm.nih.gov/pubmed/11438412
Fulop T.: Acute Pyelonephritis Workup. 2012. (updated: Dec 2018). http:// emedicine.medscape.com/article/245559-workup Furr J., Watts T., Street R., Cross B., Slobodov G., Patel S.: Contemporary Trends in the Inpatient Management of Fournier’s Gangrene: Predictors of Length of Stay and Mortality Based on Population-based Sample. Urology. 2017, 102, 79–84. doi: 10.1016/j.urology.2016.09.021. https://www.ncbi.nlm. nih.gov/pubmed/27693572
Garcia-Perdomo H.A., López H., Carbonell J., Castillo D., Cataño J.G., Serón P.: Efficacy of antibiotic prophylaxis in patients undergoing cystoscopy: A randomized clinical trial. World J Urol. 2013, 31 (6), 1433–1439. doi: 10.1007/ s00345-013-1034-2. https://www.ncbi.nlm.nih.gov/pubmed/23412704
Garibaldi R.A., Burke J.P., Dickman M.L., Smith C.B.: Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974, 291 (5), 215–219. doi: 10.1056/NEJM197408012910501. https:// www.ncbi.nlm.nih.gov/pubmed/4834750
Geerlings S.E.: SWAB Guidelines for Antimicrobial Therapy of Complicated Urinary Tract Infections in Adults. SWAB Guidelines, 2013. https://www. ncbi.nlm.nih.gov/pubmed/17100128
Gerstner G.J., Müller G., Nahler G.: Amoxicillin in the treatment of asymptomatic bacteriuria in pregnancy: a single dose of 3 g amoxicillin versus a 4-day course of 3 doses 750 mg amoxicillin. Gynecol Obstet Invest. 1989, 27 (2), 84–87. doi: 10.1159/000293624. https://www.ncbi.nlm.nih.gov/ pubmed/2659442
Ghafoori M., Shakiba M., Seifmanesh H., Hoseini K.: Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iranian J Radiol. 2012, 9 (2), 67–70. doi: 10.5812/iranjradiol.7561. https://www. ncbi.nlm.nih.gov/pubmed/23329966
Gill B.C., Shoskes D.A.: Bacterial prostatitis. Curr Opin Infect Dis. 2016, 29 (1), 86–91. doi: 10.1097/QCO.0000000000000222. https://www.ncbi.nlm. nih.gov/pubmed/26555038
Gleckman R., Esposito A., Crowley M., Natsios G.A.: Reliability of a single urine culture in establishing diagnosis of asymptomatic bacteriuria in adult males. J Clin Microbiol. 1979, 9 (5), 596–597. https://www.ncbi.nlm.nih. gov/pubmed/383746
Goff D.A., Kullar R., Goldstein E.J.C., Gilchrist M., Nathwani D., Cheng A.C. i wsp.: A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017, 17 (2), e56–e63. doi: 10.1016/S1473-3099(16)30386-3. https://www.ncbi. nlm.nih.gov/pubmed/27866945
Gold E.M., Traub F.B., Daichman I., Terris M.: Asymptomatic bacteriuria during pregnancy. Obstet Gynecol. 1966, 27 (2), 206–209. https://www.ncbi. nlm.nih.gov/pubmed/5325600
Gould C.V., Umscheid C.A., Agarwal R.K., Kuntz G., Pegues D.A.: Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010, 31 (4), 319–326. doi: 10.1086/651091. https:// www.ncbi.nlm.nih.gov/pubmed/20156062
Grabe M., Forsgren A., Björk T., Hellsten S.: Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur J Clin Microbiol. 1987, 6 (1), 11–17. doi.: 10.1007/ bf02097183. https://www.ncbi.nlm.nih.gov/pubmed/3569248
Grabe M., Forsgren A., Hellsten S.: The effect of a short antibiotic course in transurethral prostatic resection. Scand J Urol Nephrol. 1984, 18 (1), 37–42. doi: 10.3109/00365598409182161. https://www.ncbi.nlm.nih. gov/pubmed/6202000
Green H., Rahamimov R., Goldberg E., Leibovici L., Gafter U., Bishara J. i wsp.: Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: Retrospective observational study. Eur J Clin Microbiol Infect Dis. 2013, 32 (1), 127–131. doi: 10.1007/ s10096-012-1727-2. https://www.ncbi.nlm.nih.gov/pubmed/22918514
Guenaga K.F., Matos D., Wille-Jørgensen P.: Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev, 2011: CD001544. doi: 10.1002/14651858.CD001544.pub4. https://www.ncbi.nlm.nih.gov/ pubmed/21901677
Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G. i wsp.: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011, 52 (2), e103. doi: 10.1093/cid/ ciq257. https://www.ncbi.nlm.nih.gov/pubmed/21292654
Gupta K., Hooton T.M., Roberts P.L., Stamm W.E.: Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med. 2007, 167, 2207–2212. doi: 10.1001/archinte.167.20.2207. https:// www.ncbi.nlm.nih.gov/pubmed/17998493
Gupta K., Stamm W.E.: Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents. 2002, 19 (6), 554–556. doi: 10.1016/s0924- 8579(02)00104-8. https://www.ncbi.nlm.nih.gov/pubmed/12135847
Gurbuz C., Güner B., Atış G., Canat L., Caşkurlu T.: Are prophylactic antibiotics necessary for urodynamic study? Kaohsiung J Med Sci. 2013, 29 (6), 325. doi: 10.1016/j.kjms.2012.06.001. https://www.ncbi.nlm.nih.gov/ pubmed/20377490 Guyatt G.H., Oxman A.D., Kunz R., Falck-Ytter Y., Vist G.E., Liberati A. i wsp.: Going from evidence to recommendations. BMJ. 2008, 336, 1049–1051. doi: 10.1136/bmj.39493.646875.AE. https://www.ncbi.nlm.nih.gov/ pubmed/18467413
Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schunemann H.J.: What is “quality of evidence” and why is it important to clinicians? BMJ. 2008, 336, 995–998. doi: 10.1136/bmj.39490.551019.BE. https://www. ncbi.nlm.nih.gov/pubmed/18456631
Haddadeen C., Dickinson L., Chawishly E., Lau R., Watkin N.: Comparative regional audit of urology and genito-urinary departments in the management of acute epididymo-orchitis. HIV Medicine. 2010, 11, 45. https:// www.ncbi.nlm.nih.gov/pubmed/70186144
Haggerty C.L., Gottlieb S.L., Taylor B.D., Low N., Xu F., Ness R.B.: Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010, 201 Suppl 2, S134–S155. doi: 10.1086/652395. https://www.ncbi. nlm.nih.gov/pubmed/20470050
Hansson S., Jodal U., Lincoln K., Svanborg-Edén C.: Untreated asymptomatic bacteriuria in girls: II – Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections. BMJ. 1989, 298 (6677), 856– 859. doi: 10.1136/bmj.298.6677.856. https://www.ncbi.nlm.nih.gov/ pubmed/2497823
Hara R., Jo Y., Fujii T., Kondo N., Yokoyoma T., Miyaji Y.: Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology. 2008, 71 (2), 191–195. doi: 10.1016/j.urology.2007.09.029. https:// www.ncbi.nlm.nih.gov/pubmed/18308081
Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E. i wsp.: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001, 164 (3), 396–402. doi: 10.1164/ajrccm.164.3.2009052. https:// www.ncbi.nlm.nih.gov/pubmed/11500339
Harding G.K., Zhanel G.G., Nicolle L.E., Cheang M.: Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 2002, 347 (20), 1576–1583. doi: 10.1056/NEJMoa021042. https://www.ncbi. nlm.nih.gov/pubmed/12432044
Harnisch J.P., Berger R.E., Alexander E.R., Monda G., Holmes K.K.: Aetiology of acute epididymitis. Lancet. 1977, 1, 819–821. doi: 10.1016/s0140- 6736(77)92773-8. https://www.ncbi.nlm.nih.gov/pubmed/67333
Harris R.E., Gilstrap L.C., Pretty A.: Single-dose antimicrobial therapy for asymptomatic bacteriuria during pregnancy. Obstet Gynecol. 1982, 59 (5), 546–549. https://www.ncbi.nlm.nih.gov/pubmed/7070725
Hartstein A.I., Garber S.B., Ward T.T., Jones S.R., Morthland V.H.: Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control. 1981, 2 (5), 380–386. doi: 10.1017/s0195941700055533. https://www.ncbi.nlm.nih.gov/pubmed/6795141
Hermanides H.S., Hulscher M.E., Schouten J.A., Prins J.M., Geerlings S.E.: Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis. 2008, 46 (5), 703–711. doi: 10.1086/527384. https://www.ncbi. nlm.nih.gov/pubmed/18230045
Heyns C.F.: Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol. 2012, 30 (1), 77–83. doi: 10.1007/s00345-011-0725- 9. https://www.ncbi.nlm.nih.gov/pubmed/21720861
Hill J.B., Sheffield J.S., McIntire D.D., Wendel G.D. Jr.: Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005, 105 (1), 18–23. doi: 10.1097/01. AOG.0000149154.96285.a0. https://www.ncbi.nlm.nih.gov/pubmed/15625136
Hirakauva E., Bianchi-Ferraro A.M., Zucchi E.V.M., Kajikawa M.M., Girão M.J., Sartori M.G.: Incidence of urinary infection in women after urodynamic study (UDS). Int Urogynecol J Pelvic Floor Dysfunct, 2011. 22. Hooton T.M.: Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012, 366 (11), 1028–1037. doi: 10.1056/NEJMcp1104429. https://www.ncbi.nlm.nih.gov/pubmed/22417256
Hooton T.M.: Prevention of recurrent urogenital tract infections in adult women, In: EAU/International Consultation on Urological Infections. European Association of Urology: The Netherlands, 2010. Hooton T.M.: Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001, 17 (4), 259–268. doi: 10.1016/s0924-8579(00)00350-2. https:// www.ncbi.nlm.nih.gov/pubmed/11295405
Hooton T.M., Bradley S.F., Cardenas D.D., Colgan R., Geerlings S.E., Rice J.C. i wsp.: Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010, 50 (5), 625–663. doi: 10.1086/650482. https://www.ncbi.nlm.nih.gov/ pubmed/20175247
Hooton T.M., Roberts P.L., Stapleton A.E.: Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA. 2012, 307 (6), 583–589. doi: 10.1001/jama.2012.80. https://www. ncbi.nlm.nih.gov/pubmed/22318279
Hooton T.M., Scholes D., Gupta K., Stapleton A.E., Roberts P.L., Stamm W.E.: Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. Jama. 2005, 293 (8), 949–955. doi: 10.1001/jama.293.8.949. https://www.ncbi.nlm.nih.gov/pubmed/15728165
Horan T.C., Andrus M., Dudeck M.A.: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36 (5) 309– 332. doi: 10.1016/j.ajic.2008.03.002. https://www.ncbi.nlm.nih.gov/ pubmed/18538699
Horner P.J., Blee K., Falk L., van der Meijden W., Moi H.: 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016, 27 (11), 928–937. doi: 10.1177/0956462416648585. https://www. ncbi.nlm.nih.gov/pubmed/27147267
Hotchkiss, R.S., Karl I.E.: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348 (2), 138–150. doi: 10.1056/NEJMra021333. https:// www.ncbi.nlm.nih.gov/pubmed/12519925
Howell M.D., Davis A.M.: Management of Sepsis and Septic Shock. JAMA. 2017, 317 (8), 847–848. doi: 10.1001/jama.2017.0131. https://www.ncbi. nlm.nih.gov/pubmed/28114603
Hsieh C.H., Yang S.S., Chang S.J.: The Effectiveness of Prophylactic Antibiotics with Oral Levofloxacin against Post-Shock Wave Lithotripsy Infectious Complications: A Randomized Controlled Trial. Surg Infect (Larchmit). 2016, 17 (3), 346–351. doi: 10.1089/sur.2015.129. https://www.ncbi.nlm. nih.gov/pubmed/26910613
Hua L.X., Zhang J.X., Wu H.F., Zhang W., Qian L.X., Xia G.W. i wsp.: [The diagnosis and treatment of acute prostatitis: report of 35 cases]. Zhonghua Nan Ke Xue. 2005, 11 (12), 897–899. https://www.ncbi.nlm.nih.gov/ pubmed/16398358
Hulscher M.E., Grol R.P., van der Meer J.W.: Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010, 10 (3), 167–175. doi: 10.1016/S1473-3099(10)70027-X. https://www.ncbi. nlm.nih.gov/pubmed/20185095
Huttner A., Verhaegh E.M., Harbarth S., Muller A.E., Theuretzbacher U., Mouton J.W.: Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015, 70 (9), 2456–2464. doi: 10.1093/jac/dkv147. https://www.ncbi.nlm.nih.gov/pubmed/26066581
Isen K., Küpeli B., Sinik Z., Sözen S., Bozkirli I.: Antibiotic prophylaxis for transrectal biopsy of the prostate: A prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol. 1999, 31 (4), 491– 495. doi: 10.1023/a:1007115312039. https://www.ncbi.nlm.nih.gov/ pubmed/10668944
Ito S., Hanaoka N., Shimuta K., Seike K., Tsuchiya T., Yasuda M. i wsp.: Male nongonococcal urethritis: From microbiological etiologies to demographic and clinical features. Int J Urol. 2016, 23 (4), 325–331. doi: 10.1111/iju.13044. https://www.ncbi.nlm.nih.gov/pubmed/26845624
Jacobsen S.M., Stickler D.J., Mobley H.L., Shirtliff M.E.: Complicated catheterassociated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008, 21 (1), 26–59. doi: 10.1128/CMR.00019-07. https://www.ncbi.nlm.nih.gov/pubmed/18202436
Jallali N., Withey S., Butler P.E.: Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005, 189 (4), 462– 466. doi: 10.1016/j.amjsurg.2005.01.012. https://www.ncbi.nlm.nih.gov/ pubmed/15820462
Jepson R.G., Williams G., Craig J.C.: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012, 10, CD001321. doi: 10.1002/14651858.CD001321.pub5. https://www.ncbi.nlm.nih.gov/ pubmed/23076891
Jimenez-Cruz J.F., Tormo F.B., Gómez J.G.: Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. J Urol. 1988, 139 (5), 967–970. doi: 10.1016/s0022-5347(17)42733-9. https://www.ncbi. nlm.nih.gov/pubmed/3283385
Johansen T.E., Botto H., Cek M., Grabe M., Tenke P., Wagenlehner F.M. i wsp.: Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents. 2011, 38 Suppl. 64–70. doi: 10.1016/j.ijantimicag.2011.09.009. https://www.ncbi. nlm.nih.gov/pubmed/22018988
Kanjanawongdeengam P., Viseshsindh W., Santanirand P., Prathombutr P., Nilkulwattana S.: Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial. J Med Assoc Thai. 2009, 92 (12), 1621–1626. https://www. ncbi.nlm.nih.gov/pubmed/20043564
Kapoor D.A., Klimberg I.W., Malek G.H., Wegenke J.D., Cox C.E., Patterson A.L. i wsp.: Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology. 1998, 52 (4), 552–558. doi: 10.1016/ s0090-4295(98)00296-9. https://www.ncbi.nlm.nih.gov/pubmed/9763070
Karian L.S., Chung S.Y., Lee E.S.: Reconstruction of Defects After Fournier Gangrene: A Systematic Review. Eplasty. 2015, 15, e18. https://www.ncbi. nlm.nih.gov/pubmed/26171090
Kass E.H.: Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956, 69, 56–64. https://www.ncbi.nlm.nih.gov/ pubmed/13380946
Kass E.H.: Pyelonephritis and bacteriuria. A major problem in preventive medicine. Ann Intern Med. 1962, 56, 46–53. doi: 10.7326/0003-4819-56- 1-46. https://www.ncbi.nlm.nih.gov/pubmed/14454174
Kazemier B.M., Koningstein F.N., Schneeberger C., Ott A., Bossuyt P.M., de Miranda E. i wsp.: Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015, 15 (11), 1324–1333. doi: 10.1016/S1473-3099(15)00070-5. https:// www.ncbi.nlm.nih.gov/pubmed/26255208
Kim S.Y., Dupree J.M., Le B.V., Kim D.Y., Zhao L.C., Kundu S.D.: A Contemporary Analysis of Fournier Gangrene Using the National Surgical Quality Improvement Program. Urology. 2015, (5), 1052–1057. doi: 10.1016/j. urology.2014.08.063. https://www.ncbi.nlm.nih.gov/pubmed/25770725
Kincaid-Smith P., Bullen M.: Bacteriuria in Pregnancy. Lancet. 1965, 1, 395– 399. doi: 10.1016/s0140-6736(65)90001-2. https://www.ncbi.nlm.nih. gov/pubmed/14238090
Kirkcaldy R.D., Harvey A., Papp J.R., Del Rio C., Soge O.O., Holmes K.K. i wsp.: Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ. 2016, 65 (7), 1–19. doi: 10.15585/mmwr.ss6507a1. https:// www.ncbi.nlm.nih.gov/pubmed/27414503
Kontiokari T., Sundqvist K., Nuutinen M., Pokka T., Koskela M., Uhari M.: Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001, 322, 1571. doi: 10.1136/bmj.322.7302.1571. https://www.ncbi.nlm.nih.gov/ pubmed/11431298
Koves B., Cai T., Veeratterapillay R., Pickard R., Seisen T., Lam T.B. i wsp.: Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel. Eur Urol. 2017, 72 (6), 865–868. doi: 10.1016/j. eururo.2017.07.014. https://www.ncbi.nlm.nih.gov/pubmed/28754533
Kranjcec B., Papes D., Altarac S.: D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014, 32 (1), 79–84. doi: 10.1007/s00345-013-1091-6. https://www. ncbi.nlm.nih.gov/pubmed/23633128
Krieger J.N.: Recurrent lower urinary tract infections in men. J New Rem Clin. 1998, 47, 4. Krieger J.N.: Trichomoniasis in men: old issues and new data. Sex Transm Dis. 1995, 22 (2), 83–96. https://www.ncbi.nlm.nih.gov/pubmed/7624817
Krieger J.N., Egan K.J., Ross S.O., Jacobs R., Berger R.E.: Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis”. Urology. 1996, 48 (5), 715–721. doi: 10.1016/S0090-4295(96)00421-9. https://www.ncbi.nlm.nih.gov/pubmed/8911515
Krieger J.N., Nyberg L. Jr, Nickel J.C.: NIH consensus definition and classification of prostatitis. JAMA. 1999, 282 (3), 236–237. doi: 10.1001/ jama.282.3.236. https://www.ncbi.nlm.nih.gov/pubmed/10422990
Kunin C.M., McCormack R.C.: Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966, 274 (21), 1155– 1161. doi: 10.1056/NEJM196605262742101. https://www.ncbi.nlm.nih. gov/pubmed/5934951
Kunin C.M.: Urinary tract infections: detection, prevention and management. 5th ed. Williams and Wilkins, Baltimore 1997. Lauerman M., Kolesnik O., Sethuraman K., Rabinowitz R., Joshi M., Clark E. i wsp.: Less is More? Antibiotic duration and outcomes in fournier’s gangrene. J Trauma Acute Care Surg. 2017, 83 (3), 443–448. doi: 10.1097/ TA.0000000000001562. https://www.ncbi.nlm.nih.gov/pubmed/28538648
Lecomte F., Allaert F.A.: Single-dose treatment of cystitis with fosfomycin trometamol (Monuril): analysis of 15 comparative trials on 2,048 patients. Giorn It Ost Gin. 1997, 19, 399. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D. i wsp.: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31 (4), 1250–1256. doi: 10.1097/01. CCM.0000050454.01978.3B. https://www.ncbi.nlm.nih.gov/ pubmed/12682500
Li C., Zhou X., Liu L.F., Qi F., Chen J.B., Zu X.B.: Hyperbaric oxygen therapy as an adjuvant therapy for comprehensive treatment of Fournier’s gangrene. Urol Int. 2015, 94 (4), 453–458. doi: 10.1159/000366137. https://www. ncbi.nlm.nih.gov/pubmed/25677386
Lifshitz E., Kramer L.: Outpatient urine culture: does collection technique matter? Arch Intern Med. 2000, 160 (16), 2537–2540. doi: 10.1001/ archinte.160.16.2537. https://www.ncbi.nlm.nih.gov/pubmed/10979067
Liker Y., Türkeri L., Korten V., Tarvan T., Özveri H., Simsek F.: The role of antibiotics in patients with increased risk of infection during extracorporeal shock wave lithotripsy (ESWL) treatment. Marmara Med J. 1996, 9, 174– 177. https://www.ncbi.nlm.nih.gov/pubmed/26377368
Lindert K.A., Kabalin J.N., Terris M.K.: Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000, 164 (1), 76–80. https://www.ncbi.nlm.nih.gov/pubmed/10840428
Lipsky B.A., Byren I., Hoey C.T.: Treatment of bacterial prostatitis. Clin Infect Dis. 2010, 50, 1641–1652. doi: 10.1086/652861. https://www.ncbi.nlm. nih.gov/pubmed/20459324
Lista F., Redondo C., Meilán E., García-Tello A., Ramón de Fata F., Angulo J.C.: Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin. Actas Urol Esp. 2014, 38 (6), 391–396. doi: 10.1016/j.acuro.2014.01.002. https://www.ncbi.nlm.nih.gov/pubmed/24775812
Little P.J.: The incidence of urinary infection in 5000 pregnant women. Lancet. 1966, 2, 925–928. doi: 10.1016/s0140-6736(66)90534-4. https:// www.ncbi.nlm.nih.gov/pubmed/4162367
Litwin M.S., McNaughton-Collins M., Fowler F.J. Jr, Nickel J.C., Calhoun E.A., Pontari M.A. i wsp.: The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999, 162 (2), 369–375. doi: 10.1016/s0022-5347(05)68562-x. https://www.ncbi.nlm. nih.gov/pubmed/10411041
Lo C.W., Yang S.S., Hsieh C.H., Chang S.J.: Effectiveness of Prophylactic Antibiotics against Post-Ureteroscopic Lithotripsy Infections: Systematic Review and Meta-Analysis. Surg Infect. 2015, 16 (4), 415–420. doi: 10.1089/ sur.2014.013. https://www.ncbi.nlm.nih.gov/pubmed/26207401
Ludwig M., Schroeder-Printzen I., Schiefer H.G., Weidner W.: Diagnosis and therapeutic management of 18 patients with prostatic abscess. Urology. 1999, 53 (2), 340–345. doi: 10.1016/s0090-4295(98)00503-2. https://www. ncbi.nlm.nih.gov/pubmed/9933051
Lumbiganon P., Villar J., Laopaiboon M., Widmer M., Thinkhamrop J., Carroli G. i wsp.: One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: A randomized controlled trial. Obstet Gynecol. 2009, 113, 339–345. doi: 10.1097/AOG.0b013e318195c2a2. https://www. ncbi.nlm.nih.gov/pubmed/19155904
Lutay N., Ambite I., Grönberg Hernandez J., Rydström G., Ragnarsdóttir B., Puthia M. i wsp.: Bacterial control of host gene expression through RNA polymerase II. J Clin Invest. 2013, 123 (6), 2366–2379. doi: 10.1172/JCI66451. https://www.ncbi.nlm.nih.gov/pubmed/23728172
Lu Y., Tianyong F., Ping H., Liangren L., Haichao Y., Qiang W.: Antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary: A systematic review and meta-analysis. J Urol. 2012, 188 (2), 441–448. doi: 10.1016/j.juro.2012.04.014. https://www. ncbi.nlm.nih.gov/pubmed/22704118
Madersbacher H., van Ophoven A., van Kerrebroeck P.E.: GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans – a review. Neurourol Urodyn. 2013, 32 (1), 9–18. doi: 10.1002/ nau.22256. https://www.ncbi.nlm.nih.gov/pubmed/22782909
Maki D.G., Tambyah P.A.: Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001, 7 (2), 342–347. doi: 10.3201/ eid0702.010240. https://www.ncbi.nlm.nih.gov/pubmed/11294737
Marschall J., Carpenter C.R., Fowler S., Trautner B.W.: Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: Meta-analysis. BMJ. 2013, 346: f3147. doi: 10.1136/bmj.f3147. https://www.ncbi.nlm. nih.gov/pubmed/23757735
Martin G.S., Mannino D.M., Eaton S., Moss M.: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348 (16), 1546–1554. doi: 10.1056/NEJMoa022139. https://www.ncbi.nlm. nih.gov/pubmed/12700374
Masterton R.G., Evans D.C., Strike P.W.: Single-dose amoxycillin in the treatment of bacteriuria in pregnancy and the puerperium – a controlled clinical trial. Br J Obstet Gynaecol. 1985, 92 (5), 498–505. doi: 10.1111/j.1471- 0528.1985.tb01355.x. https://www.ncbi.nlm.nih.gov/pubmed/3888250
Mayersak J.S.: Transrectal ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome. A report of a 5 year clinical study of 75 patients. Int Surg. 1998, 83, 347–349. https://www.ncbi.nlm.nih.gov/pubmed/10096759
Meares E.M., Stamey T.A.: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968, 5 (5), 492–518. https://www. ncbi.nlm.nih.gov/pubmed/4870505
Melekos M.D.: Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol. 1990, 22 (3), 257–262. doi: 10.1007/bf02550403. https://www. ncbi.nlm.nih.gov/pubmed/2210982
Meyer W.H., Huland H., Becker H.: Transrectal prostatic biopsy: The incidence of fever and sepsis after treatment with antibiotics. Aktuelle Urol, 1987. 18: 22. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., Goyal M., Fuchs B.D., Shah C.V. i wsp.: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009, 37 (5), 1670– 1677. doi: 10.1097/CCM.0b013e31819fcf68. https://www.ncbi.nlm.nih. gov/pubmed/19325467
Millar L.K., Wing D.A., Paul R.H., Grimes D.A.: Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol. 1995, 86, 560–564. doi: 10.1016/0029-7844(95)00244-l. https://www. ncbi.nlm.nih.gov/pubmed/7675380
Mody L., Juthani-Mehta M.: Urinary tract infections in older women: a clinical review. JAMA. 2014, 311 (8), 844–854. doi: 10.1001/jama.2014.303. https://www.ncbi.nlm.nih.gov/pubmed/24570248
Mombelli G., Pezzoli R., Pinoja-Lutz G., Monotti R., Marone C., Franciolli M.: Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med. 1999, 159 (1), 53–58. doi: 10.1001/archinte.159.1.53. https://www.ncbi.nlm.nih.gov/pubmed/9892331
Monnet X., Marik P.E., Teboul J.L.: Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016, 6 (1), 111. doi: 10.1186/s13613-016- 0216-7. https://www.ncbi.nlm.nih.gov/pubmed/27858374
Moradi M., Abbasi M., Moradi A., Boskabadi A., Jalali A.: Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. Urol J. 2005, 2 (1), 32–35. https://www.ncbi.nlm.nih.gov/pubmed/17629893
Mouncey P.R., Osborn T.M., Power G.S., Harrison D.A., Sadique M.Z., Grieve R.D. i wsp.: Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015, 372 (14), 1301–1311. doi: 10.1056/NEJMoa1500896. https://www.ncbi.nlm.nih.gov/pubmed/25776532
Mrkobrada M., Ying I., Mokrycke S., Dresser G., Elsayed S., Bathini V. i wsp.: CUA Guidelines on antibiotic prophylaxis for urologic procedures. Can Urol Assoc J. 2015, 9, 13–22. doi: 10.5489/cuaj.2382. https://www.ncbi.nlm. nih.gov/pubmed/25737749
Mulla N.: Bacteriuria in pregnancy. Obstet Gynecol. 1960, 16, 89–92. https:// www.ncbi.nlm.nih.gov/pubmed/14425118
Murphy D.M., Stassen L., Carr M.E., Gillespie W.A., Cafferkey M.T., Falkiner F.R.: Bacteraemia during prostatectomy and other transurethral operations: influence of timing of antibiotic administration. J Clin Pathol. 1984, 37 (6), 673–676. doi: 10.1136/jcp.37.6.673. https://www.ncbi.nlm.nih.gov/ pubmed/6725613
Naber K.G., Cho Y.H., Matsumoto T., Schaeffer A.J.: Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009, 33 (2), 111–119. doi: 10.1016/j.ijantimicag.2008.08.011. https://www.ncbi.nlm.nih.gov/pubmed/18963856
Naber K.G., Pilatz A., Weidner W., Naber K.: Prostatitits, epididymitis and orchitis. W: Red. D. Armstrong, J. Cohen, Infectious diseases. Mosby, London 1999. Naber K.G., Schito G., Botto H., Palou J., Mazzei T.: Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008, 54 (5), 1164–1175. doi: 10.1016/j.eururo.2008.05.010. https://www. ncbi.nlm.nih.gov/pubmed/18511178
Nicholson A., Rait G., Murray-Thomas T., Hughes G., Mercer C.H., Cassell J.: Management of epididymo-orchitis in primary care: Results from a large UK primary care database. Br J Gen Pract. 2010, 60, e407–422. doi: 10.3399/ bjgp10X532413. https://www.ncbi.nlm.nih.gov/pubmed/20883615
Nickel J.C.: Effective office management of chronic prostatitis. Urol Clin North Am. 1998, 25 (4), 677–684. doi: 10.1016/s0094-0143(05)70056-2. https://www.ncbi.nlm.nih.gov/pubmed/10026774
Nickel J.C., Shoskes D., Wang Y., Alexander R.B., Fowler J.E. Jr, Zeitlin S. i wsp.: How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006, 176 (1), 119–124. doi: 10.1016/S0022- 5347(06)00498-8. https://www.ncbi.nlm.nih.gov/pubmed/16753385
Nicolle L.E.: Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 1997, 11 (3), 647–662. doi: 10.1016/s0891-5520(05)70378-0. https:// www.ncbi.nlm.nih.gov/pubmed/9378928
Nicolle L.E.: Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother. 2000, 46 Suppl 1, 35–39. https://www.ncbi.nlm. nih.gov/pubmed/11051622
Nicolle L.E.: Urinary tract infections in patients with spinal injuries. Curr Infect Dis Rep. 2014, 16 (1), 390. doi: 10.1007/s11908-013-0390-9. https:// www.ncbi.nlm.nih.gov/pubmed/24445675
Nicolle L.E., Bjornson J., Harding G.K., MacDonell J.A.: Bacteriuria in elderly institutionalized men. N Engl J Med. 1983, 309 (23), 1420–1425. doi: 10.1056/NEJM198312083092304. https://www.ncbi.nlm.nih.gov/ pubmed/6633618
Nicolle L.E., Bradley S., Colgan R., Rice J.C., Schaeffer A., Hooton T.M.: Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005, 40 (5), 643–654. doi: 10.1086/427507.https://www.ncbi.nlm.nih.gov/pubmed/15714408
Nicolle L.E., Mayhew W.J., Bryan L.: Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med. 1987, 83 (1), 27–33. doi: 10.1016/0002- 9343(87)90493-1. https://www.ncbi.nlm.nih.gov/pubmed/3300325
Ohkawa M., Yamaguchi K., Tokunaga S., Nakashima T., Shoda R.: Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum. Urol Int. 1993, 51 (3), 129–132. doi: 10.1159/000282530. https://www.ncbi.nlm.nih.gov/pubmed/8249222
Olsen L., Nielsen I.K., Zachariassen A., Sederberg-Olsen J., Frimodt-Möller N.: Single-dose versus six-day therapy with sulfamethizole for asymptomatic bacteriuria during pregnancy. A prospective randomised study. Dan Med Bull. 1989, 36 (5), 486–487. https://www.ncbi.nlm.nih.gov/pubmed/2680315
Origuen J., López-Medrano F., Fernández-Ruiz M., Polanco N., Gutiérrez E., González E. i wsp.: Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant. 2016, 16 (10), 2943–2953. doi: 10.1111/ajt.13829. https:// www.ncbi.nlm.nih.gov/pubmed/27088545
Ouslander J.G., Schapira M., Schnelle J.F., Uman G., Fingold S., Tuico E.L.: Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med. 1995, 122 (10), 749–754. doi: 10.7326/0003-4819-122-10-199505150-00003. https://www.ncbi.nlm. nih.gov/pubmed/7717597
Papp J.R., Schachter J., Gaydos C.A., Van Der Pol B.: Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014. MMWR Recomm Rep. 2014, 63, 1–19. https://www. ncbi.nlm.nih.gov/pubmed/24622331
Pathak U.N., Tang K., Williams L.L., Stuart K.L.: Bacteriuria of pregnancy: results of treatment. J Infect Dis. 1969, 120, 91–103. doi: 10.1093/ infdis/120.1.91. https://www.ncbi.nlm.nih.gov/pubmed/5816817
Pedler S.J., Bint A.J.: Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy. Antimicrob Agents Chemother. 1985, 27 (4), 508–510. doi: 10.1128/aac.27.4.508. https:// www.ncbi.nlm.nih.gov/pubmed/4004191
Perletti G., Marras E., Wagenlehner F.M., Magri V.: Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database Syst Rev. 2013: CD009071. doi: 10.1002/14651858.CD009071.pub2. https://www.ncbi.nlm.nih.gov/ pubmed/23934982
Peterson J., Kaul S., Khashab M., Fisher A., Kahn J.B.: Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Clin Ther. 2007, 29 (10), 2215–2221. doi: 10.1016/j.clinthera.2007.10.008. https://www. ncbi.nlm.nih.gov/pubmed/18042477
Pfau A., Sacks T.G.: Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis. 1992, 14 (4), 810–814. https:// www.ncbi.nlm.nih.gov/pubmed/1576275
Phillips B., Ball C., Sackett D., Badenoch D., Straus S., Haynes B. i wsp.: Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. 1998. http://www.cebm.net/ oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
Pilatz A., Hossain H., Kaiser R., Mankertz A., Schüttler C.G., Domann E. i wsp.: Acute Epididymitis Revisited: Impact of Molecular Diagnostics on Etiology and Contemporary Guideline Recommendations. Eur Urol. 2015, 68 (3), 428–435. doi: 10.1016/j.eururo.2014.12.005. https://www.ncbi.nlm.nih. gov/pubmed/25542628
Pilatz A., Wagenlehner F., Hans-Christian S., Rusz A., Weidner W.: Impact of bacterial epididymitis on semen quality after antibiotic treatment. J Urol. 2012, 1: e443. doi: 10.1016/j.juro.2012.02.1199. https://www.ncbi.nlm. nih.gov/pubmed/70720788
Pitout J.D.: Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010, 70 (3), 313–333. doi: 10.2165/11533040-000000000-00000. https://www.ncbi.nlm.nih.gov/pubmed/20166768
Plettenberg A.: STI – Sexually transmitted infections (Article in German). Ifi-Card, 2nd Edition June 2014. Polascik T.J., Oesterling J.E., Partin A.W.: Prostate specific antigen: a decade of discovery – what we have learned and where we are going. J Urol. 1999, 162 (2), 293–306. doi: 10.1016/s0022-5347(05)68543-6. https://www. ncbi.nlm.nih.gov/pubmed/10411025
Potts L., Cross S., MacLennan W.J., Watt B.: A double-blind comparative study of norfloxacin versus placebo in hospitalised elderly patients with asymptomatic bacteriuria. Arch Gerontol Geriatr. 1996, 23 (2), 153–161. doi: 10.1016/0167-4943(96)00715-7. https://www.ncbi.nlm.nih.gov/ pubmed/15374159
Pregazzi R., Mazzatenta E., Bouchè C.: [Single-dose antibiotic therapy of asymptomatic bacteriuria in pregnancy. Results and complications]. Minerva Ginecol. 1987, 39 (4), 289–292. https://www.ncbi.nlm.nih.gov/pubmed/3601207
ProCESS Investigators, Yealy D.M., Kellum J.A., Huang D.T., Barnato A.E., Weissfeld L.A., Pike F. i wsp.: A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014, 370 (18), 1683–1693. doi: 10.1056/ NEJMoa1401602. https://www.ncbi.nlm.nih.gov/pubmed/24635773
Radmayr C., Bogaert G., Dogan H.S., Kočvara R., Nijman J.M., Stein R. i wsp.: EAU Guidelines on Paediatric Urology. In: EAU Guidelines, edition presented at the annual EAU Congress Barcelona 2019. ISBN 978-94-92671- 04-2. https://uroweb.org/guideline/paediatric-urology/
Raz R., Stamm W.E.: A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993, 329 (11), 753–756. doi: 10.1056/NEJM199309093291102. https://www. ncbi.nlm.nih.gov/pubmed/8350884
Reeves D.S.: Laboratory and clinical studies with sulfametopyrazine as a treatment for bacteriuria in pregnancy. J Antimicrob Chemother. 1975, 1 (2), 171–186. doi: 10.1093/jac/1.2.171. https://www.ncbi.nlm.nih.gov/ pubmed/1100589
Renneberg J., Paerregaard A.: Single-day treatment with trimethoprim for asymptomatic bacteriuria in the elderly patient. J Urol, 1984, 132 (5), 934– 935. doi: 10.1016/s0022-5347(17)49954-x. https://www.ncbi.nlm.nih.gov/ pubmed/6387184
Reyner K., Heffner A.C., Karvetski C.H.: Urinary obstruction is an important complicating factor in patients with septic shock due to urinary infection. Am J Emerg Med. 2016, 34 (4), 694–696. doi: 10.1016/j.ajem.2015.12.068. https://www.ncbi.nlm.nih.gov/pubmed/26905806
Riedl C.R., Plas E., Hübner W.A., Zimmerl H., Ulrich W., Pflüger H.: Bacterial colonization of ureteral stents. Eur Urol. 1999, 36 (1), 53–59. doi: 10.1159/000019927. https://www.ncbi.nlm.nih.gov/pubmed/10364656
Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B. i wsp.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345 (19), 1368–1377. doi: 10.1056/NEJMoa010307. https://www.ncbi.nlm.nih.gov/pubmed/11794169
Robertson J.G., Livingstone J.R., Isdale M.H.: The managment and complications of asymptomatic bacteriuria in pregnancy. Report of a study on 8,275 patients. J Obstet Gynaecol Br Commonw. 1968, 75 (1), 59–65. doi: 10.1111/j.1471-0528.1968.tb00121.x. https://www.ncbi.nlm.nih.gov/ pubmed/5635245
Robinson A.J., Grant J.B., Spencer R.C., Potter C., Kinghorn G.R.: Acute epididymitis: why patient and consort must be investigated. Br J Urol. 1990, 66 (6), 642–645. doi: 10.1111/j.1464-410x.1990.tb07200.x. https://www. ncbi.nlm.nih.gov/pubmed/2265337
Roghmann F., von Bodman C., Löppenberg B., Hinkel A., Palisaar J., Noldus J.: Is there a need for the Fournier’s gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier’s gangrene. BJU Int. 2012, 110 (9), 1359–1365. doi: 10.1111/j.1464-410X.2012.11082.x. https://www.ncbi.nlm.nih.gov/pubmed/22494217
Rosser C.J., Bare R.L., Meredith J.W.: Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg. 1999, 177 (4), 287– 290. doi: 10.1016/s0002-9610(99)00048-3. https://www.ncbi.nlm.nih. gov/pubmed/10326844
Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E.: Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Clin Infect Dis. 1992, 15 Suppl 1, S216–S227. doi: 10.1093/clind/15.supplement_1.s216. https://www.ncbi.nlm.nih.gov/ pubmed/1477233 Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E.: General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. Eur J Clin Microbiol Infect Dis. Taukirchen, Germany. 1993, 240. doi: 10.1093/clind/15.supplement_1.s216. https://academic. oup.com/cid/article/15/Supplement_1/S216/272999
Rudenko N., Dorofeyev A.: Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung. 2005, 55 (7), 420–427. doi: 10.1055/s-0031-1296881. https://www.ncbi. nlm.nih.gov/pubmed/16080282
Ruebush I.T.K., McConville J.H., Calia F.M.: A double-blind study of trimethoprim-sulfamethoxazole prophylaxis in patients having transrectal needle biopsy of the prostate. J Urol. 1979, 122 (4), 492–494. doi: 10.1016/ s0022-5347(17)56477-0. https://www.ncbi.nlm.nih.gov/pubmed/384025
Saint S., Greene M.T., Fakih M.G.: Preventing Catheter-Associated Urinary Tract Infections. N Engl J Med. 2016, 375 (13), 1298–1299. doi: 10.1056/ NEJMc1609988. https://www.ncbi.nlm.nih.gov/pubmed/27682041
Saint S., Lipsky B.A.: Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med. 1999, 159 (8), 800–808. doi: 10.1001/ archinte.159.8.800. https://www.ncbi.nlm.nih.gov/pubmed/10219925
Schaeffer A.J.: Prostatitis: US perspective. Int J Antimicrob Agents. 1999, 11, 205–211. doi: 10.1016/s0924-8579(99)00046-1. https://www.ncbi. nlm.nih.gov/pubmed/10394972
Schaeffer A.J., Datta N.S., Fowler J.E. Jr, Krieger J.N., Litwin M.S., Nadler R.B i wsp.: Summary consensus statement: diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2003, 43, 1–4. doi: 10.1016/s0090-4295(02)01979-9. https://www.ncbi.nlm.nih. gov/pubmed/12521576
Schaeffer A.J., Stuppy B.A.: Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol. 1999, 161 (1), 207–211. https://www.ncbi.nlm.nih.gov/pubmed/10037399
Schaeffer A.J., Wu S.C., Tennenberg A.M., Kahn J.B.: Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. J Urol. 2005, 174 (1), 161–164. doi: 10.1097/01. ju.0000162017.24965.2b. https://www.ncbi.nlm.nih.gov/pubmed/15947609
Schneider H., Ludwig M., Hossain H.M., Diemer T., Weidner W.: The 2001 Giessen Cohort Study on patients with prostatitis syndrome – an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis. Andrologia. 2003, 35 (5), 258–262. https://www.ncbi.nlm. nih.gov/pubmed/14535851
Scholes D., Hooton T.M., Roberts P.L., Gupta K., Stapleton A.E., Stamm W.E.: Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005, 142 (1), 20–27. doi: 10.7326/0003-4819-142-1-200501040- 00008. https://www.ncbi.nlm.nih.gov/pubmed/15630106
Schuts E.C., Hulscher M.E., Mouton J.W., Verduin C.M., Stuart J.W., Overdiek H.W. i wsp.: Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016, 16 (7), 847–856. doi: 10.1016/S1473-3099(16)00065-7. https://www.ncbi. nlm.nih.gov/pubmed/26947617
Schwenger E.M., Tejani A.M., Loewen P.S.: Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015, CD008772. doi: 10.1002/14651858.CD008772.pub2. https://www.ncbi. nlm.nih.gov/pubmed/26695595
Seyrek M., Binbay M., Yuruk E., Akman T., Aslan R., Yazici O. i wsp.: Perioperative prophylaxis for percutaneous nephrolithotomy: Randomized study concerning the drug and dosage. J Endourol. 2012, 26 (11), 1431–1436. doi: 10.1089/end.2012.0242. https://www.ncbi.nlm.nih.gov/pubmed/22612061
Sharpe J.R., Sadlowski R.W., Finney R.P., Branch W.T., Hanna J.E.: Urinary tract infection after transrectal needle biopsy of the prostate. J Urol. 1982, 127 (2), 255–256. doi: 10.1016/s0022-5347(17)53730-1. https://www.ncbi. nlm.nih.gov/pubmed/7062377
Silver S.A., Baillie L., Simor A.E.: Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals? Can J Infect Dis Med Microbiol. 2009, 20 (4), 107–111. doi: 10.1155/2009/702545. https://www.ncbi.nlm. nih.gov/pubmed/21119801
Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M. i wsp.: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016, 315 (8), 801–810. doi: 10.1001/ jama.2016.0287. https://www.ncbi.nlm.nih.gov/pubmed/26903338
Skerk V., Krhen I., Schonwald S., Cajic V., Markovinovic L., Roglic S. i wsp.: The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents. 2004, 24 Suppl 1, S53–S56. doi: 10.1016/j.ijantimicag.2004.02.010. https:// www.ncbi.nlm.nih.gov/pubmed/15364308
Skerk V., Schönwald S., Krhen I., Banaszak A., Begovac J., Strugar J. i wsp.: Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents. 2003, 21 (5), 457–462. doi: 10.1016/s0924-8579(03)00056-6. https://www.ncbi.nlm.nih.gov/pubmed/12727080
Smelov V., Perekalina T., Artemenko N., Smelova N., Ukleeva G., Gorelov A.: Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome. Andrologia. 2005, 37, 61–64. doi: 10.1111/j.1439- 0272.2005.00654.x. https://www.ncbi.nlm.nih.gov/pubmed/16026425
Sobel J.D., Kauffman C.A., McKinsey D., Zervos M., Vazquez J.A., Karchmer A.W. i wsp.: Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 2000, 30 (1), 19–24. doi: 10.1086/313580. https://www.ncbi.nlm.nih.gov/pubmed/10619727
Sorensen M.D., Krieger J.N.: Fournier’s Gangrene: Epidemiology and Outcomes in the General US Population. Urol Int. 2016, 97 (3), 249–259. doi: 10.1159/000445695. https://www.ncbi.nlm.nih.gov/pubmed/27172977
Sousa R., Muñoz-Mahamud E., Quayle J., Dias da Costa L., Casals C., Scott P.: Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Inf Dis. 2014, 59 (1), 41–47. doi: 10.1093/cid/ciu235. https://www.ncbi. nlm.nih.gov/pubmed/24723280
Spoorenberg V., Hulscher M.E., Akkermans R.P., Prins J.M., Geerlings S.E.: Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin Infect Dis. 2014, 58 (2), 164–169. doi: 10.1093/ cid/cit688. https://www.ncbi.nlm.nih.gov/pubmed/24158412
Spoorenberg V., Hulscher M.E., Geskus R.B., de Reijke T.M., Opmeer B.C., Prins J.M. i wsp.: [Better antibiotic use in complicated urinary tract infections; multicentre cluster randomised trial of 2 improvement strategies]. Ned Tijdschr Geneeskd. 2016, 160, D460. https://www.ncbi.nlm.nih.gov/ pubmed/27438395
Stamm W.E., Hooton T.M.: Management of urinary tract infections in adults. N Engl J Med. 1993, 329 (18), 1328–1334. doi: 10.1056/ NEJM199310283291808. https://www.ncbi.nlm.nih.gov/pubmed/8413414
Stevens D.L., Bisno A.L., Chambers H.F., Dellinger E.P., Goldstein E.J., Gorbach S.L. i wsp.: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014, 59 (2), 147–159. doi: 10.1093/cid/ciu296. https://www.ncbi.nlm.nih.gov/pubmed/24947530
Stothers L.: A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002, 9 (3), 1558–1562. https://www. ncbi.nlm.nih.gov/pubmed/12121581
Street E.J., Joyce A., Wilson J.: BASHH UK guideline for the management of epididymo-orchitis, 2010. Int J STD AIDS. 2011, 22 (7), 361–365. doi: 10.1258/ ijsa.2011.011023. https://www.ncbi.nlm.nih.gov/pubmed/21729951
Street E.J., Justice E.D., Kopa Z., Portman M.D., Ross J.D., Skerlev M. i wsp.: The 2016 European guideline on the management of epididymo-orchitis. Int J STD AIDS, 2017, 28 (8), 744–749. doi: 10.1177/0956462417699356. https://www.ncbi.nlm.nih.gov/pubmed/28632112
Subrahmanyam U., Ugane S.P.: Honey dressing beneficial in treatment of fournier’s gangrene. Indian J Surg. 2004, 66 (2), 75–77. http://citeseerx. ist.psu.edu/viewdoc/download?doi=10.1.1.554.4604&rep=rep1&type=pdf
Sunden F., Håkansson L., Ljunggren E., Wullt B.: Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol. 2010, 184 (1), 179–185. doi: 10.1016/j. juro.2010.03.024. https://www.ncbi.nlm.nih.gov/pubmed/20483149
Swartz S.L., Kraus S.J., Herrmann K.L., Stargel M.D., Brown W.J., Allen S.D.: Diagnosis and etiology of nongonococcal urethritis. J Infect Dis. 1978, 138, 445–454. doi: 10.1093/infdis/138.4.445. https://www.ncbi.nlm.nih. gov/pubmed/213495
Taher Y., Ozen H., Akdogan B., Unal S., Dogan S.: MP48-11 Prospective randomized controlled study to assess the effect of perineal region cleansing with povidone iodine before transrectal needle biopsy of the prostate on infectious complications. J Urol. 2015, 193 (45), e598. doi: 10.1016/j.juro.2015.02.1685. https://www.jurology.com/doi/full/10.1016/j.juro.2015.02.1685
Takenaka A., Hara R., Ishimura T., Fujii T., Jo Y., Nagai A. i wsp.: A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostatic Dis. 2008, 11 (2), 134–138. doi: 10.1038/sj.pcan.4500985. https://www.ncbi.nlm. nih.gov/pubmed/17533394
Tandogdu Z., Bartoletti R., Cai T., Çek M., Grabe M., Kulchavenya E.: Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003- 2013. World J Urol. 2016, 34 (8), 1193–1200. doi: 10.1007/s00345-015- 1722-1. https://www.ncbi.nlm.nih.gov/pubmed/26658886
Tanner J., Dumville J.C., Norman G., Fortnam M.: Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev. 2016: CD004288. doi: 10.1002/14651858.CD004288.pub3. https://www.ncbi.nlm.nih.gov/ pubmed/26799160
Tanner J., Norrie P., Melen K.: Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev. 2011, CD004122. doi: 10.1002/14651858.CD004122.pub4. https://www.ncbi.nlm.nih.gov/ pubmed/22071812
Tekdogan U., Tuncel A., Eroglu M., Unsal A., Atan A., Balbay M.: The efficiency of prophylactic antibiotic treatment in patients without risk factor who underwent transrectal. Turk Uroloji Dergisi. 2006, 32, 261–267. https:// www.researchgate.net/publication/289651865
Tencer J.: Asymptomatic bacteriuria – a long-term study. Scand J Urol Nephrol. 1988, 22 (1), 31–34. doi: 10.1080/00365599.1988.11690380. https://www.ncbi.nlm.nih.gov/pubmed/3387908
Tenke P., Kovacs B., Bjerklund Johansen T.E., Matsumoto T., Tambyah P.A., Naber K.G. i wsp.: European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008, 31 Suppl 1, S68–S78. doi: 10.1016/j.ijantimicag.2007.07.033. https:// www.ncbi.nlm.nih.gov/pubmed/18006279
The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014, 371, 1496–1506. doi: 10.1056/NEJMoa1404380. https://www.nejm.org/doi/ full/10.1056/NEJMoa1404380
The PRISM Investigators: Early, Goal-Directed Therapy for Septic Shock – A Patient-Level Meta-Analysis. N Engl J Med. 2017, 376, 2223–2234. doi: 10.1056/NEJMoa1701380. https://www.nejm.org/doi/full/10.1056/ NEJMoa1701380
Thompson P.M., Pryor J.P., Williams J.P., Eyers D.E., Dulake C., Scully M.F. i wsp.: The problem of infection after prostatic biopsy: The case for the transperineal approach. Br J Urol. 1982, 54 (6), 736–740. doi: 10.1111/j.1464- 410x.1982.tb13637.x. https://www.ncbi.nlm.nih.gov/pubmed/7150932
Thomsen A.C., Mørup L., Hansen K.B.: Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet. 1987, 1, 591– 593. doi: 10.1016/s0140-6736(87)90234-0. https://www.ncbi.nlm.nih. gov/pubmed/2881132
Thoumsin H., Aghayan M., Lambotte R.: Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. Infection. 1990, 18 Suppl 2, S94–S97. doi: 10.1007/ bf01643435. https://www.ncbi.nlm.nih.gov/pubmed/2286469
Trautner B.W.: Asymptomatic bacteriuria: when the treatment is worse than the disease. Nat Rev Urol. 2011, 9 (2), 85–93. doi: 10.1038/nrurol.2011.192. https://www.ncbi.nlm.nih.gov/pubmed/22143416
Turner J.A., Ciol M.A., Von Korff M., Berger R.: Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 2003, 169 (2), 580–583. doi: 10.1097/01.ju.0000047620.95034.a5. https://www.ncbi.nlm.nih.gov/pubmed/12544311
Tuzel E., Aktepe O.C., Akdogan B.: Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy. J Endourol. 2013, 27 (2), 172–176. doi: 10.1089/end.2012.0331. https://www.ncbi.nlm. nih.gov/pubmed/22908891
U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER). Complicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry 2018. https://www. fda.gov/downloads/Drugs/Guidances/ucm070981.pdf
U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER). Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment. 2015. http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/default.htm
Ulleryd P., Sandberg T.: Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003, 35 (1), 34–39. doi: 10.1080/0036554021000026988. https://www.ncbi.nlm.nih.gov/pubmed/12685882
van Buul L.W., Vreeken H.L., Bradley S.F., Crnich C.J., Drinka P.J., Geerlings S.E. i wsp.: The Development of a Decision Tool for the Empiric Treatment of Suspected Urinary Tract Infection in Frail Older Adults: A Delphi Consensus Procedure. J Am Med Dir Assoc. 2018, 19 (9), 757–764 doi: 10.1016/j. jamda.2018.05.001. https://www.ncbi.nlm.nih.gov/pubmed/29910137
van der Starre W.E., van Nieuwkoop C., Paltansing S., van’t Wout J.W., Groeneveld G.H., Becker M.J. i wsp.: Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother. 2011, 66 (3), 650–656. doi: 10.1093/jac/dkq465. https://www.ncbi.nlm.nih.gov/pubmed/21123286
van Haarst, E.P., van Andel G., Heldeweg E.A., Schlatmann T.J., van der Horst H.J.: Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections. Urology. 2001, 57 (6), 1068– 1072. doi: 10.1016/s0090-4295(01)00971-2. https://www.ncbi.nlm.nih. gov/pubmed/23867306
van Nieuwkoop C., Hoppe B.P., Bonten T.N., Van’t Wout J.W., Aarts N.J., Mertens B.J. i wsp.: Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010, 51 (11), 1266–1272. doi: 10.1086/657071. https://www.ncbi.nlm.nih.gov/pubmed/21034195
Vazquez J.C., Villar J.: Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev. 2000, CD002256. doi: 10.1002/14651858.CD002256. https://www.ncbi.nlm.nih.gov/ pubmed/10908537
Vickovic N., Skerk V., Granic J., Vargovic M., Pasini M., Turcic P.: Metronidazole 1.5 gram dose for 7 or 14 days in the treatment of patients with chronic prostatitis caused by Trichomonas vaginalis: A randomized study. J Chemother. 2010, 22 (5), 364–365. doi: 10.1179/joc.2010.22.5.364. https://www.ncbi. nlm.nih.gov/pubmed/21123162
Wagenlehner F.M., Hoyme U., Kaase M., Fünfstück R., Naber K.G., Schmiemann G.: Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011, 108 (24), 415–423. doi: 10.3238/arztebl.2011.0415. https://www.ncbi.nlm. nih.gov/pubmed/21776311
Wagenlehner F.M., Naber K.G.: Prostatitis: the role of antibiotic treatment. World J Urol. 2003, 21 (2), 105–108. doi: 10.1007/s00345-003-0333-4. https://www.ncbi.nlm.nih.gov/pubmed/12687400
Wagenlehner F.M., Pilatz A., Bschleipfer T., Diemer T., Linn T., Meinhardt A. i wsp.: Bacterial prostatitis. World J Urol. 2013, 31 (4), 711–716. doi: 10.1007/ s00345-013-1055-x. https://www.ncbi.nlm.nih.gov/pubmed/23519458
Wagenlehner F., Tandogdu Z., Bartoletti R., Cai T., Cek M., Kulchavenya E. i wsp.: The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections. Pathogens. 2016, 5 (1). doi: 10.3390/pathogens5010010. https://www.ncbi.nlm.nih.gov/ pubmed/26797640
Wagenlehner F.M., Vahlensieck W., Bauer H.W., Weidner W., Piechota H.J., Naber K.G.: Prevention of recurrent urinary tract infections. Minerva Urol Nefrol. 2013, 65 (1), 9–20. https://www.ncbi.nlm.nih.gov/pubmed/23538307
Wagenlehner F.M., Wullt B., Perletti G.: Antimicrobials in urogenital infections. Int J Antimicrob Agents. 2011, 38 Suppl, 3–10. doi: 10.1016/j.ijantimicag.2011.09.004. https://www.ncbi.nlm.nih.gov/pubmed/22019184
Walker J.T., Singla N., Roehrborn C.G.: Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review. Rev Urol. 2016, 18 (2), 73–89. doi: 10.3909/riu0713. https://www. ncbi.nlm.nih.gov/pubmed/27601966
Wang H., Zhou X., Chen S., Zhu C., Yu X.: Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination. Zhonghua Nan Ke Xue. 2004, (7) 10, 496–498. https://www.ncbi.nlm.nih.gov/pubmed/15354517
Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. i wsp.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999, 29 (4), 745–758. doi: 10.1086/520427. https://www.ncbi.nlm.nih.gov/pubmed/10589881
Warren J.W., Damron D., Tenney J.H., Hoopes J.M., Deforge B., Muncie H.L Jr.: Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis. 1987, 155 (6), 1151– 1158. doi: 10.1093/infdis/155.6.1151. https://www.ncbi.nlm.nih.gov/ pubmed/3572035
Warren J.W., Tenney J.H., Hoopes J.M., Muncie H.L., Anthony W.C.: A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982, 146 (6), 719–723. doi: 10.1093/ infdis/146.6.719. https://www.ncbi.nlm.nih.gov/pubmed/6815281
Webster J., Alghamdi A.: Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2015: CD006353. doi: 10.1002/14651858.CD006353.pub4. https://www.ncbi.nlm.nih.gov/ pubmed/25901509
Webster J., Osborne S.: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev. 2015: CD004985. doi: 10.1002/14651858.CD004985.pub5. https://www.ncbi. nlm.nih.gov/pubmed/25927093
Wetmore C.M., Manhart L.E., Lowens M.S., Golden M.R., Whittington W.L., XetMull A.M. i wsp.: Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study. Sex Transm Dis. 2011, 38 (3), 180–186. doi: 10.1097/OLQ.0b013e3182040de9. https://www.ncbi.nlm.nih.gov/pubmed/21285914
Whalley P.J., Cunningham F.G.: Short-term versus continuous antimicrobial therapy for asymptomatic bacteriuria in pregnancy. Obstet Gynecol. 1977, 49 (3), 262–265. https://www.ncbi.nlm.nih.gov/pubmed/320525
WHO. Antimicrobial resistance: global report on surveillance 2014. http:// www.who.int/drugresistance/documents/surveillancereport/en/ Widmer M., Lopez I., Gülmezoglu A.M., Mignini L., Roganti A.: Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev, 2015: CD000491. doi: 10.1002/14651858.CD000491.pub3. https:// www.ncbi.nlm.nih.gov/pubmed/26560337
Williams G.L., Campbell H., Davies K.J.: Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. Br Med J. 1969, 3, 212–215. doi: 10.1136/bmj.3.5664.212. https://www.ncbi.nlm.nih.gov/ pubmed/5792611
Wilson M.L., Mithecll M., Morris A.J., Murray P.R., Reimer L.G., Reller L.B. i wsp.: Principles and rocedures for blood cultures; Approved Guideline. Clinical and Laboratory Standards Institute (CLSI), 2007. https://clsi.org/ media/1448/m47a_sample.pdf
Wing D.A., Hendershott C.M., Debuque L., Millar L.K.: A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol. 1998, 92 (2), 249–253. doi: 10.1016/s0029-7844(98)00156- 2. https://www.ncbi.nlm.nih.gov/pubmed/9699761
Wise G.J., Shteynshlyuger A.: Atypical infections of the prostate. Curr Prostate Rep. 2008, 6, 86–93. https://link.springer.com/article/10.1007/ s11918-008-0014-2
Witkin S.S., Jeremias J., Toth M., Ledger W.J.: Detection of Chlamydia trachomatis by the polymerase chain reaction in the cervices of women with acute salpingitis. Am J Obstet Gynecol. 1993, 168 (5), 1438–1442. doi: 10.1016/s0002-9378(11)90778-9. https://www.ncbi.nlm.nih.gov/ pubmed/8498424
Workowski K.A., Bolan G.A.: Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015, 64, 1–137. https://www.ncbi.nlm. nih.gov/pubmed/26042815
Workowski K.A., Bolan G.A.: Sexually transmitted disease treatment guidelines. Center for Disease Contol, 2015. MMWR Recomm Rep. 2015, 64 (RR-03), 1–137. PMID: 26042815. https://pubmed.ncbi.nlm.nih.
gov/26042815-sexually-transmitted-diseases-treatment-guidelines-2015/ Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK). Chronic prostatitis workshop. 1995: Bethesda, Maryland. Wren B.G.: Subclinical renal infection and prematurity. Med J Aust. 1969, 2, 596–600. https://www.ncbi.nlm.nih.gov/pubmed/5388374
Wullt B., Agace W., Mansson W.: Bladder, bowel and bugs – bacteriuria in patients with intestinal urinary diversion. World J Urol. 2004, 22 (3), 186– 195. doi: 10.1007/s00345-004-0432-x. https://www.ncbi.nlm.nih.gov/ pubmed/15309491
Yamamoto S., Ishitoya S., Segawa T., Kamoto T., Okumura K., Ogawa O.: Antibiotic prophylaxis for transrectal prostate biopsy: A prospective randomized study of tosufloxacin versus levofloxacin. Int J Urol. 2008, 15 (7), 604–606. doi: 10.1111/j.1442-2042.2008.02056.x. https://www.ncbi.nlm. nih.gov/pubmed/18462354
Yang L., Hu J., Wei H., Wang L., Zhong H.: Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy. Zhonghua Wai Ke Za Zhi. 2001, 39 (12), 940–942. https://www.ncbi.nlm.nih.gov/pubmed/16201177
Yoon B.I., Kim S., Han D.S., Ha U.S., Lee S.J., Kim H.W. i wsp.: Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother. 2012, 18 (4), 444–450. doi: 10.1007/s10156-011-0350-y. https://www.ncbi. nlm.nih.gov/pubmed/22215226
You C., Hamasuna R., Ogawa M., Fukuda K., Hachisuga T., Matsumoto T. i wsp.: The first report: An analysis of bacterial flora of the first voided urine specimens of patients with male urethritis using the 16S ribosomal RNA genebased clone library method. Microb Pathog. 2016, 95, 95–100. doi: 10.1016/j. micpath.2016.02.022. https://www.ncbi.nlm.nih.gov/pubmed/27013259
Yuan Z., He C., Yan S., Ke Y., Tang W.: Randomized controlled clinical trial on the efficacy of fosfomycin trometamol for uncomplicated gonococcal urethritis in men. Clin Microbiol Infect. 2016, 22 (6), 507–512. doi: 10.1016/j. cmi.2016.03.031. https://www.ncbi.nlm.nih.gov/pubmed/27064136
Yu L., Ma L., Yu H.: Impact of insertion timing of iodophor cotton ball on the control of infection complications after transrectal ultrasound guided prostate biopsy. Nat Med J China. 2014, 94 (8), 609–611. https://www. ncbi.nlm.nih.gov/pubmed/24762693
Zani E.L., Clark O.A., Rodrigues Netto N. Jr.: Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane database of systematic reviews, 2011. 11: CD006576. doi: 10.1002/14651858.CD006576.pub2. https://www.ncbi. nlm.nih.gov/pubmed/21563156
Zegarra Montes L.Z., Sanchez Mejia A.A., Loza Munarriz C.A., Gutierrez E.C.: Semen and urine culture in the diagnosis of chronic bacterial prostatitis. Int Braz J Urol. 2008, 34 (1), 30–37. doi: 10.1590/s1677-55382008000100006. https://www.ncbi.nlm.nih.gov/pubmed/18341719
Zermann D.H., Ishigooka M., Doggweiler R., Schmidt R.A.: Neurourological insights into the etiology of genitourinary pain in men. J Urol. 1999, 161 (3), 903–908. https://www.ncbi.nlm.nih.gov/pubmed/10022711
Zhanel G.G., Harding G.K., Nicolle L.E.: Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis. 1991, 13 (1), 150–154. doi: 10.1093/ clinids/12.5.150. https://www.ncbi.nlm.nih.gov/pubmed/2017615

REKOMENDACJE DOTYCZĄCE POSTĘPOWANIA W ZABURZENIACH SEKSUALNYCH U MĘŻCZYZN
GUIDELINES ON MALE SEXUAL DYSFUNCTION: ERECTILE DYSFUNCTION AND PREMATURE EJACULATION

REKOMENDACJE DOTYCZĄCE POSTĘPOWANIA W ZABURZENIACH SEKSUALNYCH U MĘŻCZYZN
GUIDELINES ON MALE SEXUAL DYSFUNCTION: ERECTILE DYSFUNCTION AND PREMATURE EJACULATION


K. Hatzimouratidis (przewodniczący), F. Giuliano, I. Moncada, A. Muneer, A. Salonia, P. Verze, A. Parnham, E.C. Serefoglu Tłumaczenie i przygotowanie wersji polskiej / Translation and elaboration of Polish version: Marta Sochaj1, Jolanta Słowikowska-Hilczer2

1 Katedra Humanizacji Medycyny i Seksuologii, Uniwersytet Zielonogórski; 2 Zakład Endokrynologii Płodności, Katedra Andrologii i Endokrynologii Płodności, Uniwersytet Medyczny w Łodzi Autor do korespondencji / corresponding author: Jolanta Słowikowska-Hilczer, Zakład Endokrynologii Płodności, Katedra Andrologii i Endokrynologii Płodności, Uniwersytet Medyczny w Łodzi, ul. Pomorska 251. 92-213 Łódź, tel.: 42 201-41-42, jolanta.slowikowska-hilczer@umed.lodz.pl Otrzymano/received: 25.11.2019 r. Zaakceptowano/accepted: 27.12.2019 r. DOI: 10.26404/PAO_2353-8791.2019.07


Skróty / Abbreviations
AUC – pole powierzchni pod krzywą (ang. area under the curve); CHF – zastoinowa niewydolność serca (ang. congestive heart failure); Cmax – maksymalne stężenie leku, jakie jest osiągane we krwi po podaniu (ang. maximal concentration); ED – zaburzenia erekcji (ang. erectile dysfunction); EKG – elektrokardiogram (ang. electrocardiography); IELT – wewnątrzpochwowy czas opóźnienia ejakulacji (ang. intravaginal ejaculatory latency time); EMA – Europejska Agencja Leków (ang. European Medicines Agency); IIEF – międzynarodowy indeks funkcji erekcyjnej (ang. international index of erectile function); LE – poziom wiarygodności dowodu naukowego (ang. level of evidence); LVD – niewydolność lewej komory serca (ang. left ventricular dysfunction; NTPR – nocna ocena sztywności i twardości prącia (ang. nocturnal penile tumescence and rigidity); NYHA – Nowojorskie Towarzystwo Chorób Serca (ang. New York Heart Association); PE – przedwczesny wytrysk (ang. premature ejaculation); PDE5i – inhibitory fosfodiesterazy 5 (ang. phosphodiesterase 5 inhibitors); PRO – raport pacjenta (ang. patient-reported outcome); RP – radykalne wycięcie gruczołu krokowego (ang. radical prostatectomy); SSRI – inhibitory wychwytu zwrotnego serotoniny (ang. selective serotonin re-uptake inhibitor); T½ – biologiczny okres półtrwania leku, czas, w którym stężenie leku we krwi zmniejszy się do połowy wartości początkowej (ang. plasma elimination halftime); Tmax – czas, który mija od podania leku do osiągnięcia; USG – ultrasonografia (ang. ultrasonography)

Piśmiennictwo

Piśmiennictwo

Abdel-Hamid I.A., El Naggar E.A., El Gilany A.H.: Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res. 2001, 13 (1), 41–45. doi: 10.1038/sj.ijir.3900630. https://www.ncbi.nlm.nih.gov/pubmed/11313839
Abner E.L., Schmitt F.A., Mendiondo M.S., Marcum J.L., Kryscio R.J.: Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci. 2011, 4 (2), 158–170. doi: 10.2174/1874609811104020158. https://www.ncbi.nlm. nih.gov/pubmed/21235492
Abu El-Hamd M., Abdelhamed A.: Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial. Andrologia. 2018, 50 (1). doi: 10.1111/and.12829. https://www.ncbi.nlm.nih.gov/pubmed/28497478
Adeyoju A.B., Olujohungbe A.B., Morris J., Yardumian A., Bareford D., Akenova A. i wsp.: Priapism in sickle-cell disease; incidence, risk factors and complications – an international multicentre study. BJU Int. 2002, 90 (9), 898– 902. doi: 10.1046/j.1464-410x.2002.03022.x. https://www.ncbi.nlm.nih. gov/pubmed/12460353
Akakpo W., Pineda M.A., Burnett A.L.: Critical Analysis of Satisfaction Assessment After Penile Prosthesis Surgery. Sex Med Rev. 2017, 5 (2), 244–251. doi: 10.1016/j.sxmr.2017.01.001. https://www.ncbi.nlm.nih. gov/pubmed/28143706
Akkus E., Carrier S., Rehman J., Breza J., Kadioglu A., Lue T.F.: Is colchicine effective in Peyronie’s disease? A pilot study. Urology. 1994, 44 (2), 291– 295. doi: 10.1016/s0090-4295(94)80155-x. https://www.ncbi.nlm.nih. gov/pubmed/8048212
Akman T., Sanli O., Uluocak N., Akbulut F., Nane I., Demir S. i wsp.: The most commonly altered type of Peyronie’s disease deformity under oral colchicine treatment is lateral curvature that mostly shifts to the dorsal side. Andrologia. 2011, 43 (1), 28–33. doi: 10.1111/j.1439-0272.2009.01004.x. https://www.ncbi.nlm.nih.gov/pubmed/21219379
Alberti L., Torlasco C., Lauretta L., Loffi M., Maranta F., Salonia A. i wsp.: Erectile dysfunction in heart failure patients: a critical reappraisal. Andrology. 2013, 1 (2), 177–191. doi: 10.1111/j.2047-2927.2012.00048.x. https://www.ncbi. nlm.nih.gov/pubmed/23339018
Alexander Tonseth K., Egge T., Kolbenstvedt A., Hedlund H.: Evaluation of patients after treatment of arterial priapism with selective micro-embolization. Scand J Urol Nephrol. 2006, 40 (1), 49–52. doi: 10.1080/00365590500338040. https://www.ncbi.nlm.nih.gov/pubmed/16452056
Althof S.E.: Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J Urol. 2006, 175, 842–848. doi: 10.1016/S0022- 5347(05)00341-1. https://www.ncbi.nlm.nih.gov/pubmed/16469562
Althof S.E., Abdo C.H., Dean J., Hackett G., McCabe M., McMahon C.G. i wsp.: International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med. 2010, 7, (9), 2947–2969. doi: 10.1111/j.1743-6109.2010.01975.x. https://www.ncbi.nlm.nih.gov/ pubmed/21050394
Althof S.E., McMahon C.G., Waldinger M.D., Serefoglu E.C., Shindel A.W., Adaikan P.G. i wsp.: An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med. 2014 (6), 11, 1392–1422. doi: 10.1111/jsm.12504. https://www. ncbi.nlm.nih.gov/pubmed/24848686
Althof S.E., Rosen R.C., Perelman M.A., Rubio-Aurioles E.: Standard operating procedures for taking a sexual history. J Sex Med. 2013, 10 (1), 26–35. doi: 10.1111/j.1743-6109.2012.02823.x. https://www.ncbi.nlm.nih.gov/ pubmed/22970717
Althof S., Rosen R., Symonds T., Mundayat R., May K., Abraham L.: Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006, 3 (3), 465–475. doi: 10.1111/j.1743-6109.2006.00239.x. https://www.ncbi.nlm. nih.gov/pubmed/16681472
Althof S.E., Symonds T.: Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am. 2007, 34 (4), 581– 589. doi: 10.1016/j.ucl.2007.08.001. https://www.ncbi.nlm.nih.gov/ pubmed/17983898
Alwaal A., Al-Mannie R., Carrier S.: Future prospects in the treatment of erectile dysfunction: focus on avanafil. Drug Des Devel Ther. 2011, 5, 435–443. doi: 10.2147/DDDT.S15852. https://www.ncbi.nlm.nih.gov/pubmed/22087063
American Psychiatric Association., Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Text Revision. [Access date February 2014] Revision. 2000, American Psychiatric Publishing Inc: Washington, DC. http:// dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596 Anaissie J., Hellstrom W.J.: Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review. Res Rep Urol. 2016, 8, 123–131. doi: 10.2147/RRU.S68560. https://www.ncbi.nlm.nih.gov/pubmed/27536559
Anderson M.S., Shankey T.V., Lubrano T., Mulhall J.P.: Inhibition of Peyronie’s plaque fibroblast proliferation by biologic agents. Int J Impot Res. 2000, 12 Suppl 3, S25–S31. doi: 10.1038/sj.ijir.3900558. https://www.ncbi.nlm. nih.gov/pubmed/11002396
Antonini G., Busetto G.M., De Berardinis E., Giovannone R., Vicini P., Del Giudice F. i wsp.: Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: Evaluation of efficacy, satisfaction profile and complications. Int J Impot Res. 2016, 28 (1), 4–8. doi: 10.1038/ijir.2015.33. https://www.ncbi.nlm.nih.gov/pubmed/26657316
Arafa M., Eid H., El-Badry A., Ezz-Eldine K., Shamloul R.: The prevalence of Peyronie’s disease in diabetic patients with erectile dysfunction. Int J Impot Res. 2007, 19 (2), 213–217. doi: 10.1038/sj.ijir.3901518. https://www.ncbi. nlm.nih.gov/pubmed/16915304
Arafa M., Shamloul R.: Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE). J Sex Med. 2007, 4 (6), 1750–1756. doi: 10.1111/j.1743-6109.2006.00213.x. https://www.ncbi.nlm.nih.gov/ pubmed/17970977
Arango O., Castro R., Dominguez J., Gelabert A.: Complete resolution of posttraumatic high-flow priapism with conservative treatment. Int J Impot Res. 1999, 11 (2), 115–117. https://www.ncbi.nlm.nih.gov/pubmed/10356672
Ateyah A., Rahman El-Nashar A., Zohdy W., Arafa M., Saad El-Den H.: Intracavernosal irrigation by cold saline as a simple method of treating iatrogenic prolonged erection. J Sex Med. 2005, 2 (2), 248–253. doi: 10.1111/j.1743-6109.2005.20235.x. https://www.ncbi.nlm.nih.gov/ pubmed/16422893
Atikeler M.K., Gecit I., Senol F.A.: Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia. 2002, 34 (6), 356–359. doi: 10.1046/j.1439-0272.2002.00511.x. https://www.ncbi.nlm.nih.gov/ pubmed/12472618
Bai Y., Pu C., Han P., Li J., Yuan H., Tang Y. i wsp.: Selective Serotonin Reuptake Inhibitors Plus Phosphodiesterase-5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis. Urology. 2015, 86 (4), 758–764. doi: 10.1016/j.urology.2015.06.045. https://www.ncbi.nlm.nih.gov/ pubmed/26247816
Bailey A.J., Tarlton J.F., Van der Stappen J., Sims T.J., Messina A.: The continuous elongation technique for severe Dupuytren’s disease. A biochemical mechanism. J Hand Surg Br. 1994, 19 (4), 522–527. doi: 10.1016/0266- 7681(94)90220-8. https://www.ncbi.nlm.nih.gov/pubmed/7964107
Baillargeon J., Urban R.J., Kuo Y.F., Ottenbacher K.J., Raji M.A., Du F. i wsp.: Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. Ann Pharmacother. 2014, 48 (9), 1138–1144. doi: 10.1177/1060028014539918. https://www.ncbi.nlm.nih.gov/pubmed/24989174 Ballas S.K., Lyon D.: Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease. J Clin Apher. 2016, 31 (1), 5–10. doi: 10.1002/jca.21394. https://www.ncbi.nlm.nih.gov/pubmed/25809639
Bar Yosef Y., Binyamini J., Matzkin H., Ben-Chaim J.: Midline dorsal plication technique for penile curvature repair. J Urol. 2004, 172, 1368–1369. doi: 10.1097/01.ju.0000138341.68365.b6. https://www.ncbi.nlm.nih.gov/ pubmed/15371846
Bar-Or D., Salottolo K.M., Orlando A., Winkler J.V.: A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol. 2012, 61 (4), 736–743. doi: 10.1016/j.eururo.2011.08.039. https://www.ncbi.nlm.nih. gov/pubmed/21889833
Bartolucci P., Galactéros F.: Clinical management of adult sickle-cell disease. Curr Opin Hematol. 2012, 19 (3), 149–155. doi: 10.1097/ MOH.0b013e328351c35f. https://www.ncbi.nlm.nih.gov/pubmed/22357165
Basaria S., Coviello A.D., Travison T.G., Storer T.W., Farwell W.R., Jette A.M. i wsp.: Adverse events associated with testosterone administration. N Engl J Med. 2010, 363 (2), 109–122. doi: 10.1056/NEJMoa1000485. https:// www.ncbi.nlm.nih.gov/pubmed/20592293
Baskin L.S., Duckett J.W., Lue T.F.: Penile curvature. Urology. 1996, 48 (3), 347–356. doi: 10.1016/S0090-4295(96)00213-0. https://www.ncbi.nlm. nih.gov/pubmed/8804484
Bastuba M.D., Saenz de Tejada I., Dinlenc C., Sarazen A., Krane R.J., Goldstein I.: Arterial priapism: diagnosis, treatment and long-term followup. J Urol. 1994, 151 (5), 1231–1237. doi: 10.1016/s0022-5347(17)35219-9. https:// www.ncbi.nlm.nih.gov/pubmed/8158765
Bechara A., Casabé A., Chéliz G., Romano S., Rey H., Fredotovich N.: Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction. J Urol. 1997, 157 (6), 2132–2134. https://www.ncbi.nlm.nih. gov/pubmed/9146599
Bechara A., Casabé A., De Bonis W., Ciciclia P.G.: Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors. Sex Med. 2016, 4 (4), e225–232. doi: 10.1016/j.esxm.2016.06.001. https:// www.ncbi.nlm.nih.gov/pubmed/27444215
Behr-Roussel D., Gorny D., Mevel K., Caisey S., Bernabé J., Burgess G. i wsp.: Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol. 2005, 47 (1), 87–91. doi: 10.1016/j.eururo.2004.09.005. https://www.ncbi.nlm. nih.gov/pubmed/15582254
Bekos A., Arvaniti M., Hatzimouratidis K., Moysidis K., Tzortzis V., Hatzichristou D.: The natural history of Peyronie’s disease: an ultrasonography-based study. Eur Urol. 2008, 53 (3), 644–650. doi: 10.1016/j.eururo.2007.07.013. https://www.ncbi.nlm.nih.gov/pubmed/17673362
Bennett N.E., Guhring P., Mulhall J.P.: Intralesional verapamil prevents the progression of Peyronie’s disease. Urology. 2007, 69 (6), 1181–1184. doi: 10.1016/j.urology.2007.02.042. https://www.ncbi.nlm.nih.gov/ pubmed/17572211
Bennett N.E., Mulhall J.P.: Sickle cell disease status and outcomes of AfricanAmerican men presenting with priapism. J Sex Med. 2008, 5 (5), 1244– 1250. doi: 10.1111/j.1743-6109.2008.00770.x. https://www.ncbi.nlm.nih. gov/pubmed/18312286
Berger R., Billups K., Brock G., Broderick G.A., Dhabuwala C.B., Goldstein I. i wsp.: Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res. 2001, 13 Suppl 5, S39–43. doi: 10.1038/sj.ijir.3900777. https://www.ncbi. nlm.nih.gov/pubmed/11781746
Bertolotto M., Quaia E., Mucelli F.P., Ciampalini S., Forgács B., Gattuccio I. i wsp.: Color Doppler imaging of posttraumatic priapism before and after selective embolization. Radiographics. 2003, 23 (2), 495–503. doi: 10.1148/ rg.232025077. https://www.ncbi.nlm.nih.gov/pubmed/12640162
Bertolotto M., Zappetti R., Pizzolato R., Liguori G.: Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism. Acta Radiol. 2008, 49 (6), 710–714. doi: 10.1080/02841850802027026. https://www.ncbi.nlm.nih.gov/pubmed/18568565
Besiroglu H., Otunctemur A., Ozbek E.: The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med. 2015, 12 (6), 1309–1318. doi: 10.1111/jsm.12885. https://www.ncbi.nlm.nih.gov/pubmed/25872648
Bettocchi C., Palumbo F., Spilotros M., Lucarelli G., Palazzo S., Battaglia M. i wsp.: Patient and partner satisfaction after AMS inflatable penile prosthesis implant. J Sex Med. 2010, 7, 304–309. doi: 10.1111/j.1743- 6109.2009.01499.x. https://www.ncbi.nlm.nih.gov/pubmed/19758282
Bhasin S., Cunningham G.R., Hayes F.J., Matsumoto A.M., Snyder P.J., Swerdloff R.S. i wsp.: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010, 95 (6), 2536–2559. doi: 10.1210/jc.2009-2354. https://www.ncbi. nlm.nih.gov/pubmed/20525905
Bhat G.S., Shastry A.: Effectiveness of ‘on demand’ silodosin in the treatment of premature ejaculation in patients dissatisfied with dapoxetine: a randomized control study. Cent European J Urol. 2016, 69 (3), 280–284. doi: 10.5173/ceju.2016.843. https://www.ncbi.nlm.nih.gov/pubmed/27729995
Biagiotti G., Cavallini G.: Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report. BJU Int. 2001, 88 (1), 63–67. doi: 10.1046/j.1464-410x.2001.02241.x. https://www.ncbi.nlm.nih.gov/ pubmed/11446848
Binmoammar T.A., Hassounah S., Alsaad S., Rawaf S., Majeed A.: The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review. JRSM Open. 2016, 7, 2054270415622602. doi: 10.1177/2054270415622602. https://www.ncbi. nlm.nih.gov/pubmed/26981254
Bivalacqua T.J., Musicki B., Hsu L.L., Gladwin M.T., Burnett A.L., Champion H.C.: Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med. 2009, 6 (9), 2494–2504. doi: 10.1111/j.1743-6109.2009.01359.x. https://www.ncbi.nlm.nih.gov/ pubmed/19523035
Bivalacqua T.J., Musicki B., Kutlu O., Burnett A.L.: New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med. 2012, 9 (1), 79–87. doi: 10.1111/j.1743-6109.2011.02288.x. https://www.ncbi.nlm. nih.gov/pubmed/21554553
Bjekic M.D., Vlajinac H.D., Sipetic S.B., Marinkovic J.M.: Risk factors for Peyronie’s disease: a case-control study. BJU Int. 2006, 97 (3), 570–574. doi: 10.1111/j.1464-410X.2006.05969.x. https://www.ncbi.nlm.nih.gov/ pubmed/16469028
Boddi V., Castellini G., Casale H., Rastrelli G., Boni L., Corona G. i wsp.: An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study. Andrology. 2015, 3 (5), 909–918. doi: 10.1111/andr.12079. https://www.ncbi.nlm.nih.gov/pubmed/26311340
Bodner D.R., Lindan R., Leffler E., Kursh E.D., Resnick M.I.: The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. J Urol. 1987, 138 (2), 310–311. doi: 10.1016/s0022- 5347(17)43130-2. https://www.ncbi.nlm.nih.gov/pubmed/3599245
Bokarica P., Parazajder J., Mazuran B., Gilja I.: Surgical treatment of Peyronie’s disease based on penile length and degree of curvature. Int J Impot Res. 2005, 17 (2), 170–174. doi: 10.1038/sj.ijir.3901255. https://www.ncbi.nlm. nih.gov/pubmed/15215882
Bolat D., Kocabas G.U., Gunlusoy B., Aydogdu O., Aydin M.E.: The relationship between acquired premature ejaculation and metabolic syndrome: a prospective, comparative study. Int J Impot Res. 2017, 29 (3), 105–109. doi: 10.1038/ijir.2017.3. https://www.ncbi.nlm.nih.gov/pubmed/28179637
Borgdorff A.J., Bernabé J., Denys P., Alexandre L., Giuliano F.: Ejaculation elicited by microstimulation of lumbar spinothalamic neurons. Eur Urol. 2008, 54 (2), 449–456. doi: 10.1016/j.eururo.2008.03.043. https://www.ncbi. nlm.nih.gov/pubmed/18394782
Brant W.O., Dean R.C., Lue T.F.: Treatment of Peyronie’s disease with oral pentoxifylline. Nat Clin Pract Urol. 2006, 3 (2), 111–115. https://www.ncbi. nlm.nih.gov/pubmed/16470210
Brant W.O., Garcia M.M., Bella A.J., Chi T., Lue T.F.: T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol. 2009, 181 (4), 1699–1705. doi: 10.1016/j.juro.2008.12.021. https://www.ncbi.nlm. nih.gov/pubmed/19233430
Braun M., Wassmer G., Klotz T., Reifenrath B., Mathers M., Engelmann U.: Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000, 12, 305–311. doi: 10.1038/sj.ijir.3900622. https:// www.ncbi.nlm.nih.gov/pubmed/11416833
Brock G., Nehra A., Lipshultz L.I., Karlin G.S., Gleave M., Seger M. i wsp.: Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol. 2003, 170, 1278–1283. doi: 10.1097/01.ju.0000086947.00547.49. https://www.ncbi.nlm.nih.gov/ pubmed/14501741
Brock G., Ni X., Oelke M., Mulhall J., Rosenberg M., Seftel A. i wsp.: Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases. J Sex Med. 2016, 13 (5), 860–875. doi: 10.1016/j.jsxm.2016.02.171. https://www.ncbi.nlm. nih.gov/pubmed/27114197
Broderick G.A.: Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. J Sex Med. 2012, 9 (1), 88–103. doi: 10.1111/j.1743- 6109.2011.02317.x. https://www.ncbi.nlm.nih.gov/pubmed/21699659
Broderick G.A., Harkaway R.: Pharmacologic erection: time-dependent changes in the corporal environment. Int J Impot Res. 1994, 6 (1), 9–16. https:// www.ncbi.nlm.nih.gov/pubmed/8019618
Broderick G.A., Kadioglu A., Bivalacqua T.J., Ghanem H., Nehra A., Shamloul R.: Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010, 7, 476–500. doi: 10.1111/j.1743-6109.2009.01625.x. https://www. ncbi.nlm.nih.gov/pubmed/20092449
Burnett A.L.: Fascia lata in penile reconstructive surgery: a reappraisal of the fascia lata graft. Plast Reconstr Surg. 1997, 99 (4), 1061–1067. doi: 10.1097/00006534-199704000-00021. https://www.ncbi.nlm.nih.gov/ pubmed/9091903
Burnett A.L.: Surgical management of ischemic priapism. J Sex Med. 2012, 9 (1), 114–120. doi: 10.1111/j.1743-6109.2011.02446.x. https://www.ncbi. nlm.nih.gov/pubmed/22221308
Burnett A.L., Allen R.P., Tempany C.M., Dover G.J., Brendler C.B.: Evaluation of erectile function in men with sickle cell disease. Urology. 1995, 45 (4), 657–663. doi: 10.1016/s0090-4295(99)80059-4. https://www.ncbi.nlm. nih.gov/pubmed/7716848
Burnett A.L., Bivalacwua T.J.: Priapism: new concepts in medical and surgical management. Urol Clin North Am. 2011, 38 (2), 185–194. doi: 10.1016/j. ucl.2011.02.005. https://www.ncbi.nlm.nih.gov/pubmed/21621085
Burnett A.L., Bivalacqua T.J., Champion H.C., Musicki B.: Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med. 2006, 3 (6), 1077–1084. doi: 10.1111/j.1743-6109.2006.00333.x. https://www.ncbi.nlm.nih.gov/ pubmed/17100941
Burnett A.L., Bivalacqua T.J., Champion H.C., Musicki B.: Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology. 2006, 67 (5), 1043–1048. doi: 10.1016/j.urology.2005.11.045. https://www. ncbi.nlm.nih.gov/pubmed/16698365
Burnett A.L., Pierorazio P.M.: Corporal “snake” maneuver: corporoglanular shunt surgical modification for ischemic priapism. J Sex Med. 2009, 6 (4), 1171–1176. doi: 10.1111/j.1743-6109.2008.01176.x. https://www.ncbi. nlm.nih.gov/pubmed/19207268
Burnett A.L., Sharlip I.D.: Standard operating procedures for priapism. J Sex Med. 2013, 10 (1), 180–194. doi: 10.1111/j.1743-6109.2012.02707.x. https://www.ncbi.nlm.nih.gov/pubmed/22462660
Burns P.R., Rosen R.C., Dunn M., Baygani S.K., Perelman M.A.: Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5mg once daily. J Sex Med. 2015, 12 (3), 720–727. doi: 10.1111/jsm.12818. https://www.ncbi. nlm.nih.gov/pubmed/25615445
Buvat J., Costa P., Morlier D., Lecocq B., Stegmann B., Albrecht D.: Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction. J Urol. 1998, 159 (1), 116–119. doi: 10.1016/s0022-5347(01)64030-8. https:// www.ncbi.nlm.nih.gov/pubmed/9400450
Buvat J., Hatzichristou D., Boess F.G., Büttner H., Gehchan N., Henneges C. i wsp.: Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study. Int J Clin Pract. 2014, 68 (9), 1087–1099. doi: 10.1111/ijcp.12449. https://www.ncbi. nlm.nih.gov/pubmed/25123817
Buvat J., Maggi M., Gooren L., Guay A.T., Kaufman J., Morgentaler A. i wsp.: Endocrine aspects of male sexual dysfunctions. J Sex Med. 2010, 7, 1627– 1656. doi: 10.1111/j.1743-6109.2010.01780.x. https://www.ncbi.nlm.nih. gov/pubmed/20388162
Byers E.S., Grenier G.: Premature or rapid ejaculation: heterosexual couples’ perceptions of men’s ejaculatory behavior. Arch Sex Behav. 2003, 32 (3), 261–270. doi: 10.1023/a:1023417718557. https://www.ncbi.nlm.nih. gov/pubmed/12807298
Cakan M., Altu Gcaron U., Aldemir M.: Is the combination of superselective transcatheter autologous clot embolization and duplex sonographyguided compression therapy useful treatment option for the patients with high-flow priapism? Int J Impot Res. 2006, 18 (2), 141–145. doi: 10.1038/ sj.ijir.3901373. https://www.ncbi.nlm.nih.gov/pubmed/16079900
Calof O.M., Singh A.B., Lee M.L., Kenny A.M., Urban R.J., Tenover J.L. i wsp.: Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005, 60 (11), 1451–1457. doi: 10.1093/ gerona/60.11.1451. https://www.ncbi.nlm.nih.gov/pubmed/16339333
Cantasdemir M., Gulsen F., Solak S., Numan F.: Posttraumatic high-flow priapism in children treated with autologous blood clot embolization: longterm results and review of the literature. Pediatr Radiol. 2011, 41 (6), 627–632. doi: 10.1007/s00247-010-1912-3. https://www.ncbi.nlm.nih. gov/pubmed/21127852
Capogrosso P., Colicchia M., Ventimiglia E., Castagna G., Clementi M.C., Suardi N. i wsp.: One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice. J Sex Med. 2013, 10 (7), 1833–1841. doi: 10.1111/jsm.12179. https://www. ncbi.nlm.nih.gov/pubmed/23651423
Capogrosso P., Ventimiglia E., Boeri L., Serino A., Russo A., La Croce G. i wsp.: Time of onset of vardenafil orodispersible tablet in a real-life setting - looking beyond randomized clinical trials. Expert Rev Clin Pharmacol. 2017, 10 (3), 339–344. doi: 10.1080/17512433.2017.1288567. https://www.ncbi. nlm.nih.gov/pubmed/28129714
Carani C., Isidori A.M., Granata A., Carosa E., Maggi M., Lenzi A. i wsp.: Multicenter study on the prevalence of sexual symptoms in male hypoand hyperthyroid patients. J Clin Endocrinol Metab. 2005, 90 (12), 6472–6479. doi: 10.1210/jc.2005-1135. https://www.ncbi.nlm.nih.gov/ pubmed/16204360
Caretta N., de Kreutzenberg S.V., Valente U., Guarneri G., Ferlin A., Avogaro A. i wsp.: Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes. Endocrine. 2016, 53 (3), 831–838. doi: 10.1007/s12020-015- 0851-z. https://www.ncbi.nlm.nih.gov/pubmed/26758995
Carrieri M.P., Serraino D., Palmiotto F., Nucci G., Sasso F.: A case-control study on risk factors for Peyronie’s disease. J Clin Epidemiol, 1998, 51 (6), 511– 515. doi: 10.1016/s0895-4356(98)00015-8. https://www.ncbi.nlm.nih. gov/pubmed/9636000
Carson C.C.: Penile prosthesis implantation in the treatment of Peyronie’s disease. Int J Impot Res. 1998, 10 (2), 125–128. doi: 10.1038/sj.ijir.3900330. https://www.ncbi.nlm.nih.gov/pubmed/9647951
Carson C., Gunn K.: Premature ejaculation: definition and prevalence. Int J Impot Res. 2006, 18 Suppl 1, S5–13. doi: 10.1038/sj.ijir.3901507. https:// www.ncbi.nlm.nih.gov/pubmed/16953247
Carson C.C., Mulcahy J.J., Govier F.E.: Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. AMS 700CX Study Group. J Urol. 2000, 164 (2), 376–380. https://www.ncbi.nlm.nih.gov/pubmed/10893589
Carson C.C., Mulcahy J.J., Harsch M.R.: Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol. 2011, 185 (2), 614–618. doi: 10.1016/j. juro.2010.09.094. https://www.ncbi.nlm.nih.gov/pubmed/21168870
Carson C.C., Sadeghi-Nejad H., Tursi J.P., Smith T.M., Kaufman G.J., Gilbert K. i wsp.: Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie’s disease (PD). BJU Int. 2015, 116 (5), 815–822. doi: 10.1111/bju.13120. https:// www.ncbi.nlm.nih.gov/pubmed/25818264
Casabe A.R., Sarotto N., Gutierrez C., Bechara A.J.: Satisfaction assessment with malleable prosthetic implant of Spectra (AMS) and Genesis (Coloplast) models. Int J Impot Res. 2016, 28 (6), 228–233. doi: 10.1038/ijir.2016.33. https://www.ncbi.nlm.nih.gov/pubmed/27557609
Castiglione F., Albersen M., Hedlund P., Gratzke C., Salonia A., Giuliano F.: Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis. Eur Urol. 2016, 69 (5), 904–916. doi: 10.1016/j. eururo.2015.12.028. https://www.ncbi.nlm.nih.gov/pubmed/26749092
Cavallini G.: Resolution of erectile dysfunction after an andrological visit in a selected population of patients affected by psychogenic erectile dysfunction. Asian J Androl. 2017, 19 (2), 219–222. doi: 10.4103/1008-682X.172646. https://www.ncbi.nlm.nih.gov/pubmed/26806083
Cavallini G., Biagiotti G., Koverech A., Vitali G.: Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie’s disease. BJU Int. 2002, 89 (9), 895–900. doi: 10.1046/j.1464- 410x.2002.02738.x. https://www.ncbi.nlm.nih.gov/pubmed/12010235
Cavallini G., Modenini F., Vitali G.: Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie’s disease. Urology. 2007, 69 (5), 950–954. doi: 10.1016/j.urology.2007.01.080. https://www.ncbi.nlm.nih. gov/pubmed/17482941
Champion H.C., Bivalacqua T.J., Takimoto E., Kass D.A., Burnett A.L.: Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A. 2005, 102 (5), 1661–1666. doi: 10.1073/ pnas.0407183102. https://www.ncbi.nlm.nih.gov/pubmed/15668387 Chaudhary M., Sheikh N., Asterling S., Ahmad I., Greene D.: Peyronie’s disease with erectile dysfunction: penile modeling over inflatable penile prostheses. Urology. 2005, 65 (4), 760–764. doi: 10.1016/j.urology.2004.10.039. https://www.ncbi.nlm.nih.gov/pubmed/15833523
Chen J., Mabjeesh N.J., Matzkin H., Greenstein A.: Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology. 2003, 61 (1), 197–200. doi: 10.1016/s0090- 4295(02)02075-7. https://www.ncbi.nlm.nih.gov/pubmed/12559295
Chen L., Staubli S.E., Schneider M.P., Kessels A.G., Ivic S., Bachmann L.M. i wsp.: Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: A trade-off network meta-analysis. Eur Urol. 2015, 68 (4), 674– 680. doi: 10.1016/j.eururo.2015.03.031. https://www.ncbi.nlm.nih.gov/ pubmed/25817916
Chen Y.F., Lin H.H., Lu C.C., Hung C.T., Lee M.H., Hsu C.Y.: Gout and a Subsequent Increased Risk of Erectile Dysfunction in Men Aged 64 and Under: A Nationwide Cohort Study in Taiwan. J Rheumatol. 2015, 42 (10), 1898–1905. doi: 10.3899/jrheum.141105. https://www.ncbi.nlm.nih.gov/ pubmed/26077405
Christodoulidou M., Pearce I.: Infection of Penile Prostheses in Patients with Diabetes Mellitus. Surg Infect (Larchmt). 2016, 17 (1), 2–8. doi: 10.1089/ sur.2015.164. https://www.ncbi.nlm.nih.gov/pubmed/26426099
Chun J.L., McGregor A., Krishnan R., Carson C.C.: A comparison of dermal and cadaveric pericardial grafts in the modified Horton-Devine procedure for Peyronie’s disease. J Urol. 2001, 166 (1), 185–188. https://www.ncbi. nlm.nih.gov/pubmed/11435853
Chung E., Broc G.B.: A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases. Expert Opin Pharmacother. 2011, 12 (8), 1341–1348. doi: 10.1517/14656566.2011.584064. https:// www.ncbi.nlm.nih.gov/pubmed/21548725
Chung E., Cartmill R.: Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial. BJU Int. 2015, 5, 46–49. doi: 10.1111/ bju.13035. https://www.ncbi.nlm.nih.gov/pubmed/25828173
Chung E., Deyoung L., Brock G.B.: The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med. 2011, 8 (5), 1472–1477. doi: 10.1111/j.1743-6109.2011.02217.x. https://www.ncbi.nlm.nih.gov/pubmed/21324095
Chung E., Van C.T., Wilson I., Cartmill R.A.: Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol. 2013, 31 (3), 591–595. doi: 10.1007/ s00345-012-0859-4. https://www.ncbi.nlm.nih.gov/pubmed/22457032
Cipollone G., Nicolai M., Mastroprimiano G., Iantorno R., Longeri D., Tenaglia R.: [Betamethasone versus placebo in Peyronie’s disease]. Arch Ital Urol Androl. 1998, 70 (4), 165–168. https://www.ncbi.nlm.nih.gov/pubmed/9823662
Clavijo R.I., Kohn T.P., Kohn J.R., Ramasamy R.: Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2017, 14 (1), 27–35. doi: 10.1016/j. jsxm.2016.11.001. https://www.ncbi.nlm.nih.gov/pubmed/27986492
Cookson M.S., Nadig P.W.: Long-term results with vacuum constriction device. J Urol. 1993, 149 (2), 290–294. doi: 10.1016/s0022-5347(17)36059-7. https:// www.ncbi.nlm.nih.gov/pubmed/8426404 Coombs P.G., Heck M., Guhring P., Narus J., Mulhall J.P.: A review of outcomes of an intracavernosal injection therapy programme. BJU Int. 2012, 110 (11), 1787–1791. doi: 10.1111/j.1464-410X.2012.11080.x. https://www. ncbi.nlm.nih.gov/pubmed/22564343
Cooper K., Martyn-St James M., Kaltenthaler E., Dickinson K., Cantrell A., Wylie K. i wsp.: Behavioral Therapies for Management of Premature Ejaculation: A Systematic Review. Sex Med. 2015, 3 (3), 174–188. doi: 10.1002/sm2.65. https://www.ncbi.nlm.nih.gov/pubmed/26468381
Corbetta J.P., Durán V., Burek C., Sager C., Weller S., Paz E. i wsp.: High flow priapism: diagnosis and treatment in pediatric population. Pediatr Surg Int. 2011, 27 (11), 1217–1221. doi: 10.1007/s00383-011-2911-7. https:// www.ncbi.nlm.nih.gov/pubmed/21544645 Cordeiro E.R., Cathelineau X., Thüroff S., Marberger M., Crouzet S., de la Rosette J.J.: High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int. 2012, 110 (9), 1228–1242. doi: 10.1111/j.1464- 410X.2012.11262.x. https://www.ncbi.nlm.nih.gov/pubmed/22672199
Cormio L., Massenio P., La Rocca R., Verze P., Mirone V., Carrieri G.: The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation. J Sex Med. 2015, 12 (7), 1609–1615. doi: 10.1111/ jsm.12925. https://www.ncbi.nlm.nih.gov/pubmed/26077706
Cormio L., Zucchi A., Lorusso F., Selvaggio O., Fioretti F., Porena M. i wsp.: Surgical treatment of Peyronie’s disease by plaque incision and grafting with buccal mucosa. Eur Urol. 2009, 55 (6), 1469–1475. doi: 10.1016/j. eururo.2008.11.041. https://www.ncbi.nlm.nih.gov/pubmed/19084325
Corona G., Maseroli E., Rastrelli G., Isidori A.M., Sforza A., Mannucci E. i wsp.: Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf. 2014, 13 (10), 1327–1351. doi: 10.1517/14740338.2014.950653. https://www.ncbi.nlm. nih.gov/pubmed/25139126
Corona G., Rastrelli G., Burri A., Jannini E.A., Maggi M.: The safety and efficacy of Avanafil, a new 2nd generation PDE5i: Comprehensive review and meta-analysis. Expert Opin Drug Saf. 2016, 15 (2), 237–247. doi: 10.1517/14740338.2016.1130126. https://www.ncbi.nlm.nih.gov/ pubmed/26646748
Corona G., Rastrelli G., Burri A., Serra E., Gianfrilli D., Mannucci E. i wsp.: Firstgeneration phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology. 2016, 4 (6), 1002–1009. doi: 10.1111/ andr.12255. https://www.ncbi.nlm.nih.gov/pubmed/27636710
Corona G., Rastrelli G., Limoncin E., Sforza A., Jannini E.A., Maggi M. i wsp.: Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2015, 12 (12), 2291–2300. doi: 10.1111/jsm.13041. https://www.ncbi.nlm.nih.gov/pubmed/26552599 Costa P., Potempa A.J.: Intraurethral alprostadil for erectile dysfunction: a review of the literature. Drugs. 2012, 72 (17), 2243–2254. doi: 10.2165/11641380-000000000-00000. https://www.ncbi.nlm.nih.gov/ pubmed/23170913
Cui H., Liu B., Song Z., Fang J., Deng Y., Zhang S. i wsp.: Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andrologia. 2015, 47 (1), 20–24. doi: 10.1111/and.12216. https:// www.ncbi.nlm.nih.gov/pubmed/24387078
Curran M., Keating G.: Tadalafil. Drugs. 2003, 63 (20), 2203–2212. doi: 10.2165/00003495-200363200-00004. https://www.ncbi.nlm.nih.gov/ pubmed/14498756
D’Aleo G., Rifici C., Kofler M., Saltuari L., Bramanti P.: Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury. Spine (Phila Pa 1976). 2009, 34 (3), E127–129. doi: 10.1097/ BRS.0b013e31818d04ff. https://www.ncbi.nlm.nih.gov/pubmed/19179913
Dalkin B.L., Carter M.F.: Venogenic impotence following dermal graft repair for Peyronie’s disease. J Urol. 1991, 146 (3), 849–851. doi: 10.1016/s0022- 5347(17)37941-7. https://www.ncbi.nlm.nih.gov/pubmed/1843616 Daoud A.S., Bataineh H., Otoom S., Abdul-Zahra E.: The effect of Vigabatrin, Lamotrigine and Gabapentin on the fertility, weights, sex hormones and biochemical profiles of male rats. Neuro Endocrinol Lett. 2004, 25 (3), 178– 183. https://www.ncbi.nlm.nih.gov/pubmed/15349082
Darouiche R.O., Bella A.J., Boone T.B., Brock G., Broderick G.A., Burnett A.L. i wsp.: North American consensus document on infection of penile prostheses. Urology. 2013, 82 (4), 937–942. doi: 10.1016/j.urology.2013.05.048. https://www.ncbi.nlm.nih.gov/pubmed/23958508 Das S.: Peyronie’s disease: excision and autografting with tunica vaginalis. J Urol. 1980, 124 (6), 818–819. doi: 10.1016/s0022-5347(17)55682-7. https:// www.ncbi.nlm.nih.gov/pubmed/7441830
Datta N.S.: Megalophallus in sickle cell disease. J Urol. 1977, 117 (5), 672– 673. doi: 10.1016/s0022-5347(17)58582-1. https://www.ncbi.nlm.nih.gov/ pubmed/859210
Davila H.H., Parker J., Webster J.C., Lockhart J.L., Carrion R.E.: Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. J Sex Med. 2008, 5 (4), 1025–1028. doi: 10.1111/j.1743-6109.2007.00715.x. https://www.ncbi. nlm.nih.gov/pubmed/18194188
Davis-Joseph B., Tiefer L., Melman A.: Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology. 1995, 45 (3), 498–502. doi: 10.1016/s0090-4295(99)80022-3. https://www. ncbi.nlm.nih.gov/pubmed/7879338
De Amicis L.A., Goldberg D.C., LoPiccolo J., Friedman J., Davies L.: Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav. 1985, 14 (6), 467–489. doi: 10.1007/bf01541749. https://www.ncbi.nlm.nih.gov/ pubmed/4084048 de Carufel F., Trudel G.: Effects of a new functional-sexological treatment for premature ejaculation. J Sex Marital Ther. 2006, 32 (2), 97–114. doi: 10.1080/00926230500442292. https://www.ncbi.nlm.nih.gov/ pubmed/16418103
Debruyne F.M., Gittelman M., Sperling H., Börner M., Beneke M.: Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. J Sex Med. 2011, 8 (10), 2912–2923. doi: 10.1111/j.1743-6109.2011.02462.x. https://www. ncbi.nlm.nih.gov/pubmed/21883954
DeBusk R., Drory Y., Goldstein I., Jackson G., Kaul S., Kimmel S.E. i wsp.: Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol. 2000, 86 (2), 175–181. doi: 10.1016/s0002-9149(00)00896-1. https://www. ncbi.nlm.nih.gov/pubmed/10913479
DeCastro B.J., Costabile R.A., McMann L.P., Peterson A.C.: Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial. J Urol. 2008, 179 (5), 1930–1932. doi: 10.1016/j. juro.2008.01.039. https://www.ncbi.nlm.nih.gov/pubmed/18353393
Desanctis P.N., Furey C.A.: Steroid injection therapy for Peyronie’s disease: a 10-year summary and review of 38 cases. J Urol. 1967, 97 (1), 114–116. doi: 10.1016/s0022-5347(17)62993-8. https://www.ncbi.nlm.nih.gov/ pubmed/6016195
Deveci S., Hopps C.V., O’Brien K., Parker M., Guhring P., Mulhall J.P.: Defining the clinical characteristics of Peyronie’s disease in young men. J Sex Med. 2007, 4 (2), 485–490. doi: 10.1111/j.1743-6109.2006.00344.x. https:// www.ncbi.nlm.nih.gov/pubmed/17081219
Devine C.J., Horton C.E.: Surgical treatment of Peyronie’s disease with a dermal graff. J Urol. 1974, 111 (1), 44–49. doi: 10.1016/s0022-5347(17)59886- 9. https://www.ncbi.nlm.nih.gov/pubmed/4273261
Devine C.J., Somers K.D., Jordan S.G., Schlossberg S.M.: Proposal: trauma as the cause of the Peyronie’s lesion. J Urol. 1997, 157 (1), 285–290. doi: 10.1016/ s0022-5347(01)65361-8. https://www.ncbi.nlm.nih.gov/pubmed/8976281
Di Stasi S.M., Giannantoni A., Capelli G., Jannini E.A., Virgili G., Storti L. i wsp.: Transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. BJU Int. 2003, 91 (9), 825–829. doi: 10.1046/j.1464- 410x.2003.04242.x. https://www.ncbi.nlm.nih.gov/pubmed/12780842
Dinsmore W.W., Wyllie M.G.: Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction. BJU Int. 2008, 102 (8), 933–937. doi: 10.1111/j.1464-410X.2008.07764.x. https://www. ncbi.nlm.nih.gov/pubmed/18485029
Dong J.Y., Zhang Y.H., Qin L.Q.: Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011, 58 (13), 1378–1385. doi: 10.1016/j.jacc.2011.06.024. https://www. ncbi.nlm.nih.gov/pubmed/21920268
DSM, V., American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 2013, Arlington, VA. http://www.dsm5. org/psychiatrists/practice/dsm
Dubocq F.M., Tefilli M.V., Grignon D.J., Pontes J.E., Dhabuwala C.B.: High flow malignant priapism with isolated metastasis to the corpora cavernosa. Urology. 1998, 51 (2), 324–326. doi: 10.1016/s0090-4295(97)00607- 9. https://www.ncbi.nlm.nih.gov/pubmed/9495721
Duman D.G., Biçakci E., Çelikel Ç.A., Akbal C.: Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction: A Prospective Pilot Study. J Sex Med. 2016, 13 (3), 383–388. doi: 10.1016/j.jsxm.2015.12.030. https://www. ncbi.nlm.nih.gov/pubmed/26853046
Duncan M.R., Berman B., Nseyo U.O.: Regulation of the proliferation and biosynthetic activities of cultured human Peyronie’s disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol. 1991, 25 (2), 89–94. doi: 10.3109/00365599109024539. https://www.ncbi.nlm.nih. gov/pubmed/1651559
Dunn K.M., Croft P.R., Hackett G.I.: Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health. 1999, 53 (3), 144–148. doi: 10.1136/jech.53.3.144. https://www.ncbi.nlm.nih.gov/ pubmed/10396490
Eardley I., Donatucci C., Corbin J., El-Meliegy A., Hatzimouratidis K., McVary K. i wsp.: Pharmacotherapy for erectile dysfunction. J Sex Med. 2010, 7, 524–540. doi: 10.1111/j.1743-6109.2009.01627.x. https://www.ncbi.nlm. nih.gov/pubmed/20092451
Eardley I., Montorsi F., Jackson G., Mirone V., Chan M.L., Loughney K. i wsp.: Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, openlabel, crossover study. BJU Int. 2007, 100 (1), 122–129. doi: 10.1111/j.1464- 410X.2007.06916.x. https://www.ncbi.nlm.nih.gov/pubmed/17552960
Ebbehoj J.: A new operation for priapism. Scand J Plast Reconstr Surg. 1974, 8 (3), 241–242. doi: 10.3109/02844317409084400. https://www.ncbi.nlm. nih.gov/pubmed/4458048
Ebbehoj J., Metz P.: Congenital penile angulation. Br J Urol. 1987, 60 (3), 264–266. doi: 10.1111/j.1464-410x.1987.tb05497.x. https://www.ncbi. nlm.nih.gov/pubmed/3676675
Ebbehoj J., Metz P.: New operation for “krummerik” (penile curvature). Urology. 1985, 26 (1), 76–78. doi: 10.1016/0090-4295(85)90264-x. https:// www.ncbi.nlm.nih.gov/pubmed/3892851
Egeberg A., Hansen P.R., Gislason G.H., Skov L., Thyssen J.P.: Erectile dysfunction in male adults with atopic dermatitis and psoriasis. J Sex Med. 2017, 14 (3), 380–386. doi: 10.1016/j.jsxm.2016.12.233. https://www.ncbi.nlm. nih.gov/pubmed/28109691
Egydio P.H., Lucon A.M., Arap S.: A single relaxing incision to correct different types of penile curvature: surgical technique based on geometrical principles. BJU Int. 2004, 94 (7), 1147–1157. doi: 10.1111/j.1464-410X.2004.05220.x. https://www.ncbi.nlm.nih.gov/pubmed/15541152
Ehrlich H.P.: Scar contracture: cellular and connective tissue aspects in Peyronie’s disease. J Urol. 1997, 157 (1), 316–319. doi: 10.1016/s0022- 5347(01)65368-0. https://www.ncbi.nlm.nih.gov/pubmed/8976288
Eland I.A., van der Lei J., Stricker B.H., Sturkenboom M.J.: Incidence of priapism in the general population. Urology. 2001, 57 (5), 970–972. doi: 10.1016/ s0090-4295(01)00941-4. https://www.ncbi.nlm.nih.gov/pubmed/11337305 El-Bahnasawy M.S., Dawood A., Farouk A.: Low-flow priapism: risk factors for erectile dysfunction. BJU Int. 2002, 89 (3), 285–290. doi: 10.1046/j.1464- 4096.2001.01510.x. https://www.ncbi.nlm.nih.gov/pubmed/11856112
El-Nashaar A., Shamlout R.: Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. J Sex Med. 2007, 4 (2), 491–496. doi: 10.1111/j.1743-6109.2006.00243.x. https://www.ncbi.nlm.nih.gov/pubmed/17367444
El-Sakka A.I., Rashwan H.M., Lue T.F.: Venous patch graft for Peyronie’s disease. Part II: outcome analysis. J Urol. 1998, 162, 2050–2053. doi: 10.1097/00005392-199812010-00030. https://www.ncbi.nlm.nih.gov/ pubmed/9817321
EMA. Assessement Report - Xiapex (Collagenase Clostridium Histolyticum). 2014. https://www.ema.europa.eu/documents/assessment-report/ xiapex-epar-public-assessment-report_en.pdf Emond A.M., Holman R., Hayes R.J., Serjeant G.R.: Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980, 140 (11), 1434– 1437. https://www.ncbi.nlm.nih.gov/pubmed/6159833
Eracleous E., Kondou M., Aristidou K., Eliades S., Pantziaris M., Posporis T.: Use of Doppler ultrasound and 3-dimensional contrast-enhanced MR angiography in the diagnosis and follow-up of post-traumatic high-flow priapism in a child. Pediatr Radiol. 2000, 30 (4), 265–267. doi: 10.1007/s002470050736. https://www.ncbi.nlm.nih.gov/pubmed/10789908
Ercole C.J., Pontes J.E., Pierce J.M.: Changing surgical concepts in the treatment of priapism. J Urol. 1981, 125 (2), 210–211. doi: 10.1016/ s0022-5347(17)54971-x. https://www.ncbi.nlm.nih.gov/pubmed/7206057
Essed E., Schroeder F.H.: New surgical treatment for Peyronie disease. Urology. 1985, 25 (6), 582–587. doi: 10.1016/0090-4295(85)90285-7. https://www. ncbi.nlm.nih.gov/pubmed/4012950
Faerber G.J., Konnak J.W.: Results of combined Nesbit penile plication with plaque incision and placement of Dacron patch in patients with severe Peyronie’s disease. J Urol. 1993, 149, 1319–1320. https://www.ncbi.nlm. nih.gov/pubmed/8479026
Falcone M., Rolle L., Ceruti C., Timpano M., Sedigh O., Preto M. i wsp.: Prospective analysis of the surgical outcomes and patients’ satisfaction rate after the AMS Spectra penile prosthesis implantation. Urology. 2013, 82 (2), 373– 376. doi: 10.1016/j.urology.2013.04.027. https://www.ncbi.nlm.nih.gov/ pubmed/23791218
Fallon B.: Cadaveric dura mater graft for correction of penile curvature in Peyronie disease. Urology. 1990, 35 (2), 127–129. doi: 10.1016/0090- 4295(90)80058-u. https://www.ncbi.nlm.nih.gov/pubmed/2305535
Fan D., Liu L., Ding N., Liu S., Hu Y., Cai G. i wsp.: Male sexual dysfunction and ankylosing spondylitis: a systematic review and metaanalysis. J Rheumatol. 2015, 42 (2), 252–257. doi: 10.3899/jrheum.140416. https:// www.ncbi.nlm.nih.gov/pubmed/25448789
Fang S.C., Rosen R.C., Vita J.A., Ganz P., Kupelian V.: Changes in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey. J Sex Med. 2015, 12 (1), 100–108. doi: 10.1111/jsm.12715. https://www.ncbi.nlm.nih.gov/ pubmed/25293632
Farag Y.M., Guallar E., Zhao D., Kalyani R.R., Blaha M.J., Feldman D.I. i wsp.: Vitamin D deficiency is independently associated with greater prevalence of erectile dysfunction: The National Health and Nutrition Examination Survey (NHANES) 2001–2004. Atherosclerosis. 2016, 252, 61–67. doi: 10.1016/j.atherosclerosis.2016.07.921. https://www.ncbi.nlm.nih.gov/ pubmed/27505344
FDA, U. Warning letter to William Weldon, CEO & Chairman of Johnson & Johnson, regarding Ultram-ER web advertisement. 2009. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994, 151 (1), 54–61. doi: 10.1016/ s0022-5347(17)34871-1. https://www.ncbi.nlm.nih.gov/pubmed/8254833
Fernandez-Balsells M.M., Murad M.H., Lane M., Lampropulos J.F., Albuquerque F., Mullan R.J. i wsp.: Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010, 95 (6), 2560–2575. doi: 10.1210/jc.2009-2575. https://www. ncbi.nlm.nih.gov/pubmed/20525906 Ferrini M.G., Davila H.H., Kovanecz I., Sanchez S.P., Gonzalez-Cadavid N.F., Rajfer J.: Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology. 2006, 68 (2), 429–435. doi: 10.1016/j.urology.2006.05.011. https://www. ncbi.nlm.nih.gov/pubmed/16904479
Ferrini M.G., Kovanecz I., Nolazco G., Rajfer J., Gonzalez-Cadavid N.F.: Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie’s disease. BJU Int. 2006, 97 (3), 625–633. doi: 10.1111/j.1464-410X.2006.05955.x. https://www.ncbi.nlm.nih.gov/ pubmed/16469038
Ferrini M.G., Kovanecz I., Sanchez S., Vernet D., Davila H.H., Rajfer J. i wsp.: Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod. 2007, 76 (5), 915–923. doi: 10.1095/biolreprod.106.059642. https:// www.ncbi.nlm.nih.gov/pubmed/17287493
Ficarra V., Novara G., Ahlering T.E., Costello A., Eastham J.A., Graefen M. i wsp.: Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012, 62 (3), 418– 420. doi: 10.1016/j.eururo.2012.05.046. https://www.ncbi.nlm.nih.gov/ pubmed/22749850
Fisher W.A., Eardley I., McCabe M., Sand M.: Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med. 2009, 6, 2746–2760. doi: 10.1111/j.1743-6109.2009.01457.x. https://www. ncbi.nlm.nih.gov/pubmed/19694926 Fojecki G.L., Tiessen S., Osther P.J.: Effect of Low-Energy Linear Shockwave Therapy on Erectile Dysfunction – A Double-Blinded, Sham-Controlled, Randomized Clinical Trial. J Sex Med. 2017, 14 (1), 106–112. doi: 10.1016/j. jsxm.2016.11.307. https://www.ncbi.nlm.nih.gov/pubmed/27938990
Forgue S.T., Patterson B.E., Bedding A.W., Payne C.D., Phillips D.L., Wrishko R.E. i wsp.: Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006, 61 (3), 280–288. doi: 10.1111/j.1365-2125.2005.02553.x. https:// www.ncbi.nlm.nih.gov/pubmed/16487221
Fowler J.E., Koshy M., Strub M., Chinn S.K.: Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol. 1991, 145 (1), 65–68. doi: 10.1016/s0022-5347(17)38248-4. https:// www.ncbi.nlm.nih.gov/pubmed/1984102
Frink M.C., Hennies H.H., Englberger W., Haurand M., Wilffert B.: Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung. 1996, 46 (11), 1029–1036. https://www.ncbi.nlm. nih.gov/pubmed/8955860
Furtado P.S., Costa M.P., Ribeiro do Prado Valladares F., Oliveira da Silva L., Lordêlo M., Lyra I. i wsp.: The prevalence of priapism in children and adolescents with sickle cell disease in Brazil. Int J Hematol. 2012, 95 (6), 648– 651. doi: 10.1007/s12185-012-1083-0. https://www.ncbi.nlm.nih.gov/ pubmed/22539365
Gacci M., Andersson K.E., Chapple C., Maggi M., Mirone V., Oelke M. i wsp.: Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Eur Urol. 2016, 70 (1), 124–133. doi: 10.1016/j. eururo.2015.12.048. https://www.ncbi.nlm.nih.gov/pubmed/26806655
Gandaglia G., Briganti A., Jackson G., Kloner R.A., Montorsi F., Montorsi P. i wsp.: A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014, 65 (5), 968–978. doi: 10.1016/j. eururo.2013.08.023. https://www.ncbi.nlm.nih.gov/pubmed/24011423
Garaffa G., Sacca A., Christopher A.N., Ralph D.J.: Circumcision is not mandatory in penile surgery. BJU Int. 2010, 105 (2), 222–224. doi: 10.1111/j.1464- 410X.2009.08763.x. https://www.ncbi.nlm.nih.gov/pubmed/19594732
Garcia-Gomez B., Ralph D., Levine L., Moncada-Iribarren I., Djinovic R., Albersen M. i wsp.: Grafts for Peyronie’s disease: a comprehensive review. Andrology. 2018, 6 (1), 117–126. doi: 10.1111/andr.12421. https://www.ncbi.nlm.nih. gov/pubmed/29266877
Gazzaruso C., Coppola A., Montalcini T., Valenti C., Garzaniti A., Pelissero G. i wsp.: Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine. 2011, 40 (2), 273–279. doi: 10.1007/s12020-011-9523- 9. https://www.ncbi.nlm.nih.gov/pubmed/21861245
Gbadoe A.D., Atakouma Y., Kusiaku K., Assimadi J.K.: Management of sickle cell priapism with etilefrine. Arch Dis Child. 2001, 85 (1), 52–53. doi: 10.1136/ adc.85.1.52. https://www.ncbi.nlm.nih.gov/pubmed/11420201
Gelbard M.K., Dorey F., James K.: The natural history of Peyronie’s disease. J Urol. 1990, 144 (6), 1376–1379. doi: 10.1016/s0022-5347(17)39746-x. https://www.ncbi.nlm.nih.gov/pubmed/2231932
Gelbard M.K., Hayden B.: Expanding contractures of the tunica albuginea due to Peyronie’s disease with temporalis fascia free grafts. J Urol. 1991, 145 (4), 772–776. doi: 10.1016/s0022-5347(17)38447-1. https://www.ncbi. nlm.nih.gov/pubmed/2005698
Gelbard M.K., James K., Riach P., Dorey F.: Collagenase versus placebo in the treatment of Peyronie’s disease: a double-blind study. J Urol. 1993, 149 (1), 56–58. doi: 10.1016/s0022-5347(17)35998-0. https://www.ncbi.nlm.nih. gov/pubmed/8417217
Gennaro R., Barletta D., Paulis G.: Intralesional hyaluronic acid: an innovative treatment for Peyronie’s disease. Int Urol Nephrol. 2015, 47 (10), 1595–1602. doi: 10.1007/s11255-015-1074-1. https://www.ncbi.nlm.nih. gov/pubmed/26257044
Ghanem H.M., Salonia A., Martin-Morales A.: SOP: physical examination and laboratory testing for men with erectile dysfunction. J Sex Med. 2013, 10 (1), 108–110. doi: 10.1111/j.1743-6109.2012.02734.x. https://www.ncbi. nlm.nih.gov/pubmed/22524416
Gholami S.S., Lue T.F.: Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol. 2002. 167 (5), 2066–2069. https://www.ncbi.nlm.nih.gov/pubmed/11956440
Giannetta E., Feola T., Gianfrilli D., Pofi R., Dall’Armi V., Badagliacca R. i wsp.: Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials. BMC Med. 2014, 12, 185. doi: 10.1186/s12916-014-0185-3. https://www.ncbi.nlm.nih.gov/ pubmed/25330139
Gittelman M., McMahon C.G., Rodríguez-Rivera J.A., Beneke M., Ulbrich E., Ewald S.: The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. Int J Clin Pract. 2010, 64 (5), 594–603. doi: 10.1111/j.1742-1241.2010.02358.x. https://www.ncbi.nlm.nih.gov/pubmed/20456213
Giuliano F.: 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Trends Neurosci. 2007, 30 (2), 79–84. doi: 10.1016/j.tins.2006.12.002. https://www.ncbi.nlm.nih.gov/ pubmed/17169440
Giuliano F., Jackson G., Montorsi F., Martin-Morales A., Raillard P.: Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract. 2010, 64 (2), 240–255. doi: 10.1111/j.1742-1241.2009.02254.x. https://www.ncbi.nlm.nih.gov/ pubmed/19900167
Giuliano F., Patrick D.L., Porst H., La Pera G., Kokoszka A., Merchant S. i wsp.: Premature ejaculation: results from a five-country European observational study. Eur Urol. 2008, 53 (5), 1048–1057. doi: 10.1016/j.eururo.2007.10.015. https://www.ncbi.nlm.nih.gov/pubmed/17950985
Glickman L., Godoy G., Lepor H.: Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol. 2009, 181 (2), 731–735. doi: 10.1016/j.juro.2008.10.019. https://www.ncbi.nlm.nih. gov/pubmed/19091349
Glina F.P., de Freitas Barboza J.W., Nunes V.M., Glina S., Bernardo W.M.: What Is the Impact of Bariatric Surgery on Erectile Function? A Systematic Review and Meta-Analysis. Sex Med Rev. 2017, 5 (3), 393–402. doi: 10.1016/j. sxmr.2017.03.008. https://www.ncbi.nlm.nih.gov/pubmed/28526630
Glina S., Ghanem H.: SOP: corpus cavernosum assessment (cavernosography/ cavernosometry). J Sex Med. 2013, 10 (1), 111–114. doi: 10.1111/j.1743- 6109.2012.02795.x. https://www.ncbi.nlm.nih.gov/pubmed/22971225
Glina S., Sharlip I.D., Hellstrom W.J.: Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med. 2013, 10 (1), 115–119. doi: 10.1111/j.1743- 6109.2012.02816.x. https://www.ncbi.nlm.nih.gov/pubmed/22971247
Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A.: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998, 338 (20), 1397–1404. doi: 10.1056/ NEJM199805143382001. https://www.ncbi.nlm.nih.gov/pubmed/9580646
Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A.: Oral sildenafil in the treatment of erectile dysfunction. 1998. J Urol. 2002, 167, 1197–1203. doi: 10.1016/s0022-5347(02)80386-x. https://www.ncbi. nlm.nih.gov/pubmed/11905901
Goldstein I., McCullough A.R., Jones L.A., Hellstrom W.J., Bowden C.H., Didonato K. i wsp.: A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012, 9 (4), 1122–1133. doi: 10.1111/j.1743-6109.2011.02629.x. https://www.ncbi.nlm.nih.gov/pubmed/22248153
Goldstein I., Tseng L.J., Creanga D., Stecher V., Kaminetsky J.C.: Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction. J Sex Med. 2016, 13 (5), 852–859. doi: 10.1016/j.jsxm.2016.02.166. https://www.ncbi. nlm.nih.gov/pubmed/27114196
Gonzalez-Cadavid N.F., Rajfer J.: Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie’s disease. Nat Clin Pract Urol. 2005, 2 (6), 291–297. doi: 10.1038/ncpuro0201. https://www.ncbi. nlm.nih.gov/pubmed/16474811
Gorich J., Ermis C., Krämer S.C., Fleiter T., Wisianowsky C., Basche S. i wsp.: Interventional treatment of traumatic priapism. J Endovasc Ther. 2002, 9 (5), 614–617. doi: 10.1177/152660280200900511. https://www.ncbi.nlm. nih.gov/pubmed/12431145
Gratzke C., Angulo J., Chitaley K., Dai Y.T., Kim N.N., Paick J.S. i wsp.: Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010, 7, 445–475. doi: 10.1111/j.1743-6109.2009.01624.x. https://www.ncbi. nlm.nih.gov/pubmed/20092448
Grayhack J.T., McCullough W., O’Conor V.J. Jr, Trippel O.: Venous bypass to control priapism. Invest Urol. 1964, 1, 509–513. https://www.ncbi.nlm. nih.gov/pubmed/14130594
Greco E.A., Spera G., Aversa A.: Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol. 2006, 50 (3), 940–947. doi: 10.1016/j.eururo.2006.06.049. https://www. ncbi.nlm.nih.gov/pubmed/16979814
Greenfield J.M., Lucas S., Levine L.A.: Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature. J Urol, 2006, 175 (1), 238–241. doi: 10.1016/S0022-5347(05)00063- 7. https://www.ncbi.nlm.nih.gov/pubmed/16406919
Greenfield J.M., Shah S.J., Levine LA.: Verapamil versus saline in electromotive drug administration for Peyronie’s disease: a double-blind, placebo controlled trial. J Urol. 2007, 177 (3), 972–975. doi: 10.1016/j.juro.2006.10.065. https://www.ncbi.nlm.nih.gov/pubmed/17296390
Grenier G., Byers E.S.: Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav. 1995, 24 (2), 447–472. doi: 10.1007/ bf01541858. https://www.ncbi.nlm.nih.gov/pubmed/7661658
Griffiths M.R., Priestley G.C.: A comparison of morphoea and lichen sclerosus et atrophicus in vitro: the effects of para-aminobenzoate on skin fibroblasts. Acta Derm Venereol. 1992, 72 (1), 15–18. https://www.ncbi.nlm. nih.gov/pubmed/1350132
Gross M.S., Phillips E.A., Balen A., Eid J.F., Yang C., Simon R. i wsp.: The Malleable Implant Salvage Technique: Infection Outcomes after Mulcahy Salvage Procedure and Replacement of Infected Inflatable Penile Prosthesis with Malleable Prosthesis. J Urol. 2016, 195 (3), 694–697. doi: 10.1016/j. juro.2015.08.091. https://www.ncbi.nlm.nih.gov/pubmed/26343986
Gruenwald I., Appel B., Kitrey N.D., Vardi Y.: Shockwave treatment of erectile dysfunction. Ther Adv Urol. 2013, 5 (2), 95–99. doi: 10.1177/1756287212470696. https://www.ncbi.nlm.nih.gov/pubmed/23554844
Gruenwald I., Appel B., Vardi Y.: Low-intensity extracorporeal shock wave therapy – a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012, 9 (1), 259–264. doi: 10.1111/j.1743-6109.2011.02498.x. https://www.ncbi. nlm.nih.gov/pubmed/22008059
Gruenwald I., Shenfeld O., Chen J., Raviv G., Richter S., Cohen A. i wsp.: Positive effect of counseling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil. Eur Urol. 2006, 50 (1), 134– 140. doi: 10.1016/j.eururo.2006.01.042. https://www.ncbi.nlm.nih.gov/ pubmed/16527391
Gupta A., Seth T., Gupta A.: Successful use of terbutaline in persistent priapism in a 12-year-old boy with chronic myeloid leukemia. Pediatr Hematol Oncol. 2009, 26 (1), 70–73. doi: 10.1080/08880010802435146. https:// www.ncbi.nlm.nih.gov/pubmed/19206011
Gupta B.P., Murad M.H., Clifton M.M., Prokop L., Nehra A., Kopecky S.L.: The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011, 171 (20), 1797–1803. doi: 10.1001/archinternmed.2011.440. https://www.ncbi.nlm.nih.gov/pubmed/21911624
Gupta R., Kirschen J., Barrow R.C. 2nd, Eid J.F.: Predictors of success and risk factors for attrition in the use of intracavernous injection. J Urol. 1997, 157 (5), 1681–1686. https://www.ncbi.nlm.nih.gov/pubmed/9112505
Gupta S., Salimpour P., Saenz de Tejada I., Daley J., Gholami S., Daller M. i wsp.: A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. J Urol. 1998, 159 (5), 1529–1536. doi: 10.1097/00005392- 199805000-00033. https://www.ncbi.nlm.nih.gov/pubmed/9554348
Gur S., Limin M., Hellstrom W.J.: Current status and new developments in Peyronie’s disease: medical, minimally invasive and surgical treatment options. Expert Opin Pharmacother. 2011, 12 (6), 931–944. doi: 10.1517/14656566.2011.544252. https://www.ncbi.nlm.nih.gov/ pubmed/21405946
Guyatt G.H., Oxman A.D., Kunz R., Falck-Ytter Y., Vist G.E., Liberati A. i wsp.: Going from evidence to recommendations. BMJ. 2008, 336, 1049–1051. doi: 10.1136/bmj.39493.646875.AE. https://www.ncbi.nlm.nih.gov/ pubmed/18467413
Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schünemann H.J.: What is “quality of evidence” and why is it important to clinicians? BMJ. 2008, 336, 995–998. doi: 10.1136/bmj.39490.551019.BE. https://www. ncbi.nlm.nih.gov/pubmed/18456631
Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P. i wsp.: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336, 924–926. doi: 10.1136/ bmj.39489.470347.AD. https://www.ncbi.nlm.nih.gov/pubmed/18436948
Habous M., Farag M., Williamson B., Laban O., Mahmoud S., Abdelwahab O. i wsp.: Conservative Therapy is an Effective Option in Patients With Localized Infection After Penile Implant Surgery. J Sex Med. 2016, 13 (6), 972–975. doi: 10.1016/j.jsxm.2016.04.064. https://www.ncbi.nlm.nih.gov/ pubmed/27162191
Haddad R.M., Kennedy C.C., Caples S.M., Tracz M.J., Boloña E.R., Sideras K. i wsp.: Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007, 82 (1), 29–39. doi: 10.4065/82.1.29. https://www.ncbi.nlm.nih.gov/ pubmed/17285783
Haglind E., Carlsson S., Stranne J., Wallerstedt A., Wilderäng U., Thorsteinsdottir T. i wsp.: Urinary Incontinence and Erectile Dysfunction after Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial. Eur Urol. 2015, 68 (2), 216–225. doi: 10.1016/j.eururo.2015.02.029. https://www.ncbi.nlm.nih.gov/pubmed/25770484
Hakim L.S., Kulaksizoglu H., Mulligan R., Greenfield A., Goldstein I.: Evolving concepts in the diagnosis and treatment of arterial high flow priapism. J Urol. 1996, 155 (2), 541–548. https://www.ncbi.nlm.nih.gov/pubmed/8558656
Hanafy H.M., Saad S.M., Al-Ghorab M.M.: Ancient Egyptian medicine: contribution to urology. Urology. 1974, 4 (1), 114–120. doi: 10.1016/0090- 4295(74)90124-1. https://www.ncbi.nlm.nih.gov/pubmed/21323001
Hatzichristodoulou G., Gschwend J.E., Lahme S.: Surgical therapy of Peyronie’s disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique. Int J Impot Res. 2013, 25 (5), 183–187. doi: 10.1038/ijir.2013.7. https://www.ncbi.nlm.nih.gov/pubmed/23446807
Hatzichristou D., Kirana P.S., Banner L., Althof S.E., Lonnee-Hoffmann R.A., Dennerstein L.: Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires. J Sex Med. 2016, 13 (8), 1166–1182. doi: 10.1016/j.jsxm.2016.05.017. https:// www.ncbi.nlm.nih.gov/pubmed/27436074
Hatzichristou D., Moysidis K., Apostolidis A., Bekos A., Tzortzis V., Hatzimouratidis K. i wsp.: Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. Eur Urol. 2005, 47 (4), 518– 522. doi: 10.1016/j.eururo.2004.12.005. https://www.ncbi.nlm.nih.gov/
pubmed/15774252 Hatzichristou D., Rosen R.C., Derogatis L.R., Low W.Y., Meuleman E.J., Sadovsky R. i wsp.: Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med. 2010, 7, 337–348. doi: 10.1111/j.1743- 6109.2009.01619.x. https://www.ncbi.nlm.nih.gov/pubmed/20092443
Hatzichristou D., Salpiggidis G., Hatzimouratidis K., Apostolidis A., Tzortzis V., Bekos A.: Management strategy for arterial priapism: therapeutic dilemmas. J Urol. 2002, 168 (2), 2074–2077. doi: 10.1097/01.ju.0000032743.39599. ae. https://www.ncbi.nlm.nih.gov/pubmed/12394712
Hatzichristou D., Hatzimouratidis K., Apostolidis A., Ioannidis E., Yannakoyorgos K., Kalinderis A.: Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test. Eur Urol. 1999, 36 (1), 60–67. doi: 10.1159/000019928. https://www.ncbi.nlm.nih.gov/pubmed/10364657
Hatzichristou D., Hatzimouratidis K., Apostolidis A., Tzortzis V., Bekos A., Ioannidis E.: Corporoplasty using tunica albuginea free grafts for penile curvature: surgical technique and long-term results. J Urol. 2002, 167 (3), 1367–1370. https://www.ncbi.nlm.nih.gov/pubmed/11832734
Hatzichristou D., Hatzimouratidis K., Ioannides E., Yannakoyorgos K., Dimitriadis G., Kalinderis A.: Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. J Urol. 1998, 159 (6), 1921–1926. https://www.ncbi. nlm.nih.gov/pubmed/9598488
Hatzimouratidis K., Amar E., Eardley I., Giuliano F., Hatzichristou D., Montorsi F. i wsp.: Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010, 57 (5), 804–814. doi: 10.1016/j. eururo.2010.02.020. https://www.ncbi.nlm.nih.gov/pubmed/20189712
Hatzimouratidis K., Eardley I., Giuliano F., Hatzichristou D., Moncada I., Salonia A. i wsp.: EAU guidelines on penile curvature. Eur Urol. 2012, 62 (3), 543– 552. doi: 10.1016/j.eururo.2012.05.040. https://www.ncbi.nlm.nih.gov/ pubmed/22658761
Hatzimouratidis K., Giuliano F., Moncada I., Muneer A., Salonia A., Verze P.: EAU Guidelines Panel on Male Sexual Dysfunction. EAU guidelines on Penile Curvature. Edn. presented at the EAU Annual Congress Paris. 2012: Arnhem, The Netherlands. http://uroweb.org/guideline/penile-curvature/
Hatzimouratidis K., Giuliano F., Moncada I., Muneer A., Salonia A., Verze P.: Guideline Associates: A. Parnham, E.C. Serefogluet al., EAU Guidelines Panel on Male Sexual Dysfunction. EAU guidelines on Male Sexual Dysfunction. Edn. presented at the EAU Annual Congress Munich 2016. http://uroweb. org/guideline/male-sexual-dysfunction/ Hatzimouratidis K., Moysidis K., Bekos A., Tsimtsiou Z., Ioannidis E., Hatzichristou D.: Treatment strategy for “non-responders” to tadalafil and vardenafil: a real-life study. Eur Urol. 2006, 50 (1), 126–132. doi: 10.1016/j. eururo.2006.02.060. https://www.ncbi.nlm.nih.gov/pubmed/16564127
Hatzimouratidis K., Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A. i wsp.: Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016, 13 (4), 465–488. doi: 10.1016/j.jsxm.2016.01.016. https:// www.ncbi.nlm.nih.gov/pubmed/27045254
Hauck E.W., Hauptmann A., Bschleipfer T., Schmelz H.U., Altinkilic B.M., Weidner W.: Questionable efficacy of extracorporeal shock wave therapy for Peyronie’s disease: results of a prospective approach. J Urol. 2004, 171 (1), 296–299. doi: 10.1097/01.ju.0000099891.68488.4e. https://www.ncbi.nlm.nih.gov/ pubmed/14665898
Hawton K., Catalan J., Martin P., Fagg J.: Long-term outcome of sex therapy. Behav Res Ther. 1986, 24 (6), 665–675. doi: 10.1016/0005-7967(86)90062- 8. https://www.ncbi.nlm.nih.gov/pubmed/3800838
Hayashi Y., Kojima Y., Mizuno K., Tozawa K., Sasaki S., Kohri K.: Modified technique of dorsal plication for penile curvature with or without hypospadias. Urology. 2002, 59 (4), 584–586. doi: 10.1016/s0090-4295(02)01555-8. https://www.ncbi.nlm.nih.gov/pubmed/11927319
Heidenreich A., Bastian P.J., Bellmunt J., Bolla M., Joniau S., van der Kwast T. i wsp.: EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014, 65 (1), 124–137. doi: 10.1016/j.eururo.2013.09.046. https://www.ncbi.nlm.nih. gov/pubmed/24207135
Hellstrom W.J., Bivalacqua T.J.: Peyronie’s disease: etiology, medical, and surgical therapy. J Androl. 2000, 21 (3), 347–354. https://www.ncbi.nlm. nih.gov/pubmed/10819440
Hellstrom W.J., Feldman R.A., Coyne K.S., Kaufman G.J., Smith T.M., Tursi J.P. i wsp.: Self-report and Clinical Response to Peyronie’s Disease Treatment: Peyronie’s Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies. Urology. 2015, 86 (2), 291–298. doi: 10.1016/j.urology.2015.04.047. https://www.ncbi.nlm.nih. gov/pubmed/26199168
Hellstrom W.J., Feldman R., Rosen R.C., Smith T., Kaufman G., Tursi J.: Bother and distress associated with Peyronie’s disease: validation of the Peyronie’s disease questionnaire. J Urol. 2013, 190 (2), 627–634. doi: 10.1016/j. juro.2013.01.090. https://www.ncbi.nlm.nih.gov/pubmed/23376705
Hellstrom W.J., Kaminetsky J., Belkoff L.H., Goldstein I., Tursi J.P., Uy J. i wsp.: Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study. J Urol. 2015, 194 (2), 485–492. doi: 10.1016/j.juro.2014.12.101. https://www. ncbi.nlm.nih.gov/pubmed/25591992
Hellstrom W.J., Kendirci M., Matern R., Cockerham Y., Myers L., Sikka S.C. i wsp.: Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s disease. J Urol. 2006, 176 (1), 394–398. doi: 10.1016/S0022-5347(06)00517-9. https://www.ncbi.nlm.nih.gov/ pubmed/16753449
Hellstrom W.J., Montague D.K., Moncada I., Carson C., Minhas S., Faria G. i wsp.: Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010, 7, 501–523. doi: 10.1111/j.1743-6109.2009.01626.x. https://www.ncbi.nlm.nih.gov/pubmed/20092450
Henry G.D., Brinkman M.J., Mead S.F., Delk J.R. 2nd, Cleves M.A., Jennermann C. i wsp.: A survey of patients with inflatable penile prostheses: assessment of timing and frequency of intercourse and analysis of implant durability. J Sex Med. 2012, 9 (6), 1715–1721. doi: 10.1111/j.1743-6109.2012.02729.x. https://www.ncbi.nlm.nih.gov/pubmed/22568579
Henry G.D., Donatucci C.F., Conners W., Greenfield J.M., Carson C.C., Wilson S.K. i wsp.: An outcomes analysis of over 200 revision surgeries for penile prosthesis implantation: a multicenter study. J Sex Med. 2012, 9 (1), 309– 315. doi: 10.1111/j.1743-6109.2011.02524.x. https://www.ncbi.nlm.nih. gov/pubmed/22082149
Hisasue S., China T., Horiuchi A., Kimura M., Saito K., Isotani S. i wsp.: Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction. Int J Urol. 2016, 23 (1), 80–84. doi: 10.1111/ iju.12955. https://www.ncbi.nlm.nih.gov/pubmed/26501992
Hoyerup P., Azawi N.H.: Partial priapism. BMJ Case Rep. 2013, 2013. doi: 10.1136/bcr-2013-200031. https://www.ncbi.nlm.nih.gov/ pubmed/23933863
Hsu C.Y., Lin C.L., Kao C.H.: Gout is associated with organic and psychogenic erectile dysfunction. Eur J Intern Med. 2015, 26 (9), 691–695. doi: 10.1016/j. ejim.2015.06.001. https://www.ncbi.nlm.nih.gov/pubmed/26089189
Hubler J., Szanto A., Konyves K.: Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol. 2003, 35 (4), 519–521. doi: 10.1023/b:urol.0000025617.97048. ae. https://www.ncbi.nlm.nih.gov/pubmed/15198160
Husain J., Lynn N.N., Jones D.K., Collins G.N., O’Reilly P.H.: Extracorporeal shock wave therapy in the management of Peyronie’s disease: initial experience. BJU Int. 2000, 86 (4), 466–468. doi: 10.1046/j.1464- 410x.2000.00827.x. https://www.ncbi.nlm.nih.gov/pubmed/10971273
Ilkay A.K., Levine L.A.: Conservative management of high-flow priapism. Urology. 1995, 46 (3), 419–424. https://www.ncbi.nlm.nih.gov/ pubmed/7660524
Inamoto T., Azuma H., Iwamoto Y., Sakamoto T., Katsuoka Y.A.: rare case of penile metastasis of testicular cancer presented with priapism. Hinyokika Kiyo. 2005, 51 (9), 639–642. https://www.ncbi.nlm.nih.gov/pubmed/16229380
Incrocci L., Jensen P.T.: Pelvic radiotherapy and sexual function in men and women. J Sex Med. 2013, 10 Suppl 1, 53–64. doi: 10.1111/jsm.12010. https:// www.ncbi.nlm.nih.gov/pubmed/23387912
Isgoren A., Saitz T.R., Serefoglu E.C.: Erectile function outcomes after robotassisted radical prostatectomy: is it superior to open retropubic or laparoscopic approach? Sex Med Rev. 2014, 2 (2), 20–23. doi: 10.1002/smrj.21. https://www.ncbi.nlm.nih.gov/pubmed/27784540
Isidori A.M., Buvat J., Corona G., Goldstein I., Jannini E.A., Lenzi A. i wsp.: A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014, 65 (1), 99–112. doi: 10.1016/j.eururo.2013.08.048. https://www.ncbi.nlm.nih. gov/pubmed/24050791
Jackson G.: Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. Am J Cardiol. 2005, 96, 32M–36M. doi: 10.1016/j.amjcard.2005.07.009. https://www.ncbi.nlm.nih.gov/pubmed/16387564
Jackson G., Montorsi P., Adams M.A., Anis T., El-Sakka A., Miner M. i wsp.: Cardiovascular aspects of sexual medicine. J Sex Med. 2010, 7, 1608–1626. doi: 10.1111/j.1743-6109.2010.01779.x. https://www.ncbi.nlm.nih.gov/ pubmed/20388161
Jarow J.P., Lowe F.C.: Penile trauma: an etiologic factor in Peyronie’s disease and erectile dysfunction. J Urol. 1997, 158 (4), 1388–1390. doi: 10.1016/ s0022-5347(01)64222-8. https://www.ncbi.nlm.nih.gov/pubmed/9302127
Ji S., Zang Z., Ma H., Gu M., Han Y., Wang L. i wsp.: Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors. Int J Impot Res. 2016, 28 (3), 96–100. doi: 10.1038/ijir.2016.6. https://www.ncbi.nlm.nih.gov/pubmed/26865100
Johannes C.B., Araujo A.B., Feldman H.A., Derby C.A., Kleinman K.P., McKinlay J.B.: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000, 163 (2), 460–463. https://www.ncbi.nlm.nih.gov/pubmed/10647654
Jordan G.H.: The use of intralesional clostridial collagenase injection therapy for Peyronie’s disease: a prospective, single-center, non-placebocontrolled study. J Sex Med. 2008, 5 (1), 180–187. doi: 10.1111/j.1743- 6109.2007.00651.x. https://www.ncbi.nlm.nih.gov/pubmed/18173766 Junemann K.P., Persson-Jünemann C., Alken P.: Pathophysiology of erectile dysfunction. Semin Urol. 1990, 8 (2), 80–93. https://www.ncbi.nlm.nih. gov/pubmed/2191403
Kadioglu A., Akman T., Sanli O., Gurkan L., Cakan M., Celtik M. i wsp.: Surgical treatment of Peyronie’s disease: a critical analysis. Eur Urol. 2006, 50 (2), 235–248. doi: 10.1016/j.eururo.2006.04.030. https://www.ncbi.nlm.nih. gov/pubmed/16716495
Kadioglu A., Tefekli A., Erol H., Cayan S., Kandirali E.: Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res. 2000, 12 (5), 263–267. doi: 10.1038/sj.ijir.3900569. https:// www.ncbi.nlm.nih.gov/pubmed/11424963
Kadioglu A., Tefekli A., Erol B., Oktar T., Tunc M., Tellaloglu S.: A retrospective review of 307 men with Peyronie’s disease. J Urol. 2002, 168 (3), 1075– 1079. doi: 10.1097/01.ju.0000024040.55662.36. https://www.ncbi.nlm. nih.gov/pubmed/12187226
Kadioglu A., Tefekli A., Köksal T., Usta M., Erol H.: Treatment of Peyronie’s disease with oral colchicine: long-term results and predictive parameters of successful outcome. Int J Impot Res. 2000, 12 (3), 169–175. doi: 10.1038/ sj.ijir.3900519. https://www.ncbi.nlm.nih.gov/pubmed/11045911
Kadioglu A., Tefekli A., Usta M., Demirel S., Tellaloğlu S.: Surgical treatment of Peyronie’s disease with incision and venous patch technique. Int J Impot Res. 1999, 11 (2), 75–81. doi: 10.1038/sj.ijir.3900375. https://www.ncbi. nlm.nih.gov/pubmed/10356666
Kandel G.L., Bender L.I., Grove J.S.: Pulmonary embolism: a complication of corpus-saphenous shunt for priapism. J Urol. 1968, 99 (2), 196–197. doi: 10.1016/s0022-5347(17)62672-7. https://www.ncbi.nlm.nih.gov/ pubmed/5641077
Kang B.C., Lee D.Y., Byun J.Y., Baek S.Y., Lee S.W., Kim K.W.: Post-traumatic arterial priapism: colour Doppler examination and superselective arterial embolization. Clin Radiol. 1998, 53 (11), 830–834. doi: 10.1016/s0009- 9260(98)80195-5. https://www.ncbi.nlm.nih.gov/pubmed/9833787
Kao C.C., Lin C.L., Huang W.Y., Cha T.L., Lin T.Y., Shen C.H. i wsp.: Association Between Inflammatory Bowel Disease and Erectile Dysfunction: A Nationwide Population-Based Study. Inflamm Bowel Dis. 2016, 22 (5), 1065–1070. doi: 10.1097/MIB.0000000000000695. https://www.ncbi. nlm.nih.gov/pubmed/26863266
Karagiannis A.A., Sopilidis O.T., Brountzos E., Staios D.N., Kelekis N.L., Kelekis D.A.: High flow priapism secondary to internal urethrotomy treated with embolization. J Urol. 2004, 171 (4), 1631–1632. doi: 10.1097/01. ju.0000116287.03211.8d. https://www.ncbi.nlm.nih.gov/pubmed/15017242
Kato G.J.: Priapism in sickle-cell disease: a hematologist’s perspective. J Sex Med. 2012, 9 (1), 70–78. doi: 10.1111/j.1743-6109.2011.02287.x. https:// www.ncbi.nlm.nih.gov/pubmed/21554552
Keating G.M., Scott L.J.: Vardenafil: a review of its use in erectile dysfunction. Drugs. 2003, 63 (23), 2673–2703. doi: 10.2165/00003495-200363230- 00010. https://www.ncbi.nlm.nih.gov/pubmed/14636086
Kempeneers P., Andrianne R., Bauwens S., Georis I., Pairoux J.F., Blairy S.: Functional and psychological characteristics of belgian men with premature ejaculation and their partners. Arch Sex Behav. 2013, 42 (1), 51–66. doi: 10.1007/s10508-012-9958-y. https://www.ncbi.nlm.nih.gov/ pubmed/22695640
Kendirci M., Hellstrom W.J.: Critical analysis of surgery for Peyronie’s disease. Curr Opin Urol. 2004, 14 (6), 381–388. doi: 10.1097/00042307-200411000- 00015. https://www.ncbi.nlm.nih.gov/pubmed/15626883
Kendirci M., Usta M.F., Matern R.V., Nowfar S., Sikka S.C., Hellstrom W.J.: The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie’s disease. J Sex Med. 2005, 2 (5), 709–715. doi: 10.1111/j.1743-6109.2005.00110.x. https://www.ncbi.nlm. nih.gov/pubmed/16422829
Kerlan R.K., Gordon R.L., LaBerge J.M., Ring E.J.: Superselective microcoil embolization in the management of high-flow priapism. J Vasc Interv Radiol. 1998, 9, 85–89. doi: 10.1016/s1051-0443(98)70488-9. https://www.ncbi. nlm.nih.gov/pubmed/9468400
Keskin D., Cal C., Delibaş M., Ozyurt C., Günaydin G., Nazli O. i wsp.: Intracavernosal adrenalin injection in priapism. Int J Impot Res. 2000, 12 (6), 312–314. doi: 10.1038/sj.ijir.3900539. https://www.ncbi.nlm.nih. gov/pubmed/11416834
Khera M., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K. i wsp.: Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016, 13 (12), 1787–1804. doi: 10.1016/j.jsxm.2016.10.009. https://www.ncbi.nlm.nih.gov/pubmed/27914560
Khera M., Crawford D., Morales A., Salonia A., Morgentaler A.: A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014, 65 (1), 115–123. doi: 10.1016/j.eururo.2013.08.015. https:// www.ncbi.nlm.nih.gov/pubmed/24011426
Khoder W.Y., Waidelich R., Seitz M., Becker A.J., Buchner A., Trittschler S. i wsp.: Stief CG.Do we need the nerve sparing radical prostatectomy techniques (intrafascial vs. interfascial) in men with erectile dysfunction? Results of a single-centre study. World J Urol. 2015, 33 (3), 301–307. doi: 10.1007/ s00345-014-1302-9. https://www.ncbi.nlm.nih.gov/pubmed/24752607
Kihl B., Bratt C.G., Knutsson U., Seeman T.: Priapsim: evaluation of treatment with special reference to saphenocavernous shunting in 26 patients. Scand J Urol Nephrol. 1980, 14 (1), 1–5. doi: 10.3109/00365598009181182. https://www.ncbi.nlm.nih.gov/pubmed/7375831
Kim D.J., Hawksworth D.J., Hurwitz L.M., Cullen J., Rosner I.L., Lue T.F. i wsp.: A prospective, randomized, placebo-controlled trial of on-Demand vs. nightly sildenafil citrate as assessed by Rigiscan and the international index of erectile function. Andrology. 2016, 4 (1), 27–32. doi: 10.1111/andr.12118. https://www.ncbi.nlm.nih.gov/pubmed/26663669
Kim D.S., Yang K.M., Chung H.J., Choi H.M., Choi Y.D., Choi H.K.: AMS 700CX/ CXM inflatable penile prosthesis has high mechanical reliability at longterm follow-up. J Sex Med. 2010, 7, 2602–2607. doi: 10.1111/j.1743- 6109.2010.01801.x. https://www.ncbi.nlm.nih.gov/pubmed/20384938
Kim J.H., Lee H.J., Song Y.S.: Mesenchymal stem cell-based gene therapy for erectile dysfunction. Int J Impot Res. 2016, 28 (3), 81–87. doi: 10.1038/ ijir.2016.3. https://www.ncbi.nlm.nih.gov/pubmed/26888355
Kim K.R., Shin J.H., Song H.Y., Ko G.Y., Yoon H.K., Sung K.B. i wsp.: Treatment of high-flow priapism with superselective transcatheter embolization in 27 patients: a multicenter study. J Vasc Interv Radiol. 2007, 18 (10), 1222– 1226. doi: 10.1016/j.jvir.2007.06.030. https://www.ncbi.nlm.nih.gov/ pubmed/17911511
Kim M., Kim S.Y., Rou W.S., Hwang S.W., Lee B.S.: Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clin Mol Hepatol. 2015, 21 (4), 352–357. doi: 10.3350/cmh.2015.21.4.352. https://www.ncbi. nlm.nih.gov/pubmed/26770923
Kim S.W., Paick J.S.: Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology. 1999, 54 (3), 544–547. doi: 10.1016/s0090-4295(99)00187-9. https://www.ncbi. nlm.nih.gov/pubmed/10475369
Kirby E.W., Carson C.C., Coward R.M.: Tramadol for the management of premature ejaculation: A timely systematic review. Int J Impot Res. 2015, 27 (4), 121–127. doi: 10.1038/ijir.2015.7. https://www.ncbi.nlm.nih.gov/ pubmed/25971856
Kitrey N.D., Gruenwald I., Appel B., Shechter A., Massarwa O., Vardi Y. i wsp.: Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study. J Urol. 2016, 195 (5), 1550–1555. doi: 10.1016/j.juro.2015.12.049. https:// www.ncbi.nlm.nih.gov/pubmed/26694904
Kloner R.A., Jackson G., Emmick J.T., Mitchell M.I., Bedding A., Warner M.R. i wsp.: Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol. 2004, 172, 1935–1940. doi: 10.1097/01.ju.0000142687.75577.e4. https://www.ncbi.nlm.nih.gov/pubmed/15540759
Knoll L.D.: Use of porcine small intestinal submucosal graft in the surgical management of Peyronie’s disease. Urology. 2001, 57 (4), 753–757. doi: 10.1016/s0090-4295(00)01079-7. https://www.ncbi.nlm.nih.gov/ pubmed/11306396
Kolbenstvedt A., Egge T., Schultz A.: Arterial high flow priapism role of radiology in diagnosis and treatment. Scand J Urol Nephrol Suppl. 1996, 179, 143–146. https://www.ncbi.nlm.nih.gov/pubmed/8908681
Kostis J.B., Jackson G., Rosen R., Barrett-Connor E., Billups K., Burnett A.L. i wsp.: Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005, 96 (2), 313–321. doi: 10.1016/j.amjcard.2005.03.065. https://www.ncbi.nlm.nih.gov/pubmed/16018863
Kovanecz I., Rambhatla A., Ferrini M.G., Vernet D., Sanchez S., Rajfer J. i wsp.: Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008, 101 (2), 203–210. doi: 10.1111/j.1464-410X.2007.07223.x. https://www. ncbi.nlm.nih.gov/pubmed/17888043
Kropman R.F., Schipper J.: Hematoma or “partial priapism” in the proximal part of the corpus cavernosum. J Sex Med. 2014, 11 (10), 2618–2622. doi: 10.1111/jsm.12388. https://www.ncbi.nlm.nih.gov/pubmed/24308665

Piśmiennictwo

Kuefer R., Bartsch G. Jr, Herkommer K., Krämer S.C., Kleinschmidt K., Volkmer B.G.: Changing diagnostic and therapeutic concepts in high-flow priapism. Int J Impot Res. 2005, 17 (2), 109–113. doi: 10.1038/sj.ijir.3901257. https:// www.ncbi.nlm.nih.gov/pubmed/15229624
Kulmala R.V., Lehtonen T.A., Tammela T.L.: Priapism, its incidence and seasonal distribution in Finland. Scand J Urol Nephrol. 1995, 29 (1), 93–96. doi: 10.3109/00365599509180545. https://www.ncbi.nlm.nih.gov/ pubmed/7618054
Kumar B., Narang T., Gupta S., Gulati M.: A clinico-aetiological and ultrasonographic study of Peyronie’s disease. Sex Health. 2006, 3 (2), 113–118. doi: 10.1071/sh05031. https://www.ncbi.nlm.nih.gov/pubmed/16800397
Kurkar A., Elderwy A.A., Abulsorour S., Awad S.M., Safwat A.S., Altaher A.: A randomized, double-blind, placebo-controlled, crossover trial of “on-demand” tramadol for treatment of premature ejaculation. Urol Ann. 2015, 7 (2), 205–210. doi: 10.4103/0974-7796.150481. https://www.ncbi.nlm.nih.gov/ pubmed/25835132
Kyle J.A., Brown D.A., Hill J.K.: Avanafil for erectile dysfunction. Ann Pharmacother. 2013, 47 (10), 1312–1320. doi: 10.1177/1060028013501989. https://www.ncbi.nlm.nih.gov/pubmed/24259695
La Pera G., Pescatori E.S., Calabrese M., Boffini A., Colombo F., Andriani E. i wsp.: Peyronie’s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years. Eur Urol. 2001, 40 (5), 525–530. doi: 10.1159/000049830. https://www.ncbi.nlm. nih.gov/pubmed/11752860
Lagoda G., Sezen S.F., Cabrini M.R., Musicki B., Burnett A.L.: Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J Urol. 2013, 189 (2), 762–768. doi: 10.1016/j. juro.2012.08.198. https://www.ncbi.nlm.nih.gov/pubmed/22982429
Lahoz C., Mostaza J.M., Salinero-Fort M.A., García-Iglesias F., González-Alegre T., Estirado E. i wsp.: Peripheral atherosclerosis in patients with erectile dysfunction: A population-based study. J Sex Med. 2016, 13 (1), 63–69. doi: 10.1016/j. jsxm.2015.11.011. https://www.ncbi.nlm.nih.gov/pubmed/26755088
Lakin M.M., Montague D.K., VanderBrug Medendorp S., Tesar L., Schover L.R.: Intracavernous injection therapy: analysis of results and complications. J Urol. 1990, 143 (6), 1138–1141. doi: 10.1016/s0022-5347(17)40208-4. https://www.ncbi.nlm.nih.gov/pubmed/2342174
Langston J.P., Carson C.C.: Peyronie disease: plication or grafting. Urol Clin North Am. 2011, 38 (2), 207–216. doi: 10.1016/j.ucl.2011.03.001. https:// www.ncbi.nlm.nih.gov/pubmed/21621087
Laumann E.O., Nicolosi A., Glasser D.B., Paik A., Gingell C., Moreira E. i wsp.: Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005, 17 (1), 39–57. https://www.ncbi.nlm.nih.gov/ pubmed/15215881
Laumann E.O., Paik A., Rosen R.C.: Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999, 281 (6), 537–544. doi: 10.1001/ jama.281.6.537. https://www.ncbi.nlm.nih.gov/pubmed/10022110
Laumann E.O., Paik A., Rosen R.C.: The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res. 1999, 11 Suppl 1, S60–64. doi: 10.1038/sj.ijir.3900487. https://www.ncbi. nlm.nih.gov/pubmed/10554933
Law G., Nathoo N.A., Reiner E., Berkowitz J., Warner S.J., Mikelberg F.S.: Correlation in Severity Between Glaucoma and Erectile Dysfunction. J Glaucoma. 2016, 25 (9), 716–719. doi: 10.1097/IJG.0000000000000510. https://www.ncbi.nlm.nih.gov/pubmed/27552506
Lee D., Romero C., Alba F., Westney O.L., Wang R.: Simultaneous penile prosthesis and male sling/artificial urinary sphincter. Asian J Androl. 2013, 15 (1), 10–15. doi: 10.1038/aja.2012.115. https://www.ncbi.nlm.nih.gov/ pubmed/23202702
Lee D., Westney O.L., Wang R.: Combination surgery for erectile dysfunction and male incontinence. Curr Urol Rep. 2011, 12 (6), 461–469. doi: 10.1007/ s11934-011-0220-2. https://www.ncbi.nlm.nih.gov/pubmed/21956147 Lee J.C., Bénard F., Carrier S., Talwar V., Defoy I.: Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population? BJU Int. 2011, 107 (6), 956–960. doi: 10.1111/j.1464- 410X.2010.09691.x. https://www.ncbi.nlm.nih.gov/pubmed/20950304
Lee J.H., Lee S.W.: Relationship between premature ejaculation and chronic prostatitis/chronic pelvic pain syndrome. J Sex Med. 2015, 12 (3), 697–704. doi: 10.1111/jsm.12796. https://www.ncbi.nlm.nih.gov/pubmed/25475760
Lee W.K., Cho S.T., Lee Y.S., Lee Y.G., Oh C.Y., Yoo C. i wsp.: Can estimated intravaginal ejaculatory latency time be used interchangeably with stopwatchmeasured intravaginal ejaculatory latency time for the diagnosis of lifelong premature ejaculation? Urology. 2015, 85 (2), 375–380. doi: 10.1016/j. urology.2014.09.036. https://www.ncbi.nlm.nih.gov/pubmed/25623693
Lemberger R.J., Bishop M.C., Bates C.P.: Nesbit’s operation for Peyronie’s disease. Br J Urol. 1984, 56 (6), 721–723. doi: 10.1111/j.1464-410x.1984. tb06156.x. https://www.ncbi.nlm.nih.gov/pubmed/6534497
Leungwattanakij S., Bivalacqua T.J., Yang D.Y., Hyun J.S., Hellstrom W.J.: Comparison of cadaveric pericardial, dermal, vein, and synthetic grafts for tunica albuginea substitution using a rat model. BJU Int. 2003, 92 (1), 119–124. doi: 10.1046/j.1464-410x.2003.04279.x. https://www.ncbi.nlm. nih.gov/pubmed/12823395
Levey H.R., Kutlu O., Bivalacqua T.J.: Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J Androl. 2012, 14 (1), 156–163. doi: 10.1038/aja.2011.114. https://www.ncbi.nlm. nih.gov/pubmed/22057380
Levine L.A., Becher E.F., Bella A.J., Brant W.O., Kohler T.S., Martinez-Salamanca J.I. i wsp.: Penile Prosthesis Surgery: Current Recommendations From the International Consultation on Sexual Medicine. J Sex Med. 2016, 13 (4), 489–518. doi: 10.1016/j.jsxm.2016.01.017. https://www.ncbi.nlm.nih.gov/ pubmed/27045255
Levine L.A., Burnett A.L.: Standard operating procedures for Peyronie’s disease. J Sex Med. 2013, 10 (1), 230–244. doi: 10.1111/j.1743-6109.2012.03003.x. https://www.ncbi.nlm.nih.gov/pubmed/23211057
Levine L.A., Dimitriou R.J.: Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am. 2001, 28 (2), 335– 341. doi: 10.1016/s0094-0143(05)70142-7. https://www.ncbi.nlm.nih.gov/ pubmed/11402585
Levine L.A., Goldman K.E., Greenfield J.M.: Experience with intraplaque injection of verapamil for Peyronie’s disease. J Urol. 2002, 168 (2), 621–625. doi: 10.1016/s0022-5347(05)64691-5. https://www.ncbi.nlm.nih.gov/ pubmed/12131321
Levine L.A., Greenfield J.M.: Establishing a standardized evaluation of the man with Peyronie’s disease. Int J Impot Res. 2003, 15 Suppl 5, S103–112. doi: 10.1038/sj.ijir.3901083. https://www.ncbi.nlm.nih.gov/pubmed/14551586
Levine L.A., Guss S.P.: Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol. 1993, 150, 475–477. doi: 10.1016/s0022-5347(17)35520-9. https://www.ncbi.nlm. nih.gov/pubmed/8326584
Li Z., Chen P., Wang J., Mao Q., Xiang H., Wang X. i wsp.: The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis. Medicine (Baltimore). 2016, 95 (24), e3862. doi: 10.1097/ MD.0000000000003862. https://www.ncbi.nlm.nih.gov/pubmed/27310968
Licht M.R., Lewis R.W.: Modified Nesbit procedure for the treatment of Peyronie’s disease: a comparative outcome analysis. J Urol. 1997, 158 (2), 460–463. https://www.ncbi.nlm.nih.gov/pubmed/9224323
Liguori G., Garaffa G., Trombetta C., Capone M., Bertolotto M., Pozzi-Mucelli F. i wsp.: High-flow priapism (HFP) secondary to Nesbit operation: manage- ment by percutaneous embolization and colour Doppler-guided compression. Int J Impot Res. 2005, 17 (3), 304–306. doi: 10.1038/sj.ijir.3901251. https://www.ncbi.nlm.nih.gov/pubmed/15690066 Linda S.T., Schumm L.P., Laumann E.O., Levinson W., O’Muircheartaigh C.A., Waite L.J.: A study of sexuality and health among older adults in the United States. N Engl J Med. 2007, 357 (8), 762–774. doi: 10.1056/NEJMoa067423. https://www.ncbi.nlm.nih.gov/pubmed/17715410 Lindsay M.B., Schain D.M., Grambsch P., Benson R.C., Beard C.M., Kurland L.T.: The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991, 146 (4), 1007–1009. doi: 10.1016/s0022-5347(17)37988- 0. https://www.ncbi.nlm.nih.gov/pubmed/1895413 Lionnet F., Hammoudi N., Stojanovic K.S., Avellino V., Grateau G., Girot R. i wsp.: Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica. 2012, 97 (8), 1136–1141. doi: 10.3324/haematol.2011.055202. https://www.ncbi.nlm.nih.gov/pubmed/22315500 Lipshultz L.I., Goldstein I., Seftel A.D., Kaufman G.J., Smith T.M., Tursi J.P. i wsp.: Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie’s disease by subgroup: results from two large, doubleblind, randomized, placebo-controlled, phase III studies. BJU Int. 2015,116 (4), 650–656. doi: 10.1111/bju.13096. https://www.ncbi.nlm.nih.gov/ pubmed/25711400 Liu B.X., Xin Z.C., Zou Y.H., Tian L., Wu Y.G., Wu X.J. i wsp.: High-flow priapism: superselective cavernous artery embolization with microcoils. Urology. 2008, 72 (3), 571–573. doi: 10.1016/j.urology.2008.01.087. https://www. ncbi.nlm.nih.gov/pubmed/18619653 Liu L.H., Li E.M., Zhong S.L., Li Y.Q., Yang Z.Y., Kang R. i wsp.: Chronic periodontitis and the risk of erectile dysfunction: a systematic review and metaanalysis. Int J Impot Res. 2017, 29 (1), 43–48. doi: 10.1038/ijir.2016.43. https://www.ncbi.nlm.nih.gov/pubmed/27829669 Lowe F.C., Jarow J.P.: Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993, 42 (1), 51–53. doi: 10.1016/0090-4295(93)90338-b. https://www.ncbi.nlm.nih.gov/pubmed/8392235 Lu Z., Lin G., Reed-Maldonado A., Wang C., Lee Y.C., Lue T.F.: Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis. Eur Urol. 2017, 71 (2), 223–233. doi: 10.1016/j.eururo.2016.05.050. https://www.ncbi.nlm.nih.gov/ pubmed/27321373 Lue T.F.: Erectile dysfunction. N Engl J Med. 2000, 342 (24), 1802–1813. doi: 10.1056/NEJM200006153422407. https://www.ncbi.nlm.nih.gov/ pubmed/10853004 Lue T.F., Giuliano F., Montorsi F., Rosen R.C., Andersson K.E., Althof S. i wsp.: Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004, 1 (1), 6–23. doi: 10.1111/j.1743-6109.2004.10104.x. https:// www.ncbi.nlm.nih.gov/pubmed/16422979 Lue T.F., Pescatori E.S.: Distal cavernosum-glans shunts for ischemic priapism. J Sex Med. 2006, 3 (4), 749–752. doi: 10.1111/j.1743-6109.2006.00281.x. https://www.ncbi.nlm.nih.gov/pubmed/16839333 Lund K., Ebbehøj J.: Results of glando-cavernous anastomosis in 18 cases of priapism. Scand J Plast Reconstr Surg. 1980, 14 (3), 269–272. doi: 10.3109/02844318009106720. https://www.ncbi.nlm.nih.gov/ pubmed/7209413 Lutz A., Lacour S., Hellstrom W.: Conversion of low-flow to high-flow priapism: a case report and review (CME). J Sex Med. 2012, 9 (4), 951–954. doi: 10.1111/j.1743-6109.2012.02692.x. https://www.ncbi.nlm.nih.gov/ pubmed/22462585 Lux M., Reyes-Vallejo L., Morgentaler A., Levine L.A.: Outcomes and satisfaction rates for the redesigned 2-piece penile prosthesis. J Urol. 2007, 177 (1), 262–266. doi: 10.1016/j.juro.2006.08.094. https://www.ncbi.nlm.nih. gov/pubmed/17162061 Macaluso J.N., Sullivan J.W.: Priapism: review of 34 cases. Urology. 1985, 26 (3), 233–236. doi: 10.1016/0090-4295(85)90116-5. https://www.ncbi. nlm.nih.gov/pubmed/4035837 Maggi M., Buvat J., Corona G., Guay A., Torres L.O.: Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med. 2013, 10 (3), 661–677. doi: 10.1111/j.1743-6109.2012.02735.x. https://www.ncbi.nlm.nih.gov/ pubmed/22524444 Majzoub A., Arafa M., Al-Said S., Dabbous Z., Aboulsoud S., Khalafalla K. i wsp.: Premature ejaculation in type II diabetes mellitus patients: Association with glycemic control. Transl Androl Urol. 2016, 5 (2), 248–254. doi: 10.21037/ tau.2016.03.11. https://www.ncbi.nlm.nih.gov/pubmed/27141454 Mandava S.H., Serefoglu E.C., Freier M.T., Wilson S.K., Hellstrom W.J.: Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. J Urol. 2012, 188 (5), 1855– 1860. doi: 10.1016/j.juro.2012.07.022. https://www.ncbi.nlm.nih.gov/ pubmed/22999690 Mantadakis E., Cavender J.D., Rogers Z.R., Ewalt D.H., Buchanan G.R.: Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 1999, 21 (6), 518–522. https://www.ncbi. nlm.nih.gov/pubmed/10598664 Mantadakis E., Ewalt D.H., Cavender J.D., Rogers Z.R., Buchanan G.R.: Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000, 95 (1), 78–82. https://www.ncbi.nlm.nih.gov/pubmed/10607688 Marchal Escalona C., Herrera-Imbroda B., Clemente-Postigo M., Alcaide-Torres J., Quiñonero A., Marchal M. i wsp.: PDE5A Polymorphisms Influence on Sildenafil Treatment Success. J Sex Med. 2016, 13 (7), 1104–1110. doi: 10.1016/j. jsxm.2016.04.075. https://www.ncbi.nlm.nih.gov/pubmed/27235284 Mark K.P., Kerner I.: Event-level impact of Promescent on quality of sexual experience in men with subjective premature ejaculation. Int J Impot Res. 2016, 28 (6), 216–220. doi: 10.1038/ijir.2016.31. https://www.ncbi.nlm. nih.gov/pubmed/27557610 Marouf R.: Blood transfusion in sickle cell disease. Hemoglobin. 2011, 35 (5-6), 495–502. doi: 10.3109/03630269.2011.596984. https://www.ncbi. nlm.nih.gov/pubmed/21981466 Martin D.J., Badwan K., Parker M., Mulhall J.P.: Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol. 2002, 168 (6), 2483–2485. doi: 10.1097/01.ju.0000031440.26763. da. https://www.ncbi.nlm.nih.gov/pubmed/12441945 Martinez Portillo F., Hoang-Boehm J., Weiss J., Alken P., Jünemann K.: Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol. 2001, 39 (1), 20–23. doi: 10.1159/000052407. https:// www.ncbi.nlm.nih.gov/pubmed/11173934 Martinez-Salamanca J.I., Egui A., Moncada I., Minaya J., Ballesteros C.M., Del Portillo L.: Acute phase Peyronie’s disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. J Sex Med. 2014, 11 (2), 506–515. doi: 10.1111/jsm.12400. https://www. ncbi.nlm.nih.gov/pubmed/24261900 Martinez-Salamanca J.I., Mueller A., Moncada I., Carballido J., Mulhall J.P.: Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review. J Sex Med. 2011, 8 (7), 1880–1889. doi: 10.1111/j.1743-6109.2011.02281.x. https://www.ncbi.nlm.nih.gov/pubmed/21492405 Martyn-St James M., Cooper K., Kaltenthaler E., Dickinson K., Cantrell A., Wylie K. i wsp.: Tramadol for premature ejaculation: a systematic review and metaanalysis. [Review]. BMC Urol. 2015, 15, 6. doi: 10.1186/1471-2490-15-6. https://www.ncbi.nlm.nih.gov/pubmed/25636495 Martyn-St. James M., Cooper K., Ren K., Kaltenthaler E., Dickinson K., Cantrell A. i wsp.: Topical anaesthetics for premature ejaculation: A systematic review and meta-analysis. Sex Health. 2016, 13 (2), 114–123. doi: 10.1071/SH15042. https://www.ncbi.nlm.nih.gov/pubmed/26599522 Masters H.M., Johnson V.E.: Human Sexual Inadequacy. Ishi Press Inernational, New York 1970. [No abstract available]. McCullough A.R., Barada J.H., Fawzy A., Guay A.T., Hatzichristou D.: Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology. 2002, 60, 28–38. doi: 10.1016/s0090- 4295(02)01688-6. https://www.ncbi.nlm.nih.gov/pubmed/12414331 McMahon C.G.: A comparison of the response to the intracavernosal injection of papaverine and phentolamine, prostaglandin E1 and a combination of all three agents in the management of impotence. J Urol. 1999. 162. McMahon C.G.: Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012, 4 (5), 233–251. doi: 10.1177/1756287212453866. https://www.ncbi.nlm.nih.gov/ pubmed/23024705 McMahon C.G.: Ejaculatory latency vs. patient-reported outcomes (PROs) as study end points in premature ejaculation clinical trials. Eur Urol. 2007, 52 (2), 321–323. doi: 10.1016/j.eururo.2007.03.081. https://www.ncbi.nlm. nih.gov/pubmed/17445975 McMahon C.G.: High flow priapism due to an arterial-lacunar fistula complicating initial veno-occlusive priapism. Int J Impot Res. 2002, 14 (3), 195–196. doi: 10.1038/sj.ijir.3900828. https://www.ncbi.nlm.nih.gov/ pubmed/12058247 McMahon C.G., Abdo C., Incrocci L., Perelman M., Rowland D., Waldinger M. i wsp.: Disorders of orgasm and ejaculation in men. J Sex Med. 2004, 1, 58–65. doi: 10.1111/j.1743-6109.2004.10109.x. https://www.ncbi.nlm. nih.gov/pubmed/16422984 McMahon C.G., Althof S.E., Kaufman J.M., Buvat J., Levine S.B., Aquilina J.W. i wsp.: Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med. 2011, 8 (2), 524–539. doi: 10.1111/j.1743-6109.2010.02097.x. https://www. ncbi.nlm.nih.gov/pubmed/21059176 McMahon C.G., Giuliano F., Dean J., Hellstrom W.J., Bull S., Tesfaye F. i wsp.: Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. J Sex Med. 2013, 10 (9), 2312–2325. doi: 10.1111/jsm.12236. https://www.ncbi.nlm. nih.gov/pubmed/23845016 McMahon C.G., Lee S.W., Kim S.W., Moon du G., Kongkanand A., Tantiwongse K.: The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy: The PASSION Study. Sex Med. 2016, 4 (1), e18–27. doi: 10.1016/j.esxm.2015.12.006. https://www.ncbi.nlm.nih. gov/pubmed/26944775 McMahon C.G., Lee G., Park J.K., Adaikan P.G.: Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region. J Sex Med. 2012, 9 (2), 454–465. doi: 10.1111/j.1743-6109.2011.02507.x. https://www.ncbi.nlm.nih.gov/pubmed/22023395 McMahon C.G., McMahon C.N., Leow L.J., Winestock C.G.: Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 2006, 98 (2), 259–272. doi: 10.1111/j.1464- 410X.2006.06290.x. https://www.ncbi.nlm.nih.gov/pubmed/16879663 McMahon C.G., Porst H.: Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med. 2011, 8 (10), 2707–2725. doi: 10.1111/j.1743-6109.2011.02386.x. https://www.ncbi.nlm.nih.gov/pubmed/21771283 McMahon C.G., Samali R., Johnson H.: Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol. 1999, 162 (6), 1992–1997. doi: 10.1016/ s0022-5347(05)68085-8. https://www.ncbi.nlm.nih.gov/pubmed/10569554 McMahon C.G., Stuckey B.G., Andersen M., Purvis K., Koppiker N., Haughie S. i wsp.: Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med. 2005, 2 (3), 368–375. doi: 10.1111/j.1743-6109.2005.20351.x. https://www.ncbi.nlm.nih.gov/pubmed/16422868 McMahon C.G., Touma K.: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol. 1999, 161 (6), 1826–1830. https://www.ncbi.nlm.nih.gov/ pubmed/10332446 Meier E.R., Miller J.L.: Sickle cell disease in children. Drugs. 2012, 72 (7), 895–906. doi: 10.2165/11632890-000000000-00000. https://www.ncbi. nlm.nih.gov/pubmed/22519940 Men C., Yu L., Yuan H., Cui Y.: Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysis. Andrologia. 2016, 48 (9), 978–985. doi: 10.1111/and.12540. https:// www.ncbi.nlm.nih.gov/pubmed/26791333 Menon V., Breyer B., Copp H.L., Baskin L., Disandro M., Schlomer B.J.: Do adult men with untreated ventral penile curvature have adverse outcomes? J Pediatr Urol. 2016, 12 (1), 31.e1. doi: 10.1016/j.jpurol.2015.09.009. https:// www.ncbi.nlm.nih.gov/pubmed/26776946 Merritt A.L., Haiman C., Henderson S.O.: Myth: blood transfusion is effective for sickle cell anemia-associated priapism. CJEM. 2006, 8 (2), 119– 122. doi: 10.1017/s1481803500013609. https://www.ncbi.nlm.nih.gov/ pubmed/17175874 Metz M.E., Pryor J.L., Nesvacil L.J., Abuzzahab F. Sr, Koznar J.: Premature ejaculation: a psychophysiological review. J Sex Marital Ther. 1997, 23 (1), 3–23. doi: 10.1080/00926239708404413. https://www.ncbi.nlm.nih.gov/ pubmed/9094032 Miller S.F., Chait P.G., Burrows P.E., Steckler R.E., Khoury A.E., McLorie G.A. i wsp.: Posttraumatic arterial priapism in children: management with embolization. Radiology. 1995, 196 (1), 59–62. doi: 10.1148/radiology.196.1.7784590. https://www.ncbi.nlm.nih.gov/pubmed/7784590 Miner M., Esposito K., Guay A., Montorsi P., Goldstein I.: Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med. 2012, 9 (3), 641–651. doi: 10.1111/j.1743-6109.2012.02649.x. https://www.ncbi. nlm.nih.gov/pubmed/22372651 Mirone V., Arcaniolo D., Rivas D., Bull S., Aquilina J.W., Verze P.: Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. Eur Urol. 2014, 65 (4), 733–739. doi: 10.1016/j.eururo.2013.08.018. https://www.ncbi.nlm. nih.gov/pubmed/23993257 Mocniak M., Durkin C.M., Early K.: The use of sudafed for priapism in pediatric patients with sickle cell disease. J Pediatr Nurs. 2012, 27 (1), 82–84. doi: 10.1016/j.pedn.2011.10.006. https://www.ncbi.nlm.nih.gov/ pubmed/22041221 Modi N.B., Dresser M.J., Simon M., Lin D., Desai D., Gupta S.: Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol. 2006, 46 (3), 301–309. doi: 10.1177/0091270005284850. https://www.ncbi.nlm. nih.gov/pubmed/16490806 Molina Leyva A., Jiménez-Moleón J.J., Naranjo-Sintes R., Ruiz-Carrascosa J.C.: Sexual dysfunction in psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2015, 29 (4), 649–655. doi: 10.1111/jdv.12845. https://www. ncbi.nlm.nih.gov/pubmed/25424331 Moncada I., de Bethencourt F.R., Lledó-García E., Romero-Otero J., Turbi C., Büttner H. i wsp.: Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy. World J Urol. 2015, 33 (7), 1031– 1038. doi: 10.1007/s00345-014-1377-3. https://www.ncbi.nlm.nih.gov/ pubmed/25155034 Moncada I., Jara J., Subirá D., Castaño I., Hernández C.: Efficacy of sildenafil citrate at 12 hours after dosing: re-exploring the therapeutic window. Eur Urol. 2004, 46 (3), 357–360. doi: 10.1016/j.eururo.2004.04.025. https:// www.ncbi.nlm.nih.gov/pubmed/15306108 Monga M., Broderick G.A., Hellstrom W.J.: Priapism in sickle cell disease: the case for early implantation of the penile prosthesis. Eur Urol. 1996, 30 (1), 54–59. doi: 10.1159/000474145. https://www.ncbi.nlm.nih.gov/ pubmed/8854068 Montag S., Palmer L.S.: Abnormalities of penile curvature: chordee and penile torsion. Sci World J. 2011, 11, 1470–1478. doi: 10.1100/tsw.2011.136. https://www.ncbi.nlm.nih.gov/pubmed/21805016 Montague D.K.: Penile prosthesis implantation in the era of medical treatment for erectile dysfunction. Urol Clin North Am. 2011, 38 (2), 217– 225. doi: 10.1016/j.ucl.2011.02.009. https://www.ncbi.nlm.nih.gov/ pubmed/11402587 Montague D.K., Angermeier K.W.: Penile prosthesis implantation. Urol Clin North Am. 2001, 28 (2), 355–361. doi: 10.1016/s0094-0143(05)70144-0. https://www.ncbi.nlm.nih.gov/pubmed/11402587 Montague D.K., Angermeier K.W., Lakin M.M., Ingleright B.J.: AMS 3-piece inflatable penile prosthesis implantation in men with Peyronie’s disease: comparison of CX and Ultrex cylinders. J Urol. 1996, 156 (5), 1633–1635. https://www.ncbi.nlm.nih.gov/pubmed/8863557 Montague D.K., Jarow J., Broderick G.A., Dmochowski R.R., Heaton J.P., Lue T.F. i wsp.: American Urological Association guideline on the management of priapism. J Urol. 2003, 170, 1318–1324. doi: 10.1097/01.ju.0000087608.07371. ca. https://www.ncbi.nlm.nih.gov/pubmed/14501756 Montorsi F., Adaikan G., Becher E., Giuliano F., Khoury S., Lue T.F. i wsp.: Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010, 7 (11), 3572–3588. doi: 10.1111/j.1743-6109.2010.02062.x. https://www.ncbi.nlm.nih.gov/pubmed/21040491 Montorsi F., Brock G., Lee J., Shapiro J., Van Poppel H., Graefen M. i wsp.: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008, 54 (4), 924–931. doi: 10.1016/j.eururo.2008.06.083. https://www. ncbi.nlm.nih.gov/pubmed/18640769 Montorsi F., Brock G., Stolzenburg J.U., Mulhall J., Moncada I., Patel H.R. i wsp.: Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebocontrolled study (REACTT). Eur Urol. 2014, 65 (3), 587–596. doi: 10.1016/j. eururo.2013.09.051. https://www.ncbi.nlm.nih.gov/pubmed/24169081 Montorsi F., Guazzoni G., Strambi L.F., Da Pozzo L.F., Nava L., Barbieri L. i wsp.: Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997, 158 (4), 1408–1410. https://www.ncbi.nlm.nih.gov/pubmed/9302132 Montorsi F., McCullough A.: Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med. 2005, 2 (5), 658–667. doi: 10.1111/j.1743- 6109.2005.00117.x. https://www.ncbi.nlm.nih.gov/pubmed/16422824 Montorsi F., Nathan H.P., McCullough A., Brock G.B., Broderick G., Ahuja S. i wsp.: Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol. 2004, 172 (3), 1036–1041. doi: 10.1097/01. ju.0000136448.71773.2b. https://www.ncbi.nlm.nih.gov/pubmed/15311032 Montorsi F., Oelke M., Henneges C., Brock G., Salonia A., d’Anzeo G. i wsp.: Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy. Eur Urol. 2016, 70 (3), 529–537. doi: 10.1016/j.eururo.2016.02.036. https://www.ncbi.nlm. nih.gov/pubmed/26947602 Montorsi F., Padma-Nathan H., Buvat J., Schwaibold H., Beneke M., Ulbrich E. i wsp.: Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. J Sex Med. 2004, 1 (2), 168–178. doi: 10.1111/j.1743- 6109.2004.04025.x. https://www.ncbi.nlm.nih.gov/pubmed/16422971 Montorsi F., Salonia A., Maga T., Bua L., Guazzoni G., Barbieri L. i wsp.: Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie’s disease. J Urol. 2000, 163 (6), 1704–1708. https://www.ncbi. nlm.nih.gov/pubmed/10799165 Morales A., Barada J., Wyllie M.G.: A review of the current status of topical treatments for premature ejaculation. BJU Int. 2007, 100 (3), 493–501. doi: 10.1111/j.1464-410X.2007.07051.x. https://www.ncbi.nlm.nih.gov/ pubmed/17608824 Moreira D.M., Pimentel M., da Silva Moreira B.F., Stein A.C., Koff W.J.: Recurrent priapism in the young patient treated with baclofen. J Pediatr Urol. 2006, 2 (6), 590–591. doi: 10.1016/j.jpurol.2005.11.009. https://www.ncbi.nlm. nih.gov/pubmed/18947688 Morgia G., Castelli T., Privitera S., Al-Nakib C., Favilla V., Marchese F. i wsp.: Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I(125) implant brachytherapy for prostate cancer. A longitudinal study of a single-institution. Aging Male. 2016, 19 (1), 15–19. doi: 10.3109/13685538.2015.1083546. https://www.ncbi.nlm.nih. gov/pubmed/26376010 Moriel E.Z., Rajfer J.: Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. J Urol. 1993, 149, 1299–1300. doi: 10.1016/s0022-5347(17)36373-5. https://www.ncbi.nlm. nih.gov/pubmed/8386779 Morrison B.F., Burnett A.L.: Priapism in hematological and coagulative disorders: an update. Nat Rev Urol. 2011, 8 (4), 223–230. doi: 10.1038/ nrurol.2011.28. https://www.ncbi.nlm.nih.gov/pubmed/21403660 Morrison B.F., Burnett A.L.: Stuttering priapism: insights into pathogenesis and management. Curr Urol Rep. 2012, 13 (4), 268–276. doi: 10.1007/ s11934-012-0258-9. https://www.ncbi.nlm.nih.gov/pubmed/22648304 Moskovic D.J., Alex B., Choi J.M., Nelson C.J., Mulhall J.P.: Defining predictors of response to intralesional verapamil injection therapy for Peyronie’s disease. BJU Int. 2011, 108 (9), 1485–1499. doi: 10.1111/j.1464-410X.2010.10029.x. https://www.ncbi.nlm.nih.gov/pubmed/21733073 Mottet N., Bellmunt J., Bolla M., Briers E., Cumberbatch M.G., De Santis M. i wsp.: EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017, 71 (4), 618–629. doi: 10.1016/j.eururo.2016.08.003. https://www.ncbi.nlm. nih.gov/pubmed/27568654 Moudi E., Kasaeeyan A.A.: Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation. Nephrourol Mon. 2016, 8 (1), e32286. doi: 10.5812/numonthly.32286. https://www. ncbi.nlm.nih.gov/pubmed/26981497 Moyad M.A., Barada J.H., Lue T.F., Mulhall J.P., Goldstein I., Fawzy A.: Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II. Urol Clin North Am. 2004, 31 (2), 259–273. doi: 10.1016/j.ucl.2004.01.007. https://www.ncbi.nlm.nih.gov/pubmed/15123406 Mulcahy J.J.: Long-term experience with salvage of infected penile implants. J Urol. 2000, 163 (2), 481–482. https://www.ncbi.nlm.nih.gov/ pubmed/10647660 Mulcahy J.J., Austoni E., Barada J.H., Choi H.K., Hellstrom W.J., Krishnamurti S. i wsp.: The penile implant for erectile dysfunction. J Sex Med. 2004, 1 (1), 98–109. doi: 10.1111/j.1743-6109.2004.10115.x. https://www.ncbi.nlm. nih.gov/pubmed/16422990 Mulhall J.P., Anderson M.S., Lubrano T., Shankey T.V.: Peyronie’s disease cell culture models: phenotypic, genotypic and functional analyses. Int J Impot Res. 2002, 14 (5), 397–405. doi: 10.1038/sj.ijir.3900874. https://www.ncbi. nlm.nih.gov/pubmed/12454692 Mulhall J., Anderson M., Parker M.: A surgical algorithm for men with combined Peyronie’s disease and erectile dysfunction: functional and satisfaction outcomes. J Sex Med. 2005, 2 (1), 132–138. doi: 10.1111/j.1743- 6109.2005.20113.x. https://www.ncbi.nlm.nih.gov/pubmed/16422916 Mulhall J., Brock G.B., Glina S., Baygani S., Donatucci C.F., Maggi M. i wsp.: Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials. J Sex Med. 2016, 13 (5), 843–851. doi: 10.1016/j.jsxm.2016.02.163. https://www.ncbi.nlm.nih.gov/ pubmed/27017071 Mulhall J.P., Burnett A.L., Wang R., McVary K.T., Moul J.W., Bowden C.H. i wsp.: A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol. 2013, 189 (6), 2229–2236. doi: 10.1016/j.juro.2012.11.177. https://www.ncbi.nlm.nih.gov/pubmed/23219537 Mulhall J.P., Creech S.D., Boorjian S.A., Ghaly S., Kim E.D., Moty A. i wsp.: Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004, 171, 2350–2350. doi: 10.1097/01.ju.0000127744.18878.f1. https://www. ncbi.nlm.nih.gov/pubmed/15126819 Mulhall J.P., Daller M., Traish A.M., Gupta S., Park K., Salimpour P. i wsp.: Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol. 1997, 158 (8), 1752– 1758. doi: 10.1016/s0022-5347(01)64118-1. https://www.ncbi.nlm.nih. gov/pubmed/9334594 Mulhall J.P., Goldstein I., Bushmakin A.G., Cappelleri J.C., Hvidsten K.: Validation of the erection hardness score. J Sex Med. 2007, 4 (6), 1626–1634. doi: 10.1111/j.1743-6109.2007.00600.x. https://www.ncbi.nlm.nih.gov/ pubmed/17888069 Mulhall J.P., Jahoda A.E., Ahmed A., Parker M.: Analysis of the consistency of intraurethral prostaglandin E(1) (MUSE) during at-home use. Urology. 2001, 58 (2), 262–266. doi: 10.1016/s0090-4295(01)01164-5. https://www. ncbi.nlm.nih.gov/pubmed/11489714 Mulhall J.P., Schiff J., Guhring P.: An analysis of the natural history of Peyronie’s disease. J Urol. 2006, 175 (6), 2115–2118. doi: 10.1016/S0022- 5347(06)00270-9. https://www.ncbi.nlm.nih.gov/pubmed/16697815 Muller A., Mulhall J.P.: Peyronie’s disease intervention trials: methodological challenges and issues. J Sex Med. 2009, 6 (3), 848–861. doi: 10.1111/j.1743- 6109.2008.01081.x. https://www.ncbi.nlm.nih.gov/pubmed/19138374 Munarriz R., Munarriz R., McAuley I., Goldstein I., Traish A., Kim N.: Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med. 2006, 3 (5), 918–922. doi: 10.1111/j.1743-6109.2005.00140.x. https://www.ncbi.nlm.nih.gov/ pubmed/16942536 Muneer A., Cellek S., Dogan A., Kell P.D., Ralph D.J., Minhas S.: Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res. 2005, 17 (1), 10–18. doi: 10.1038/sj.ijir.3901231. https://www.ncbi.nlm.nih.gov/pubmed/15071490 Muneer A., Minhas S., Freeman A., Kumar P., Ralph D.J.: Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. J Sex Med. 2008, 5 (9), 2152–2159. doi: 10.1111/j.1743- 6109.2008.00862.x. https://www.ncbi.nlm.nih.gov/pubmed/18466270 Murray K.S., Bailey J., Zuk K., Lopez-Corona E., Thrasher J.B.: A prospective study of erectile function after transrectal ultrasonography-guided prostate biopsy. BJU Int. 2015, 116 (2), 190–195. doi: 10.1111/bju.13002. https:// www.ncbi.nlm.nih.gov/pubmed/25430505 Muruve N., Hosking D.H.: Intracorporeal phenylephrine in the treatment of priapism. J Urol. 1996, 155 (1), 141–143. https://www.ncbi.nlm.nih. gov/pubmed/7490814 Mwamukonda K.B., Chi T., Shindel A.W., Lue T.F.: Androgen blockade for the treatment of high-flow priapism. J Sex Med. 2010, 7 (7), 2532–2537. doi: 10.1111/j.1743-6109.2010.01838.x. https://www.ncbi.nlm.nih.gov/ pubmed/20456623 Nason G.J., McNamara F., Twyford M., O’Kelly F., White S., Dunne E. i wsp.: Efficacy of vacuum erectile devices (VEDs) after radical prostatectomy: the initial Irish experience of a dedicated VED clinic. Int J Impot Res. 2016, 28 (6), 205–208. doi: 10.1038/ijir.2016.23. https://www.ncbi.nlm.nih.gov/ pubmed/27225711 Natali A., Olianas R., Fisch M.: Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med. 2008, 5 (6), 1503–1512. doi: 10.1111/j.1743-6109.2008.00819.x. https://www. ncbi.nlm.nih.gov/pubmed/18410306 Nehra A., Grantmyre J., Nadel A., Thibonnier M., Brock G.: Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol. 2005, 173 (6), 2067–2071. doi: 10.1097/01. ju.0000158456.41788.93. https://www.ncbi.nlm.nih.gov/pubmed/15879836 Nehra A., Jackson G., Miner M., Billups K.L., Burnett A.L., Buvat J.: The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012, 87 (8), 766–778. doi: 10.1016/j.mayocp.2012.06.015. https://www.ncbi.nlm.nih. gov/pubmed/22862865 Nelson C.J., Diblasio C., Kendirci M., Hellstrom W., Guhring P., Mulhall J.P.: The chronology of depression and distress in men with Peyronie’s disease. J Sex Med. 2008, 5 (8), 1985–1990. doi: 10.1111/j.1743-6109.2008.00895.x. https://www.ncbi.nlm.nih.gov/pubmed/18554257 Nelson J.H., Winter C.C.: Priapism: evolution of management in 48 patients in a 22-year series. J Urol. 1977, 117 (4), 455–458. doi: 10.1016/s0022- 5347(17)58497-9. https://www.ncbi.nlm.nih.gov/pubmed/15137 Nesbit R.M.: Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol. 1965, 93, 230–232. doi: 10.1016/ s0022-5347(17)63751-0. https://www.ncbi.nlm.nih.gov/pubmed/14260875 Nichols D.J., Muirhead G.J., Harness J.A.: Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol. 2002, 53 Suppl 1, 5S–12S. doi: 10.1046/j.0306-5251.2001.00027.x. https://www.ncbi.nlm. nih.gov/pubmed/11879254 NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993, 270 (1), 83–90. https://www.ncbi.nlm.nih. gov/pubmed/8510302 Nixon R.G., O’Connor J.L., Milam D.F.: Efficacy of shunt surgery for refractory low flow priapism: a report on the incidence of failed detumescence and erectile dysfunction. J Urol. 2003, 170 (3), 883–886. doi: 10.1097/01. ju.0000081291.37860.a5. https://www.ncbi.nlm.nih.gov/pubmed/12913722 Numan F., Cakirer S., Işlak C., Oğüt G., Kadioğlu A., Cayan S. i wsp.: Posttraumatic high-flow priapism treated by N-butyl-cyanoacrylate embolization. Cardiovasc Intervent Radiol. 1996, 19 (4), 278–280. https://www.ncbi. nlm.nih.gov/pubmed/8755084 Numan F., Cantasdemir M., Ozbayrak M., Sanli O., Kadioglu A., Hasanefendioglu A. i wsp.: Posttraumatic nonischemic priapism treated with autologous blood clot embolization. J Sex Med. 2008, 5 (1), 173–179. doi: 10.1111/j.1743- 6109.2007.00560.x. https://www.ncbi.nlm.nih.gov/pubmed/18173765 O’Connor D.B., Lee D.M., Corona G., Forti G., Tajar A., O’Neill T.W. i wsp.: The relationships between sex hormones and sexual function in middleaged and older European men. J Clin Endocrinol Metab. 2011, 96 (10), E1577–1587. doi: 10.1210/jc.2010-2216. https://www.ncbi.nlm.nih.gov/ pubmed/21849522 Okpala I., Westerdale N., Jegede T., Cheung B.: Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol. 2002, 118 (3), 918– 921. doi: 10.1046/j.1365-2141.2002.03691.x. https://www.ncbi.nlm.nih. gov/pubmed/12181066 Olivier B., van Oorschot R., Waldinger M.D.: Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol. 1998, 13 Suppl 6, S9. doi: 10.1097/00004850-199807006- 00003. https://www.ncbi.nlm.nih.gov/pubmed/9728669 Olsen A.B., Persiani M., Boie S., Hanna M., Lund L.: Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study. Scand J Urol. 2015, 49 (4), 329–333. doi: 10.3109/21681805.2014.984326. https://www.ncbi. nlm.nih.gov/pubmed/25470423 Olujohungbe A.B., Adeyoju A., Yardumian A., Akinyanju O., Morris J., Westerdale N. i wsp.: A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study. J Androl. 2011, 32 (4), 375–382. doi: 10.2164/jandrol.110.010934. https://www.ncbi.nlm. nih.gov/pubmed/21127308 Omland T., Randby A., Hrubos-Strøm H., Røsjø H., Einvik G.: Relation of Erectile Dysfunction to Subclinical Myocardial Injury. Am J Cardiol. 2016, 118 (12), 1821–1821. doi: 10.1016/j.amjcard.2016.08.070. https://www.ncbi.nlm. nih.gov/pubmed/27780552 Otero J.R., Cruz C.R., Gómez B.G., Geli J.S., Polo J.M., Castañé E.R. i wsp.: Comparison of the patient and partner satisfaction with 700CX and Titan penile prostheses. Asian J Androl. 2017, 19 (3), 321–325. doi: 10.4103/1008- 682X.172822. https://www.ncbi.nlm.nih.gov/pubmed/26806085 Padma-Nathan H., Hellstrom W.J., Kaiser F.E., Labasky R.F., Lue T.F., Nolten W.E. i wsp.: Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997, 336 (1), 1–7. doi: 10.1056/NEJM199701023360101. https://www.ncbi.nlm.nih.gov/pubmed/8970933 Padma-Nathan H., McCullough A.R., Levine L.A., Lipshultz L.I., Siegel R., Montorsi F. i wsp.: Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008, 20 (5), 479–486. doi: 10.1038/ijir.2008.33. https://www.ncbi.nlm.nih.gov/ pubmed/18650827 Padma-Nathan H., Stecher V.J., Sweeney M., Orazem J., Tseng L.J., Deriesthal H.: Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial. Urology. 2003, 62 (3), 400–403. doi: 10.1016/s0090-4295(03)00567-3. https://www.ncbi. nlm.nih.gov/pubmed/12946731 Padma-Nathan H., Yeager J.L.: An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. Urology. 2006, 68 (2), 386–391. doi: 10.1016/j.urology.2006.02.027. https://www. ncbi.nlm.nih.gov/pubmed/16904458 Pajovic B., Dimitrovski A., Fatic N., Malidzan M., Vukovic M.: Vacuum erection device in treatment of organic erectile dysfunction and penile vascular differences between patients with DM type I and DM type II. Aging Male. 2017, 20 (1), 49–53. doi: 10.1080/13685538.2016.1230601. https://www. ncbi.nlm.nih.gov/pubmed/27690728 Palmieri A., Imbimbo C., Longo N., Fusco F., Verze P., Maletta A. i wsp.: Ejaculatory abstinence influences intravaginal ejaculatory latency time: results from a prospective randomized trial. Urol Int. 2012, 88 (4), 459–462. doi: 10.1159/000337057. https://www.ncbi.nlm.nih.gov/pubmed/22456105 Palmieri A., Suter S., Sautter T., Hauri D.: A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol. 2009, 56 (2), 363–369. doi: 10.1016/j.eururo.2009.05.012. https://www.ncbi.nlm. nih.gov/pubmed/19473751 Park N.C., Kim T.N., Park H.J.: Treatment Strategy for Non-Responders to PDE5 Inhibitors. World J Mens Health. 2013, 31 (1), 31–35. doi: 10.5534/ wjmh.2013.31.1.31. https://www.ncbi.nlm.nih.gov/pubmed/23658863 Park M.G., Yeo J.K., Cho D.Y., Kim J.W., Kim J.W., Oh M.M. i wsp.: The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome. J Sex Med. 2015, 12 (4), 966–974. doi: 10.1111/jsm.12842. https://www. ncbi.nlm.nih.gov/pubmed/25648342 Patel H.R., Ilo D., Shah N., Cuzin B., Chadwick D., Andrianne R. i wsp.: Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study. BMC Urol. 2015, 15, 31. doi: 10.1186/s12894-015-0022-9. https://www.ncbi.nlm.nih.gov/ pubmed/25879460 Pathak R.A., Rawal B., Li Z., Broderick G.A.: Novel Evidence-Based Classification of Cavernous Venous Occlusive Disease. J Urol. 2016, 196 (4), 1223– 1227. doi: 10.1016/j.juro.2016.04.089. https://www.ncbi.nlm.nih.gov/ pubmed/27164516 Patrick D.L., Althof S.E., Pryor J.L., Rosen R., Rowland D.L., Ho K.F. i wsp.: Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005, 2 (3), 358–367. doi: 10.1111/j.1743-6109.2005.20353.x. https://www.ncbi.nlm.nih.gov/pubmed/16422867 Patrick D.L., Rowland D., Rothman M.: Interrelationships among measures of premature ejaculation: the central role of perceived control. J Sex Med. 2007, 4 (3), 780–788. doi: 10.1111/j.1743-6109.2007.00464.x. https:// www.ncbi.nlm.nih.gov/pubmed/17419817 Perimenis P., Athanasopoulos A., Papathanasopoulos P., Barbalias G.: Gabapentin in the management of the recurrent, refractory, idiopathic priapism. Int J Impot Res. 2004, 16 (1), 84–85. doi: 10.1038/sj.ijir.3901165. https://www. ncbi.nlm.nih.gov/pubmed/14963477 Phillips B.: Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. 1998. http://www.cebm.net/ oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ Pickering T.G., Shepherd A.M., Puddey I., Glasser D.B., Orazem J., Sherman N. i wsp.: Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens. 2004, 17, 1135–1142. doi: 10.1016/j.amjhyper.2004.07.004. https://www. ncbi.nlm.nih.gov/pubmed/15607620 Pierorazio P.M., Bivalacqua T.J., Burnett A.L.: Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation. J Androl. 2011, 32 (4), 371–374. doi: 10.2164/jandrol.110.011890. https://www.ncbi.nlm.nih.gov/pubmed/21127306 Pineda M., Burnett A.L.: Penile Prosthesis Infections – A Review of Risk Factors, Prevention, and Treatment. Sex Med Rev. 2016, 4 (4), 389– 398. doi: 10.1016/j.sxmr.2016.03.003. https://www.ncbi.nlm.nih.gov/ pubmed/27872031 Pisano F., Falcone M., Abbona A., Oderda M., Soria F., Peraldo F. i wsp.: The importance of psychosexual counselling in the re-establishment of organic and erotic functions after penile prosthesis implantation. Int J Impot Res. 2015, 27 (5) 197–200. doi: 10.1038/ijir.2015.17. https://www.ncbi.nlm.nih. gov/pubmed/26268774 Pohl J., Pott B., Kleinhans G.: Priapism: a three-phase concept of management according to aetiology and prognosis. Br J Urol. 1986, 58 (2), 113– 118. doi: 10.1111/j.1464-410x.1986.tb09008.x. https://www.ncbi.nlm. nih.gov/pubmed/3516294 Polat E.C., Ozbek E., Otunctemur A., Ozcan L., Simsek A.: Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation. Andrologia. 2015, 47 (5), 487–492. doi: 10.1111/and.12289. https://www.ncbi.nlm.nih.gov/ pubmed/24811578 Porst H.: The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol. 1996, 155 (3), 802–815. https://www.ncbi. nlm.nih.gov/pubmed/8583582 Porst H., Burnett A., Brock G., Ghanem H., Giuliano F., Glina S. i wsp.: SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013, 10 (1), 130–171. doi: 10.1111/jsm.12023. https://www. ncbi.nlm.nih.gov/pubmed/23343170 Porst H., Gacci M., Büttner H., Henneges C., Boess F.: Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies. Eur Urol. 2014, 65 (2), 455–464. doi: 10.1016/j.eururo.2013.09.037. https://www.ncbi.nlm.nih.gov/pubmed/24119319 Porst H., McMahon C.G., Althof S.E., Sharlip I., Bull S., Aquilina J.W. i wsp.: Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. J Sex Med. 2010, 7 (6), 2231–2242. doi: 10.1111/j.1743-6109.2010.01820.x. https://www.ncbi. nlm.nih.gov/pubmed/20412423 Porst H., Montorsi F., Rosen R.C., Gaynor L., Grupe S., Alexander J.: The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007, 51 (3), 816– 823. doi: 10.1016/j.eururo.2006.07.004. https://www.ncbi.nlm.nih.gov/ pubmed/16934919 Porst H., Vardi Y., Akkus E., Melman A., Park N.C., Seftel A.D. i wsp.: Standards for clinical trials in male sexual dysfunctions. J Sex Med. 2010, 7, 414– 444. doi: 10.1111/j.1743-6109.2009.01623.x. https://www.ncbi.nlm.nih. gov/pubmed/20092447 Prieto Castro R.M., Leva Vallejo M.E., Regueiro Lopez J.C., Anglada Curado F.J., Alvarez Kindelan J., Requena Tapia M.J.: Combined treatment with vitamin E and colchicine in the early stages of Peyronie’s disease. BJU Int. 2003, 91 (6), 522–524. doi: 10.1046/j.1464-410x.2003.04134.x. https://www.ncbi. nlm.nih.gov/pubmed/12656907 Priyadarshi S.: Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res. 2004, 16 (5), 424–426. doi: 10.1038/sj.ijir.3901180. https://www.ncbi.nlm.nih.gov/pubmed/14999218 Pryor J.P.: Correction of penile curvature and Peyronie’s disease: why I prefer the Nesbit technique. Int J Impot Res. 1998, 10 (2), 129–131. doi: 10.1038/ sj.ijir.3900331. https://www.ncbi.nlm.nih.gov/pubmed/9647952 Pryor J., Akkus E., Alter G., Jordan G., Lebret T., Levine L., Mulhall J. i wsp.: Priapism. J Sex Med. 2004, 1 (1), 116–120. doi: 10.1111/j.1743- 6109.2004.10117.x. https://www.ncbi.nlm.nih.gov/pubmed/16422992 Pryor J., Farrell C.R.: Controlled clinical trial of Vitamin E in Peyronie’s disease. Prog Reprod Biol. 1983, 9, 41–45. http://www.jsm.jsexmed.org/ article/S1743-6095(15)30053-9/fulltext Pryor J.P., Fitzpatrick J.M.: A new approach to the correction of the penile deformity in Peyronie’s disease. J Urol. 1979, 122 (5), 622–623. doi: 10.1016/ s0022-5347(17)56530-1. https://www.ncbi.nlm.nih.gov/pubmed/501814 Pryor J.P., Ralph D.J.: Clinical presentations of Peyronie’s disease. Int J Impot Res. 2002, 14 (5), 414–417. doi: 10.1038/sj.ijir.3900877. https:// www.ncbi.nlm.nih.gov/pubmed/12454695 Quackels R.: [Treatment of a case of priapism by cavernospongious anastomosis]. Acta Urol Belg. 1964, 32, 5–13. https://www.ncbi.nlm.nih.gov/ pubmed/14111379 Rachid-Filho D., Cavalcanti A.G., Favorito L.A., Costa W.S., Sampaio F.J.: Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach. Urology. 2009, 74 (5), 1054–1057. doi: 10.1016/j.urology.2009.04.071. https://www.ncbi.nlm.nih.gov/pubmed/19616292 Raina R., Agarwal A., Ausmundson S., Lakin M., Nandipati K.C., Montague D.K. i wsp.: Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res. 2006, 18 (1), 77–81. doi: 10.1038/sj.ijir.3901380. https://www.ncbi.nlm.nih.gov/pubmed/16107868 Raina R., Pahlajani G., Agarwal A., Zippe C.D.: The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int. 2007, 100 (6), 1317–1321. doi: 10.1111/j.1464-410X.2007.07124.x. https://www.ncbi. nlm.nih.gov/pubmed/17850385 Rajagopalan P., Mazzu A., Xia C., Dawkins R., Sundaresan P.: Effect of highfat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. J Clin Pharmacol. 2003, 43 (3), 260–267. doi: 10.1177/0091270002250604. https://www.ncbi.nlm.nih.gov/ pubmed/12638394 Ralph D.J., al-Akraa M., Pryor J.P.: The Nesbit operation for Peyronie’s disease: 16-year experience. J Urol. 1995, 154 (4), 1362–1363. https://www. ncbi.nlm.nih.gov/pubmed/7658538 Ralph D.J., Borley N.C., Allen C., Kirkham A., Freeman A., Minhas S. i wsp.: The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism. BJU Int. 2010, 106 (11), 1714–1718. doi: 10.1111/j.1464-410X.2010.09368.x. https://www.ncbi.nlm.nih.gov/ pubmed/20438564 Ralph D.J., Brooks M.D., Bottazzo G.F., Pryor J.P.: The treatment of Peyronie’s disease with tamoxifen. Br J Urol. 1992, 70 (6), 648–651. doi: 10.1111/j.1464- 410x.1992.tb15836.x. https://www.ncbi.nlm.nih.gov/pubmed/1486392 Ralph D.J., Garaffa G., Muneer A., Freeman A., Rees R., Christopher A.N.: The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol. 2009, 56 (6), 1033–1038. doi: 10.1016/j.eururo.2008.09.044. https://www.ncbi.nlm.nih.gov/pubmed/18930579 Ralph D., Gonzalez-Cadavid N., Mirone V., Perovic S., Sohn M., Usta M. i wsp.: The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med. 2010, 7 (7), 2359–2374. doi: 10.1111/j.1743-6109.2010.01850.x. https://www.ncbi.nlm.nih.gov/pubmed/20497306 Ramos C.E., Park J.S., Ritchey M.L., Benson G.S.: High flow priapism associated with sickle cell disease. J Urol. 1995, 153 (5), 1619–1621. https:// www.ncbi.nlm.nih.gov/pubmed/7714988 Rehman J., Benet A., Melman A.: Use of intralesional verapamil to dissolve Peyronie’s disease plaque: a long-term single-blind study. Urology. 1998, 51 (4), 620–626. doi: 10.1016/s0090-4295(97)00700-0. https://www.ncbi. nlm.nih.gov/pubmed/9586617 Rehman J., Benet A., Minsky L.S., Melman A.: Results of surgical treatment for abnormal penile curvature: Peyronie’s disease and congenital deviation by modified Nesbit plication (tunical shaving and plication). J Urol. 1997, 157 (4), 1288–1291. doi: 10.1016/s0022-5347(01)64953-x. https://www. ncbi.nlm.nih.gov/pubmed/9120923 Rhoden E.L., Riedner C.E., Fuchs S.C., Ribeiro E.P., Halmenschlager G.: A crosssectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie’s disease. J Sex Med. 2010, 7, 1529–1537. doi: 10.1111/j.1743-6109.2009.01584.x. https://www.ncbi.nlm.nih.gov/ pubmed/19912489 Rhoden E.L., Teloken C., Ting H.Y., Lucas M.L., Teodósio da Ros C., Ary Vargas Souto C.: Prevalence of Peyronie’s disease in men over 50-y-old from Southern Brazil. Int J Impot Res. 2001, 13 (5), 291–293. doi: 10.1038/sj.ijir.3900727. https://www.ncbi.nlm.nih.gov/pubmed/11890516 Ricciardi R., Bhatt G.M., Cynamon J., Bakal C.W., Melman A.: Delayed high flow priapism: pathophysiology and management. J Urol. 1993, 149 (1), 119–121. doi: 10.1016/s0022-5347(17)36017-2. https://www.ncbi.nlm. nih.gov/pubmed/8417190 Richardson D., Goldmeier D.: Premature ejaculation – does country of origin tell us anything about etiology? J Sex Med. 2005, 2 (4), 508–512. doi: 10.1111/j.1743-6109.2005.00074.x. https://www.ncbi.nlm.nih.gov/ pubmed/16422845 Riley A., Segraves R.T.: Treatment of premature ejaculation. Int J Clin Pract. 2006, 60 (6), 694–697. doi: 10.1111/j.1368-5031.2006.00818.x. https:// www.ncbi.nlm.nih.gov/pubmed/16805755 Roberts J.R., Price C., Mazzeo T.: Intracavernous epinephrine: a minimally invasive treatment for priapism in the emergency department. J Emerg Med. 2009, 36 (3), 285–289. doi: 10.1016/j.jemermed.2007.10.051. https:// www.ncbi.nlm.nih.gov/pubmed/18996674 Roehrborn C.G., Egan K.B., Miner M.M., Ni X., Wong D.G., Rosen R.C.: Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment. BJU Int. 2016, 118 (1), 153–160. doi: 10.1111/bju.13406. https://www.ncbi.nlm.nih.gov/pubmed/26765325 Rogers Z.R.: Priapism in sickle cell disease. Hematol Oncol Clin North Am. 2005, 19 (5), 917–928. doi: 10.1016/j.hoc.2005.08.003. https://www.ncbi. nlm.nih.gov/pubmed/16214652 Roizenblatt M., Figueiredo M.S., Cançado R.D., Pollack-Filho F., de Almeida Santos Arruda M.M., Vicari P. i wsp.: Priapism is associated with sleep hypoxemia in sickle cell disease. J Urol. 2012, 188 (4), 1245–1251. doi: 10.1016/j. juro.2012.06.015. https://www.ncbi.nlm.nih.gov/pubmed/22902014 Rolle L., Falcone M., Ceruti C., Timpano M., Sedigh O., Ralph D.J. i wsp.: A prospective multicentric international study on the surgical outcomes and patients’ satisfaction rates of the ‘sliding’ technique for end-stage Peyronie’s disease with severe shortening of the penis and erectile dysfunction. BJU Int. 2016, 117 (5), 814–820. doi: 10.1111/bju.13371. https://www.ncbi. nlm.nih.gov/pubmed/26688436 Rooney M., Pfister W., Mahoney M., Nelson M., Yeager J., Steidle C.: Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction. J Sex Med. 2009, 6 (2), 520–534. doi: 10.1111/j.1743-6109.2008.01118.x. https://www.ncbi.nlm.nih.gov/ pubmed/19138370 Rosen R.C.: Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am. 2001, 28 (2), 269–278. doi: 10.1016/s0094- 0143(05)70137-3. https://www.ncbi.nlm.nih.gov/pubmed/11402580 Rosen R., Altwein J., Boyle P., Kirby R.S., Lukacs B., Meuleman E. i wsp.: Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003, 44 (6), 637–649. doi: 10.1016/j. eururo.2003.08.015. https://www.ncbi.nlm.nih.gov/pubmed/14644114 Rosen R.C., Cappelleri J.C., Smith M.D., Lipsky J., Peña B.M.: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999, 11 (6), 319–326. doi: 10.1038/sj.ijir.3900472. https:// www.ncbi.nlm.nih.gov/pubmed/10637462 Rosen R.C., Catania J.A., Althof S.E., Pollack L.M., O’Leary M., Seftel A.D. i wsp.: Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology. 2007, 69 (5), 805–809. doi: 10.1016/j.urology.2007.02.036. https://www.ncbi. nlm.nih.gov/pubmed/17482908 Rosen R.C., McMahon C.G., Niederberger C., Broderick G.A., Jamieson C., Gagnon D.D.: Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol. 2007, 177 (3), 1059–1064. doi: 10.1016/j.juro.2006.10.044. https://www.ncbi. nlm.nih.gov/pubmed/17296411 Rosen R.C., Padma-Nathan H., Shabsigh R., Saikali K., Watkins V., Pullman W.: Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study. J Sex Med. 2004, 1 (2), 193–200. doi: 10.1111/j.1743- 6109.2004.04028.x. https://www.ncbi.nlm.nih.gov/pubmed/16422974 Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., Mishra A.: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997, 49 (6), 822–830. doi: 10.1016/s0090-4295(97)00238-0. https://www.ncbi.nlm.nih.gov/ pubmed/9187685 Rosenberg M.T., Sadovsky R.: Identification and diagnosis of premature ejaculation. Int J Clin Pract. 2007, 61 (6), 903–908. doi: 10.1111/j.1742- 1241.2007.01337.x. https://www.ncbi.nlm.nih.gov/pubmed/17504352 Roth M., Eickelberg O., Kohler E., Erne P., Block L.H.: Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci U S A. 1996, 93 (11), 5478–5482. doi: 10.1073/pnas.93.11.5478. https://www.ncbi.nlm.nih.gov/pubmed/8643600 Rowland D., Perelman M., Althof S., Barada J., McCullough A. i wsp.: Bull S, Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med. 2004, 1 (2), 225–232. doi: 10.1111/j.1743- 6109.2004.04033.x. https://www.ncbi.nlm.nih.gov/pubmed/16429622 Rowland D.L., Patrick D.L., Rothman M., Gagnon D.D.: The psychological burden of premature ejaculation. J Urol. 2007, 177 (3), 1065–1070. doi: 10.1016/j. juro.2006.10.025. https://www.ncbi.nlm.nih.gov/pubmed/17296413 Rowland D.L., Slob A.K.: Premature ejaculation: psychophysiological considerations in theory, research, and treatment. Annu Rev Sex Res. 1997, 8, 224–253. https://www.ncbi.nlm.nih.gov/pubmed/10051895 Rutchik S., Sorbera T., Rayford R.W., Sullivan J.: Successful treatment of recalcitrant priapism using intercorporeal injection of tissue plasminogen activator. J Urol. 2001, 166 (2), 628. https://www.ncbi.nlm.nih.gov/pubmed/11458096 Saad S.T., Lajolo C., Gilli S., Marques Júnior J.F., Lima C.S., Costa F.F. i wsp.: Follow-up of sickle cell disease patients with priapism treated by hydroxyurea. Am J Hematol. 2004, 77 (1), 45–49. doi: 10.1002/ajh.20142. https:// www.ncbi.nlm.nih.gov/pubmed/15307105 Sachs B.D., Liu Y.C.: Maintenance of erection of penile glans, but not penile body, after transection of rat cavernous nerves. J Urol, 1991, 146 (3), 900– 905. doi: 10.1016/s0022-5347(17)37957-0. https://www.ncbi.nlm.nih.gov/ pubmed/1875517 Sahin S., Bicer M., Yenice M.G., Seker K.G., Yavuzsan A.H., Tugcu V.: A Prospective Randomized Controlled Study to Compare Acupuncture and Dapoxetine for the Treatment of Premature Ejaculation. Urol Int. 2016, 97 (1), 104–111. doi: 10.1159/000445253. https://www.ncbi.nlm.nih.gov/pubmed/27049323 Salem E.A., El Aasser O.: Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion. J Urol. 2010, 183 (6), 2300– 2303. doi: 10.1016/j.juro.2010.02.014. https://www.ncbi.nlm.nih.gov/ pubmed/20400140 Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K. i wsp.: Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017, 14 (3), 297–315. doi: 10.1016/j. jsxm.2016.11.324. https://www.ncbi.nlm.nih.gov/pubmed/28262100 Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., McCullough A. i wsp.: Hatzimouratidis K6,Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017, 14 (3), 285–296. doi: 10.1016/j.jsxm.2016.11.325. https://www.ncbi.nlm.nih.gov/ pubmed/28262099 Salonia A., Burnett A.L., Graefen M., Hatzimouratidis K., Montorsi F., Mulhall J.P. i wsp.: Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012, 62 (2), 261–272. doi: 10.1016/j.eururo.2012.04.046. https://www.ncbi.nlm.nih.gov/pubmed/22575909 Salonia A., Burnett A.L., Graefen M., Hatzimouratidis K., Montorsi F., Mulhall J.P. i wsp.: Prevention and management of postprostatectomy sexual dysfunctions. Part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol. 2012, 62 (2), 273–286. doi: 10.1016/j. eururo.2012.04.047. https://www.ncbi.nlm.nih.gov/pubmed/22575910 Salonia A., Castagna G., Saccà A., Ferrari M., Capitanio U., Castiglione F. i wsp.: Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. J Sex Med. 2012, 9, 2708–2715. doi: 10.1111/j.1743-6109.2012.02869.x. https://www.ncbi.nlm.nih.gov/pubmed/22897643 Salonia A., Eardley I., Giuliano F., Hatzichristou D., Moncada I., Vardi Y. i wsp.: European Association of Urology guidelines on priapism. Eur Urol. 2014, 65 (2), 480–489. doi: 10.1016/j.eururo.2013.11.008. https://www.ncbi. nlm.nih.gov/pubmed/24314827 Salonia A., Maga T., Colombo R., Scattoni V., Briganti A., Cestari A. i wsp.: A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol. 2002, 168 (6), 2486–2489. doi: 10.1097/01.ju.0000038337.86140.16. https://www.ncbi.nlm.nih.gov/ pubmed/12441946 Salonia A. i wsp.: EAU Guidelines Panel on Male Sexual Dysfunction. EAU guidelines on priapism. Edn. presented at the EAU Annual Congress Stockholm. 2014: Arnhem, The Netherlands http://uroweb.org/guideline/ priapism/ Sanda M.G., Dunn R.L., Michalski J., Sandler H.M., Northouse L., Hembroff L. i wsp.: Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008, 358 (12), 1250–1261. doi: 10.1056/ NEJMoa074311. https://www.ncbi.nlm.nih.gov/pubmed/18354103 Sandock D.S., Seftel A.D., Herbener T.E., Goldstein I., Greenfield A.J.: Perineal abscess after embolization for high-flow priapism. Urology. 1996, 48 (2), 308–311. doi: 10.1016/S0090-4295(96)00176-8. https://www.ncbi.nlm. nih.gov/pubmed/8753749 Sanford M.: Vardenafil orodispersible tablet. Drugs. 2012, 72 (1), 87–98. doi: 10.2165/11208270-000000000-00000. https://www.ncbi.nlm.nih. gov/pubmed/22191797 Sassine A.M., Wespes E., Schulman C.C.: Modified corporoplasty for penile curvature: 10 years’ experience. Urology. 1994, 44 (3), 419–421. doi: 10.1016/ s0090-4295(94)80106-1. https://www.ncbi.nlm.nih.gov/pubmed/8073558 Savoca G., Pietropaolo F., Scieri F., Bertolotto M., Mucelli F.P., Belgrano E.: Sexual function after highly selective embolization of cavernous artery in patients with high flow priapism: long-term followup. J Urol. 2004, 172 (2), 644– 647. doi: 10.1097/01.ju.0000132494.44596.33. https://www.ncbi.nlm. nih.gov/pubmed/15247752 Savoca G., Trombetta C., Ciampalini S., De Stefani S., Buttazzi L., Belgrano E.: Long-term results with Nesbit’s procedure as treatment of Peyronie’s disease. Int J Impot Res. 2000, 12 (5), 289–293. doi: 10.1038/sj.ijir.3900612. https://www.ncbi.nlm.nih.gov/pubmed/11424968 Schauer I., Schauer I., Keller E., Müller A., Madersbacher S.: Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation. Andrology. 2015, 3 (4), 661–665. doi: 10.1111/ andr.12060. https://www.ncbi.nlm.nih.gov/pubmed/26198796 Schouten, B.W., Bosch J.L., Bernsen R.M., Blanker M.H., Thomas S., Bohnen A.M.: Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study. Int J Impot Res. 2005, 17 (1), 58–62. doi: 10.1038/ sj.ijir.3901264. https://www.ncbi.nlm.nih.gov/pubmed/15510192 Schwartz E.J., Wong P., Graydon R.J.: Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004, 171, 771–774. doi: 10.1097/01.ju.0000106970.97082.61. https://www.ncbi. nlm.nih.gov/pubmed/14713808 Schwarzer U., Sommer F., Klotz T., Braun M., Reifenrath B., Engelmann U.: The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001, 88 (7), 727–730. doi: 10.1046/j.1464-4096.2001.02436.x. https://www. ncbi.nlm.nih.gov/pubmed/11890244 Screponi E., Carosa E., Di Stasi S.M., Pepe M., Carruba G., Jannini E.A.: Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001, 58 (2), 198–202. doi: 10.1016/s0090-4295(01)01151-7. https://www.ncbi. nlm.nih.gov/pubmed/11489699 Sedigh O., Rolle L., Negro C.L., Ceruti C., Timpano M., Galletto E. i wsp.: Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. Int J Impot Res. 2011, 23 (4), 158–164. doi: 10.1038/ijir.2011.23. https://www.ncbi.nlm.nih.gov/pubmed/21654814 Seftel A.D., de la Rosette J., Birt J., Porter V., Zarotsky V., Viktrup L.: Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data. Int J Clin Pract. 2013, 67 (1), 32–45. doi: 10.1111/ ijcp.12044. https://www.ncbi.nlm.nih.gov/pubmed/23082930 Segal R.L., Cabrini M.R., Harris E.D., Mostwin J.L., Bivalacqua T.J., Burnett A.L. i wsp.: Combined inflatable penile prosthesis-artificial urinary sphincter implantation: no increased risk of adverse events compared to single or staged device implantation. J Urol. 2013, 190 (6), 2183–2188. doi: 10.1016/j. juro.2013.06.084. https://www.ncbi.nlm.nih.gov/pubmed/23831315 Segal R.L., Readal N., Pierorazio P.M., Burnett A.L., Bivalacqua T.J.: Corporal Burnett “Snake” surgical maneuver for the treatment of ischemic priapism: long-term followup. J Urol. 2013, 189 (3), 1025–1029. doi: 10.1016/j. juro.2012.08.245. https://www.ncbi.nlm.nih.gov/pubmed/23017524 Semans J.H.: Premature ejaculation: a new approach. South Med J. 1956, 49 (4), 353–358. doi: 10.1097/00007611-195604000-00008. https://www. ncbi.nlm.nih.gov/pubmed/13311629 Serefoglu E.C., Mandava S.H., Gokce A., Chouhan J.D., Wilson S.K., Hellstrom W.J.: Long-term revision rate due to infection in hydrophilic-coated inflatable penile prostheses: 11-year follow-up. J Sex Med. 2012, 9 (8), 2182– 2186. doi: 10.1111/j.1743-6109.2012.02830.x. https://www.ncbi.nlm.nih. gov/pubmed/22759917 Serefoglu E.C., McMahon C.G., Waldinger M.D., Althof S.E., Shindel A., Adaikan G. i wsp.: An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014, 11 (6), 1423–1441. doi: 10.1111/jsm.12524. https://www. ncbi.nlm.nih.gov/pubmed/24848805 Serefoglu E.C., Yaman O., Cayan S., Asci .R, Orhan I., Usta M.F. i wsp.: Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. J Sex Med. 2011, 8 (2), 540–548. doi: 10.1111/j.1743- 6109.2010.02095.x. https://www.ncbi.nlm.nih.gov/pubmed/21054799 Shabsigh R., Padma-Nathan H., Gittleman M., McMurray J., Kaufman J., Goldstein I.: Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study. Urology. 2000, 55 (1), 109–113. doi: 10.1016/s0090-4295(99)00442-2. https://www.ncbi. nlm.nih.gov/pubmed/10654905 Shabsigh R.: Diagnosing premature ejaculation: a review. J Sex Med. 2006, 3 Suppl 4, 318–323. doi: 10.1111/j.1743-6109.2006.00307.x. https://www. ncbi.nlm.nih.gov/pubmed/16939476 Shaeer O., Shaeer K.: Shaeer’s Corporal Rotation III: Shortening-Free Correction of Congenital Penile Curvature-The Noncorporotomy Technique. Eur Urol. 2016, 69 (1), 129–134. doi: 10.1016/j.eururo.2015.08.004. https:// www.ncbi.nlm.nih.gov/pubmed/26298209 Shaeer O.: Shaeer’s corporal rotation for length-preserving correction of penile curvature: modifications and 3-year experience. J Sex Med. 2008, 5(11), 2716–2724. doi: 10.1111/j.1743-6109.2008.00913.x. https://www. ncbi.nlm.nih.gov/pubmed/18624969 Shah P.J., Green N.A., Adib R.S., Hamilton Stewart P.A., Smith P., Coxon R.: A multicentre double-blind controlled clinical trial of potassium para-aminobenzoate (POTABA1) in Peyronie’s disease. Progr Reprod Biol Med J. 1983, 9, 61–67. Shamloul R., el-Nashaar A.: Chronic prostatitis in premature ejaculation: a cohort study in 153 men. J Sex Med. 2006, 3 (1), 150–154. doi: 10.1111/j.1743-6109.2005.00107.x. https://www.ncbi.nlm.nih.gov/ pubmed/16409229 Shapiro R.H., Berger R.E.: Post-traumatic priapism treated with selective cavernosal artery ligation. Urology. 1997, 49 (4), 638–643. doi: 10.1016/ s0090-4295(97)00045-9. https://www.ncbi.nlm.nih.gov/pubmed/9111644 Sharlip I.: Diagnosis and treatment of premature ejaculation: the physician’s perspective. J Sex Med. 2005, 2 Suppl 2, 103–109. doi: 10.1111/j.1743- 6109.2005.20370.x. https://www.ncbi.nlm.nih.gov/pubmed/16422796 Shindel A.W., Bullock T.L., Brandes S.: Urologist practice patterns in the management of Peyronie’s disease: a nationwide survey. J Sex Med. 2008, 5 (4), 954–964. doi: 10.1111/j.1743-6109.2007.00674.x. https://www.ncbi.nlm. nih.gov/pubmed/18042214 Shindel A.W., Lin G., Ning H., Banie L., Huang Y.C., Liu G. i wsp.: Pentoxifylline attenuates transforming growth factor-beta1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. J Sex Med. 2010, 7 (6), 2077–2085. doi: 10.1111/j.1743-6109.2010.01790.x. https://www.ncbi.nlm.nih.gov/ pubmed/20367772 Shirazi M., Haghpanah A.R., Badiee M., Afrasiabi M.A., Haghpanah S.: Effect of intralesional verapamil for treatment of Peyronie’s disease: a randomized single-blind, placebo-controlled study. Int Urol Nephrol. 2009, 41 (3), 467–471. doi: 10.1007/s11255-009-9522-4. https://www.ncbi.nlm.nih. gov/pubmed/19199072 Sikka S.C., Hellstrom W.J., Brock G., Morales A.M.: Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med. 2013, 10 (1), 120–129. doi: 10.1111/j.1743- 6109.2012.02825.x. https://www.ncbi.nlm.nih.gov/pubmed/22970798 Smith J.F., Shindel A.W., Huang Y.C., Clavijo R.I., Flechner L., Breyer B.N. i wsp.: Pentoxifylline treatment and penile calcifications in men with Peyronie’s disease. Asian J Androl. 2011, 13 (2), 322–325. doi: 10.1038/aja.2010.117. https://www.ncbi.nlm.nih.gov/pubmed/21102473 Smith J.F., Walsh T.J., Lue T.F.: Peyronie’s disease: a critical appraisal of current diagnosis and treatment. Int J Impot Res. 2008, 20 (5), 445–559. doi: 10.1038/ijir.2008.30. https://www.ncbi.nlm.nih.gov/pubmed/18650828 Sohn M., Hatzinger M., Goldstein I., Krishnamurti S.: Standard operating procedures for vascular surgery in erectile dysfunction: revascularization and venous procedures. J Sex Med. 2013, 10 (1), 172–179. doi: 10.1111/j.1743- 6109.2012.02997.x. https://www.ncbi.nlm.nih.gov/pubmed/23171072 Solursh D.S., Ernst J.L., Lewis R.W., Prisant L.M., Mills T.M., Solursh L.P. i wsp.: The human sexuality education of physicians in North American medical schools. Int J Impot Res. 2003, 15 Suppl 5, S41–45. doi: 10.1038/ sj.ijir.3901071. https://www.ncbi.nlm.nih.gov/pubmed/14551576 Sommer F., Schwarzer U., Wassmer G., Bloch W., Braun M., Klotz T. i wsp.: Epidemiology of Peyronie’s disease. Int J Impot Res. 2002, 14 (3), 379– 383. doi: 10.1038/sj.ijir.3900863. https://www.ncbi.nlm.nih.gov/ pubmed/12454689 Sotomayor M.: The burden of premature ejaculation: the patient’s perspective. J Sex Med. 2005, 2 Suppl 2, 110–114. doi: 10.1111/j.1743-6109.2005.20371.x. https://www.ncbi.nlm.nih.gov/pubmed/16422797 Sperling H., Debruyne F., Boermans A., Beneke M., Ulbrich E., Ewald S.: The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. J Sex Med. 2010, 7, 1497–1507. doi: 10.1111/j.1743-6109.2010.01806.x. https://www. ncbi.nlm.nih.gov/pubmed/20233275 Spitzer M., Basaria S., Travison T.G., Davda M.N., DeRogatis L., Bhasin S.: The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial. Andrology. 2013, 1 (3), 475–482. doi: 10.1111/j.2047-2927.2013.00075.x. https://www.ncbi.nlm. nih.gov/pubmed/23494931 Spitzer M., Basaria S., Travison T.G., Davda M.N., Paley A., Cohen B. i wsp.: Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med. 2012, 157 (10), 681–691. doi: 10.7326/0003-4819-157-10-201211200- 00004. https://www.ncbi.nlm.nih.gov/pubmed/23165659 Spycher M.A., Hauri D.: The ultrastructure of the erectile tissue in priapism. J Urol. 1986, 135 (1), 142–147. doi: 10.1016/s0022-5347(17)45549- 2. https://www.ncbi.nlm.nih.gov/pubmed/3941454 Sridhar A.N., Cathcart P.J., Yap T., Hines J., Nathan S., Briggs T.P. i wsp.: Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures. J Sex Med. 2016, 13 (3), 435–443. doi: 10.1016/j.jsxm.2016.01.005. https:// www.ncbi.nlm.nih.gov/pubmed/26944466 Srirangam S.J., Manikandan R., Hussain J., Collins G.N., O’Reilly P.H.: Longterm results of extracorporeal shockwave therapy for Peyronie’s disease. J Endourol. 2006, 20 (11), 880–884. doi: 10.1089/end.2006.20.880. https:// www.ncbi.nlm.nih.gov/pubmed/17144855 Steers W.D., Selby J.B.: Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol. 1991, 146 (5), 1361–1363. doi: 10.1016/s0022- 5347(17)38095-3. https://www.ncbi.nlm.nih.gov/pubmed/1942293 Stember D.S., Mulhall J.P.: The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer. Brachytherapy. 2012, 11 (2), 87–96. doi: 10.1016/j.brachy.2012.01.002. https://www.ncbi.nlm.nih.gov/pubmed/22330103 Stolzenburg J.U., Graefen M., Kriegel C., Michl U., Martin Morales A., Pommerville P.J. i wsp.: Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: An evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo. BJU Int. 2015, 116 (2), 241–251. doi: 10.1111/bju.13030. https://www.ncbi.nlm.nih.gov/pubmed/25560809 Strebel R.T., Suter S., Sautter T., Hauri D.: Extracorporeal shockwave therapy for Peyronie’s disease does not correct penile deformity. Int J Impot Res. 2004, 16 (5), 448–451. doi: 10.1038/sj.ijir.3901192. https://www.ncbi.nlm. nih.gov/pubmed/14973523 Stuntz M., Perlaky A., des Vignes F., Kyriakides T., Glass D.: The Prevalence of Peyronie’s Disease in the United States: A Population-Based Study. PLoS One. 2016, 11 (2), e0150157. doi: 10.1371/journal.pone.0150157. https:// www.ncbi.nlm.nih.gov/pubmed/26907743 Sun Y., Luo D., Yang L., Tang C., Yang T., Hu X. i wsp.: Efficacy of Phosphodiesterase-5 Inhibitor in Men With Premature Ejaculation: A New Systematic Review and Meta-analysis. Urology. 2015, 86 (5), 947– 954. doi: 10.1016/j.urology.2015.06.051. https://www.ncbi.nlm.nih.gov/ pubmed/26278825 Sundaram C.P., Thomas W., Pryor L.E., Sidi A.A., Billups K., Pryor J.L.: Longterm follow-up of patients receiving injection therapy for erectile dysfunction. Urology. 1997, 49 (6), 932–935. doi: 10.1016/s0090-4295(97)00079- 4. https://www.ncbi.nlm.nih.gov/pubmed/9187703 Swearingen D., Nehra A., Morelos S., Peterson C.A.: Hemodynamic effect of avanafil and glyceryl trinitrate coadministration. Drugs Context. 2013, 2013, 212248. doi: 10.7573/dic.212248. https://www.ncbi.nlm.nih.gov/ pubmed/24432037 Symonds T., Perelman M., Althof S., Giuliano F., Martin M., Abraham L. i wsp.: Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res. 2007, 19 (5), 521–525. doi: 10.1038/ sj.ijir.3901567. https://www.ncbi.nlm.nih.gov/pubmed/17568761 Symonds T., Roblin D., Hart K., Althof S.: How does premature ejaculation impact a man s life? J Sex Marital Ther. 2003, 29 (5), 361–370. doi: 10.1080/00926230390224738. https://www.ncbi.nlm.nih.gov/ pubmed/14504007 Symonds T., Rosen R., Symonds T., Mundayat R., May K., Abraham L. i wsp.: Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007, 52 (2), 565–573. doi: 10.1016/j.eururo.2007.01.028. https:// www.ncbi.nlm.nih.gov/pubmed/17275165 Tajar A., Huhtaniemi I.T., O’Neill T.W., Finn J.D., Pye S.R., Lee D.M. i wsp.: Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2012, 97 (5), 1508–1516. doi: 10.1210/jc.2011-2513. https://www.ncbi. nlm.nih.gov/pubmed/22419720 Taken K., Ekin S., Arısoy A., Günes M., Dönmez M.I.: Erectile dysfunction is a marker for obstructive sleep apnea. Aging Male. 2016, 19 (2), 102–105. doi: 10.3109/13685538.2015.1131259. https://www.ncbi.nlm.nih.gov/ pubmed/26758960 Tal R., Jacks L.M., Elkin E., Mulhall J.P.: Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J Sex Med. 2011, 8 (6), 1797–1804. doi: 10.1111/j.1743-6109.2011.02240.x. https://www.ncbi.nlm.nih.gov/pubmed/21426495 Tang W., Ma L., Zhao L., Liu Y., Chen Z.: [Clinical efficacy of Viagra with behavior therapy against premature ejaculation]. Zhonghua Nan Ke Xue. 2004, 10 (5), 366–367. https://www.ncbi.nlm.nih.gov/pubmed/15190831 Taylor F.L., Levine L.A.: Peyronie’s Disease. Urol Clin North Am. 2007, 34 (4), 517–534. doi: 10.1016/j.ucl.2007.08.017. https://www.ncbi.nlm.nih. gov/pubmed/17983892 Taylor F.L., Levine L.A.: Surgical correction of Peyronie’s disease via tunica albuginea plication or partial plaque excision with pericardial graft: longterm follow up. J Sex Med. 2008, 5 (9), 2221–2228. doi: 10.1111/j.1743- 6109.2008.00941.x. https://www.ncbi.nlm.nih.gov/pubmed/18637996 Tekgül S. i wsp.: European Association of Urology guidelines on Paediatric Urology. Edn. presented at the EAU Annual Congress London, 2017. Teloken C., Rhoden E.L., Grazziotin T.M., Ros C.T., Sogari P.R., Souto C.A.: Tamoxifen versus placebo in the treatment of Peyronie’s disease. J Urol. 1999, 162 (6), 2003–2005. doi: 10.1016/s0022-5347(05)68087-1. https:// www.ncbi.nlm.nih.gov/pubmed/10569556 The Process of Care Consensus Panel. The process of care model for evaluation and treatment of erectile dysfunction. Int J Impot Res. 1999, 11 (2), 59–70. doi: 10.1038/sj.ijir.3900411. https://www.ncbi.nlm.nih.gov/ pubmed/10356665 Todd N.V.: Priapism in acute spinal cord injury. Spinal Cord. 2011, 49 (10), 1033–1035. doi: 10.1038/sc.2011.57. https://www.ncbi.nlm.nih.gov/ pubmed/21647168 Tranchant C., Braun S., Warter J.M.: [Mechanism of action of glucocorticoids: role of lipocortins]. Rev Neurol (Paris). 1989, 145 (12), 813–818. https:// www.ncbi.nlm.nih.gov/pubmed/2533385 Trost L.W., McCaslin R., Linder B., Hellstrom W.J.: Long-term outcomes of penile prostheses for the treatment of erectile dysfunction. Expert Rev Med Devices. 2013, 10 (3), 353–366. doi: 10.1586/erd.12.92. https://www. ncbi.nlm.nih.gov/pubmed/23668707 Trost L.W., Munarriz R., Wang R., Morey A., Levine L.: External Mechanical Devices and Vascular Surgery for Erectile Dysfunction. J Sex Med. 2016, 13 (11), 1579–1617. doi: 10.1016/j.jsxm.2016.09.008. https://www.ncbi. nlm.nih.gov/pubmed/27770853 Truitt W.A., Coolen L.M.: Identification of a potential ejaculation generator in the spinal cord. Science. 2002, 297, 1566–1569. doi: 10.1126/science.1073885. https://www.ncbi.nlm.nih.gov/pubmed/12202834 Tsertsvadze A., Yazdi F., Fink H.A., MacDonald R., Wilt T.J., Bella A.J. i wsp.: Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms. Urology. 2009, 74 (4), 831–836. doi: 10.1016/j. urology.2009.04.026. https://www.ncbi.nlm.nih.gov/pubmed/19592078 Tuken M., Kiremit M.C., Serefoglu E.C.: On-demand Modafinil Improves Ejaculation Time and Patient-reported Outcomes in Men With Lifelong Premature Ejaculation. Urology. 2016, 94, 139–142. doi: 10.1016/j.urology.2016.04.036. https://www.ncbi.nlm.nih.gov/pubmed/27151339 Turek S.J., Hastings S.M., Sun J.K., King G.L., Keenan H.A.: Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes. Diabetes Care. 2013, 36 (10), 3222–3226. doi: 10.2337/ dc13-0294. https://www.ncbi.nlm.nih.gov/pubmed/23780949 Twidwell J., Levine L.: Topical treatment for acute phase Peyronie’s disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study. Int J Impot Res. 2016, 28 (2), 41–45. doi: 10.1038/ijir.2015.22. https://www.ncbi.nlm.nih.gov/pubmed/26700214 Upadhyay J., Shekarriz B., Dhabuwala C.B.: Penile implant for intractable priapism associated with sickle cell disease. Urology. 1998, 51 (4), 638– 639. doi: 10.1016/s0090-4295(97)00704-8. https://www.ncbi.nlm.nih. gov/pubmed/9586621 Vaidyanathan S., Watt J.W., Singh G., Hughes P.L., Selmi F., Oo T. i wsp.: Management of recurrent priapism in a cervical spinal cord injury patient with oral baclofen therapy. Spinal Cord. 2004, 42 (2), 134–135. doi: 10.1038/ sj.sc.3101547. https://www.ncbi.nlm.nih.gov/pubmed/14765150 Van den Broeck T. i wsp.: What are the benefits and harms of testosterone treatment for male sexual dysfunction? PROSPERO: International prospective register of systematic reviews, 2015. http://www.crd.york.ac.uk/ PROSPERO/display_record.asp?ID=CRD42015028029 Vardi Y., Appel B., Jacob G., Massarwi O., Gruenwald I.: Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010, 58 (2), 243–248. doi: 10.1016/j.eururo.2010.04.004. https://www. ncbi.nlm.nih.gov/pubmed/20451317 Vardi Y., Sprecher E., Gruenwald I.: Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters. J Urol. 2000, 163 (2), 467–470. https://www.ncbi.nlm. nih.gov/pubmed/10647656 Ventimiglia E., Capogrosso P., Montorsi F., Salonia A.: The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opin Drug Saf. 2016, 15 (2), 141–152. doi: 10.1517/14740338.2016.1131818. https://www. ncbi.nlm.nih.gov/pubmed/26752541 Ventus, D., Jern P.: Lifestyle Factors and Premature Ejaculation: Are Physical Exercise, Alcohol Consumption, and Body Mass Index Associated With Premature Ejaculation and Comorbid Erectile Problems? J Sex Med. 2016, 13 (10), 1482–1487. doi: 10.1016/j.jsxm.2016.08.007. https://www.ncbi. nlm.nih.gov/pubmed/27590186 Verze P., Cai T., Magno C., Sabella F., Cucchiara V., Palmieri A. i wsp.: Comparison of Treatment of Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational Trial. J Sex Med. 2016, 13 (2), 194– 199. doi: 10.1016/j.jsxm.2015.12.017. https://www.ncbi.nlm.nih.gov/ pubmed/26805941 Vigen R., O’Donnell C.I., Barón A.E., Grunwald G.K., Maddox T.M., Bradley S.M. i wsp.: Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013, 310 (17), 1829–1836. doi: 10.1001/jama.2013.280386. https://www.ncbi. nlm.nih.gov/pubmed/24193080 Vignozzi L., Filippi S., Morelli A., Ambrosini S., Luconi M., Vannelli G.B. i wsp.: Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med. 2006, 3(3), 419–431. doi: 10.1111/j.1743-6109.2006.00208.x. https://www.ncbi.nlm.nih.gov/ pubmed/16681467 Virag R., Bachir D., Lee K., Galacteros F.: Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology. 1996, 47 (5), 777–781. doi: 10.1016/s0090- 4295(96)00027-1. https://www.ncbi.nlm.nih.gov/pubmed/8650886 Vlachopoulos C., Ioakeimidis N., Aznaouridis K., Terentes-Printzios D., Rokkas K., Aggelis A. i wsp.: Prediction of cardiovascular events with aortic stiffness in patients with erectile dysfunction. Hypertension. 2014, 64 (3), 672–678. doi: 10.1161/HYPERTENSIONAHA.114.03369. https://www.ncbi.nlm. nih.gov/pubmed/24980671 Vlachopoulos C., Jackson G., Stefanadis C., Montorsi P.: Erectile dysfunction in the cardiovascular patient. Eur Heart J. 2013, 34 (27), 2034– 2046. doi: 10.1093/eurheartj/eht112. https://www.ncbi.nlm.nih.gov/ pubmed/23616415 von Stempel C., Zacharakis E., Allen C., Ramachandran N., Walkden M., Minhas S. i wsp.: Mean velocity and peak systolic velocity can help determine ischaemic and non-ischaemic priapism. Clin Radiol. 2017, 72 (7), 611.e9. doi: 10.1016/j. crad.2017.02.021. https://www.ncbi.nlm.nih.gov/pubmed/28351471 Waldinger M.D., Hengeveld M.W., Zwinderman A.H., Olivier B.: Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol. 1998, 18 (4), 274–281. doi: 10.1097/00004714- 199808000-00004. https://www.ncbi.nlm.nih.gov/pubmed/9690692 Waldinger M.D., Hengeveld M.W., Zwinderman A.H.: Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994, 151 (9), 1377–1379. doi: 10.1176/ajp.151.9.1377. https://www.ncbi.nlm.nih.gov/pubmed/14961051 Waldinger M.D., Rietschel M., Nöthen M.M., Hengeveld M.W., Olivier B.: Familial occurrence of primary premature ejaculation. Psychiatr Genet. 1998, 8 (1), 37–40. doi: 10.1097/00041444-199800810-00007. https://www.ncbi.nlm. nih.gov/pubmed/9564687 Waldinger M.D., Schweitzer D.H.: Changing paradigms from a historical DSMIII and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II – proposals for DSM-V and ICD-11. J Sex Med. 2006, 3 (4), 693–692. doi: 10.1111/j.1743-6109.2006.00275.x. https://www.ncbi. nlm.nih.gov/pubmed/16839325 Waldinger M.D., Schweitzer D.H.: The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med. 2008, 5 (5), 1079–1087. doi: 10.1111/j.1743-6109.2008.00789.x. https://www. ncbi.nlm.nih.gov/pubmed/18331260 Waldinger M.D., Zwinderman A.H., Olivier B.: On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol. 2004, 46 (4), 510–515. doi: 10.1016/j.eururo.2004.05.005. https://www.ncbi.nlm. nih.gov/pubmed/15363569 Waldinger M.D., Zwinderman A.H., Olivier B.: SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol. 2001, 21 (6), 556–560. doi: 10.1097/00004714- 200112000-00003. https://www.ncbi.nlm.nih.gov/pubmed/11763001 Waldinger M.D., Zwinderman A.H., Schweitzer D.H., Olivier B.: Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004, 16 (4), 369–381. doi: 10.1038/sj.ijir.3901172. https://www.ncbi. nlm.nih.gov/pubmed/14961051 Waldinger M.D.: Premature ejaculation: definition and drug treatment. Drugs. 2007, 67 (4), 547–568. doi: 10.2165/00003495-200767040-00005. https:// www.ncbi.nlm.nih.gov/pubmed/173525134 Waldinger M.D.: Premature ejaculation: state of the art. Urol Clin North Am. 2007, 34 (4), 591–599. doi: 10.1016/j.ucl.2007.08.011. https://www. ncbi.nlm.nih.gov/pubmed/17352514 Waldinger M.D.: The neurobiological approach to premature ejaculation. J Urol. 2002, 168 (6), 2359–2367. doi: 10.1097/01.ju.0000035599.35887.8f. https://www.ncbi.nlm.nih.gov/pubmed/12441918 Wang C., Nieschlag E., Swerdloff R., Behre H.M., Hellstrom W.J., Gooren L.J.: Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009, 30 (1), 1–9. doi: 10.2164/jandrol.108.006486. https://www.ncbi.nlm.nih. gov/pubmed/18772485 Wang C., Nieschlag E., Swerdloff R., Behre H.M., Hellstrom W.J., Gooren L.J. i wsp.: Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol. 2009, 55 (1), 121–130. doi: 10.1016/j.eururo.2008.08.033. https://www. ncbi.nlm.nih.gov/pubmed/18762364 Wang H., Yuan J., Hu X., Tao K., Liu J., Hu D.: The effectiveness and safety of avanafil for erectile dysfunction: a systematic review and meta-analysis. Curr Med Res Opin. 2014, 30 (8), 1565–1571. doi: 10.1185/03007995.2014.909391. https://www.ncbi.nlm.nih.gov/ pubmed/24701971 Wang R., Burnett A.L., Heller W.H., Omori K., Kotera J., Kikkawa K. i wsp.: Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability. J Sex Med. 2012, 9 (8), 2122–2129. doi: 10.1111/j.1743-6109.2012.02822.x. https:// www.ncbi.nlm.nih.gov/pubmed/22759639 Wang T.D., Lee W.J., Yang S.C., Lin P.C., Tai H.C., Liu S.P. i wsp.: Clinical and Imaging Outcomes up to 1 Year Following Balloon Angioplasty for Isolated Penile Artery Stenoses in Patients With Erectile Dysfunction: The PERFECT-2 Study. J Endovasc Ther. 2016, 23 (6), 867–877. doi: 10.1177/1526602816669337. https://www.ncbi.nlm.nih.gov/ pubmed/27629440 Wang W.F., Minhas S., Ralph D.J.: Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int J Androl. 2006, 29 (5), 503–509. doi: 10.1111/j.1365-2605.2006.00689.x. https://www.ncbi.nlm.nih.gov/ pubmed/16573707 Weidner W., Hauck E.W., Schnitker J.: Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease: a prospective, placebocontrolled, randomized study. Eur Urol. 2005, 47 (4), 530–535. doi: 10.1016/j. eururo.2004.12.022. https://www.ncbi.nlm.nih.gov/pubmed/15774254 Wespes E., Amar E., Hatzichristou D., Hatzimouratidis K., Montorsi F., Pryor J. i wsp.: EAU Guidelines on erectile dysfunction: an update. Eur Urol. 2006, 49 (5), 806–815. doi: 10.1016/j.eururo.2006.01.028. https://www.ncbi. nlm.nih.gov/pubmed/16530932 Wespes E., Amar E., Hatzichristou D., Montorsi F., Pryor J., Vardi Y.: Guidelines on erectile dysfunction. Eur Urol. 2002, 41 (1), 1–5. doi: 10.1016/s0302- 2838(01)00008-2. https://www.ncbi.nlm.nih.gov/pubmed/11999460 Wespes E.iI wsp.: EAU Guidelines Panel on Male Sexual Dysfunction. EAU Guidelines on Male Sexual Dysfunction (Erectile Dysfunction and premature ejaculation). Edn. presented at the EAU Annual congress Stockholm. 2009: Arnhem, The Netherlands. http://uroweb.org/guideline/ male-sexual-dysfunction/ Weyne E., Schillebeeckx C., Jamaer C., D’Hulst P., Bozzini G., Grunert R. i wsp.: Idiopathic Partial Thrombosis (IPT) of the Corpus Cavernosum: A Hypothesis-Generating Case Series and Review of the Literature. J Sex Med. 2015, 12 (11), 2118–2125. doi: 10.1111/jsm.13036. https://www. ncbi.nlm.nih.gov/pubmed/26553854 Whooley M.A., Avins A.L., Miranda J., Browner W.S.: Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997, 12 (7), 439–445. doi: 10.1046/j.1525-1497.1997.00076.x. https://www. ncbi.nlm.nih.gov/pubmed/9229283 Wieder J.A., Brackett N.L., Lynne C.M., Green J.T., Aballa T.C.: Anesthetic block of the dorsal penile nerve inhibits vibratory-induced ejaculation in men with spinal cord injuries. Urology. 2000, 55 (6), 915–917. doi: 10.1016/ s0090-4295(99)00608-1. https://www.ncbi.nlm.nih.gov/pubmed/10840108 Williams S.B., Lei Y., Nguyen P.L., Gu X., Lipsitz S.R., Yu H.Y. i wsp.: Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer. BJU Int. 2012, 110, E92–98. doi: 10.1111/j.1464-410X.2011.10775.x. https://www.ncbi.nlm.nih.gov/pubmed/22192688 Wilson S.K.: Surgical techniques: modeling technique for penile curvature. J Sex Med. 2007, 4 (1), 231–234. doi: 10.1111/j.1743-6109.2007.00407.x. https://www.ncbi.nlm.nih.gov/pubmed/17233788 Wilson S.K., Cleves M.A., Delk J.R. 2nd.: Comparison of mechanical reliability of original and enhanced Mentor Alpha I penile prosthesis. J Urol. 1999, 162, 715–718. doi: 10.1097/00005392-199909010-00022. https://www. ncbi.nlm.nih.gov/pubmed/10458350 Wilson S.K., Delk J.R.: A new treatment for Peyronie’s disease: modeling the penis over an inflatable penile prosthesis. J Urol. 1994, 152 (4), 1121– 1123. doi: 10.1016/s0022-5347(17)32519-3. https://www.ncbi.nlm.nih. gov/pubmed/8072079 Winter C.C.: Cure of idiopathic priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology. 1976, 8 (4), 389– 391. doi: 10.1016/0090-4295(76)90498-2. https://www.ncbi.nlm.nih.gov/ pubmed/973296 Winter C.C., Khanna R.: Peyronie’s disease: results with dermo-jet injection of dexamethasone. J Urol. 1975, 114 (6), 898–900. doi: 10.1016/s0022- 5347(17)67169-6. https://www.ncbi.nlm.nih.gov/pubmed/1195471 Witt M.A., Goldstein I., Saenz de Tejada I., Greenfield A., Krane R.J.: Traumatic laceration of intracavernosal arteries: the pathophysiology of nonischemic, high flow, arterial priapism. J Urol. 1990, 143 (1), 129–132. doi: 10.1016/ s0022-5347(17)39889-0. https://www.ncbi.nlm.nih.gov/pubmed/2294241 Wyllie M.G., Powell J.A.: The role of local anaesthetics in premature ejaculation. BJU Int. 2012, 110, E943–948. doi: 10.1111/j.1464-410X.2012.11323.x. https://www.ncbi.nlm.nih.gov/pubmed/22758648 Xia Y., Li J., Shan G., Qian H., Wang T., Wu W. i wsp.: Relationship between premature ejaculation and depression: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016. 95, e4620. doi: 10.1097/ MD.0000000000004620. https://www.ncbi.nlm.nih.gov/pubmed/27583879 Yachia D.: Modified corporoplasty for the treatment of penile curvature. J Urol. 1990, 143 (1), 80–82. doi: 10.1016/s0022-5347(17)39871-3. https:// www.ncbi.nlm.nih.gov/pubmed/2294269 Yachia D., Beyar M., Aridogan I.A., Dascalu S.: The incidence of congenital penile curvature. J Urol. 1993, 150, 1478–1479. doi: 10.1016/s0022-5347(17)35816- 0. https://www.ncbi.nlm.nih.gov/pubmed/8411431 Yaxley J.W., Coughlin G.D., Chambers S.K., Occhipinti S., Samaratunga H., Zajdlewicz L. i wsp.: Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet. 2016, 388, 1057–1066. doi: 10.1016/S0140- 6736(16)30592-X. https://www.ncbi.nlm.nih.gov/pubmed/27474375 Yuan J., Desouza R., Westney O.L., Wang R.: Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Androl. 2008, 10 (1), 88–101. doi: 10.1111/j.1745-7262.2008.00314.x. https://www.ncbi. nlm.nih.gov/pubmed/18087648 Yuan J., Hoang A.N., Romero C.A., Lin H., Dai Y., Wang R.: Vacuum therapy in erectile dysfunction--science and clinical evidence. Int J Impot Res. 2010, 22 (4), 211–219. doi: 10.1038/ijir.2010.4. https://www.ncbi.nlm.nih.gov/ pubmed/20410903 Yuan J., Zhang R., Yang Z., Lee J., Liu Y., Tian J. i wsp.: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013, 63 (5), 902–912. doi: 10.1016/j.eururo.2013.01.012. https://www.ncbi. nlm.nih.gov/pubmed/23395275 Yuan J.Q., Mao C., Yang Z.Y., Fu X.H., Wong S.Y., Tang J.L.: A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. Asian J Androl. 2016, 18 (1), 60–65. doi: 10.4103/1008-682X.154304. https:// www.ncbi.nlm.nih.gov/pubmed/25966626 Yue F.G., Dong L., Hu T.T., Qu X.Y.: Efficacy of Dapoxetine for the Treatment of Premature Ejaculation: A Meta-analysis of Randomized Clinical Trials on Intravaginal Ejaculatory Latency Time, Patient-reported Outcomes, and Adverse Events. Urology. 2015, 85 (4), 856–861. doi: 10.1016/j.urology.2015.01.009. https://www.ncbi.nlm.nih.gov/pubmed/25817107 Zacharakis E., De Luca F., Raheem A.A., Garaffa G., Christopher N., Muneer A. i wsp.: Early insertion of a malleable penile prosthesis in ischaemic priapism allows later upsizing of the cylinders. Scan J Urol. 2015, 26: 1. https:// www.ncbi.nlm.nih.gov/pubmed/26116193 Zacharakis E., Garaffa G., Raheem A.A., Christopher A.N., Muneer A., Ralph D.J.: Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU Int. 2014, 114 (4), 576–581. doi: 10.1111/bju.12686. https://www.ncbi.nlm.nih.gov/pubmed/25383397 Zacharakis E., Raheem A.A., Freeman A., Skolarikos A., Garaffa G., Christopher A.N. i wsp.: The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J Urol. 2014, 191 (1), 164–168. doi: 10.1016/j.juro.2013.07.034. https://www.ncbi.nlm. nih.gov/pubmed/23892191 Zacharakis E., Ralph D.J., Walkden M., Muneer A.: Distal corpus cavernosum fibrosis and erectile dysfunction secondary to non-ischaemic priapism. Arch Ital Urol Androl. 2015, 87 (3), 258–259. doi: 10.4081/aiua.2015.3.258. https://www.ncbi.nlm.nih.gov/pubmed/26428655 Zarafonetis C.J., Horrax T.M.: Treatment of Peyronie’s disease with potassium para-aminobenzoate (potaba). J Urol. 1959, 81 (6), 770–772. doi: 10.1016/ s0022-5347(17)66108-1. https://www.ncbi.nlm.nih.gov/pubmed/13655401 Zargaroff S., Sharma V., Berhanu D., Pearl J.A., Meeks J.J., Dupree J.M. i wsp.: National trends in the treatment of penile prosthesis infections by explantation alone vs. immediate salvage and reimplantation. J Sex Med. 2014, 11 (4), 1078–1085. doi: 10.1111/jsm.12446. https://www.ncbi.nlm.nih. gov/pubmed/24628707 Zhang X.S., Wang Y.X., Huang X.Y., Leng J., Li Z., Han Y.F.: [Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation]. Zhonghua Nan Ke Xue. 2005, 11 (7), 520–522. https:// www.ncbi.nlm.nih.gov/pubmed/16078671 Zhang Y., Zheng T., Tu X., Chen X., Wang Z., Chen S. i wsp.: Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center. PLoS One. 2016, 11, e0153054. doi: 10.1371/journal.pone.0153054. https://www. ncbi.nlm.nih.gov/pubmed/27120096 Zhang Z., Xu Z., Dai Y., Chen Y.: Elevated serum homocysteine level as an independent risk factor for erectile dysfunction: a prospective pilot casecontrol study. Andrologia. 2017, 49 (6). doi: 10.1111/and.12684. https:// www.ncbi.nlm.nih.gov/pubmed/27709655 Zucchi A., Costantini E., Cai T., Cavallini G., Liguori G., Favilla V. i wsp.: Intralesional Injection of Hyaluronic Acid in Patients Affected with Peyronie’s Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study. Sex Med. 2016, 4 (2), e83–88. doi: 10.1016/j.esxm.2016.01.002. https:// www.ncbi.nlm.nih.gov/pubmed/26984291